
<html lang="en"     class="pb-page"  data-request-id="4a91b66e-12d2-4773-8733-dff895f8b840"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00228"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis" /></meta><meta name="dc.Creator" content="Qi  Qi" /></meta><meta name="dc.Creator" content="Obiamaka  Obianyo" /></meta><meta name="dc.Creator" content="Yuhong  Du" /></meta><meta name="dc.Creator" content="Haian  Fu" /></meta><meta name="dc.Creator" content="Shiyong  Li" /></meta><meta name="dc.Creator" content="Keqiang  Ye" /></meta><meta name="dc.Description" content="Asparagine endopeptidase (AEP), also called legumain, is highly expressed in various solid tumors, promoting cancer cell invasion, migration, and metastasis. It has been proposed to be a prognostic..." /></meta><meta name="Description" content="Asparagine endopeptidase (AEP), also called legumain, is highly expressed in various solid tumors, promoting cancer cell invasion, migration, and metastasis. It has been proposed to be a prognostic..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 18, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00228" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00228" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00228" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00228" /></link>
        
    
    

<title>Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00228" /></meta><meta property="og:title" content="Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0008.jpeg" /></meta><meta property="og:description" content="Asparagine endopeptidase (AEP), also called legumain, is highly expressed in various solid tumors, promoting cancer cell invasion, migration, and metastasis. It has been proposed to be a prognostic marker and therapeutic target for cancer treatment. However, an effective nonpeptide, small-molecule inhibitor against this protease has not yet been identified. Here we show that a family of xanthine derivatives selectively inhibit AEP and suppress matrix metalloproteinase (MMP) cleavage, leading to the inhibition of cancer metastasis. Through structure–activity relationship (SAR) analysis, we obtained an optimized lead compound (38u) that represses breast cancer invasion and migration. Chronic treatment of nude mice, which had been inoculated with MDA-MB-231 cells, with inhibitor 38u via oral administration robustly inhibits breast cancer lung metastasis in a dose-dependent manner, associated with blockade of MMP-2 by AEP. Therefore, our study supports that 38u might act as a potent and specific AEP inhibitor useful for cancer treatment." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00228"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00228">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00228&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00228&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00228&amp;href=/doi/10.1021/acs.jmedchem.7b00228" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7244-7255</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00151" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00164" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Qi">Qi Qi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Obiamaka++Obianyo">Obiamaka Obianyo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuhong++Du">Yuhong Du</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haian++Fu">Haian Fu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shiyong++Li">Shiyong Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keqiang++Ye">Keqiang Ye</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7657-8154" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Pathology and Laboratory Medicine <sup>‡</sup>Department of Pharmacology, Emory Chemical Biology Discovery Center Emory University School of Medicine Atlanta, Georgia 30322, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +(1) 404 712 2814. E-mail: <a href="/cdn-cgi/l/email-protection#157e6c705570787a676c3b707160"><span class="__cf_email__" data-cfemail="c3a8baa683a6aeacb1baeda6a7b6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00228&amp;href=/doi/10.1021%2Facs.jmedchem.7b00228" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7244–7255</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 18, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 March 2017</li><li><span class="item_label"><b>Published</b> online</span>18 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 September 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00228" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00228</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7244%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DQi%2BQi%252C%2BObiamaka%2BObianyo%252C%2BYuhong%2BDu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D17%26contentID%3Dacs.jmedchem.7b00228%26title%3DBlockade%2Bof%2BAsparagine%2BEndopeptidase%2BInhibits%2BCancer%2BMetastasis%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7255%26publicationDate%3DSeptember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00228"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1760</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00228" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Qi&quot;},{&quot;first_name&quot;:&quot;Obiamaka&quot;,&quot;last_name&quot;:&quot;Obianyo&quot;},{&quot;first_name&quot;:&quot;Yuhong&quot;,&quot;last_name&quot;:&quot;Du&quot;},{&quot;first_name&quot;:&quot;Haian&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Shiyong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Keqiang&quot;,&quot;last_name&quot;:&quot;Ye&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7244-7255&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00228&quot;},&quot;abstract&quot;:&quot;Asparagine endopeptidase (AEP), also called legumain, is highly expressed in various solid tumors, promoting cancer cell invasion, migration, and metastasis. It has been proposed to be a prognostic marker and therapeutic target for cancer treatment. However, an effective nonpeptide, small-molecule inhibitor against this protease has not yet been identified. Here we show that a family of xanthine derivatives selectively inhibit AEP and suppress matrix metalloproteinase (MMP) cleavage, leading to the inhibition of cancer metastasis. Through structure–activity relationship (SAR) analysis, we obtained an optimized lead compound (38u) that represses breast cancer invasion and migration. Chronic treatment of nude mice, which had been inoculated with MDA-MB-231 cells, with inhibitor 38u via oral administration robustly inhibits breast cancer lung metastasis in a dose-dependent manner, associated with blockade of MMP-2 by AEP. Therefore, our study supports that 38u might act as a potent and specific AEP inhibitor use&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00228&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00228" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00228&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00228" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00228&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00228" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00228&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00228&amp;href=/doi/10.1021/acs.jmedchem.7b00228" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00228" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00228" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00228%26sid%3Dliteratum%253Aachs%26pmid%3D28820254%26genre%3Darticle%26aulast%3DQi%26date%3D2017%26atitle%3DBlockade%2Bof%2BAsparagine%2BEndopeptidase%2BInhibits%2BCancer%2BMetastasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D17%26spage%3D7244%26epage%3D7255%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/jmcmar.2017.60.issue-17/20170914/jmcmar.2017.60.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Asparagine endopeptidase (AEP), also called legumain, is highly expressed in various solid tumors, promoting cancer cell invasion, migration, and metastasis. It has been proposed to be a prognostic marker and therapeutic target for cancer treatment. However, an effective nonpeptide, small-molecule inhibitor against this protease has not yet been identified. Here we show that a family of xanthine derivatives selectively inhibit AEP and suppress matrix metalloproteinase (MMP) cleavage, leading to the inhibition of cancer metastasis. Through structure–activity relationship (SAR) analysis, we obtained an optimized lead compound (<b>38u</b>) that represses breast cancer invasion and migration. Chronic treatment of nude mice, which had been inoculated with MDA-MB-231 cells, with inhibitor <b>38u</b> via oral administration robustly inhibits breast cancer lung metastasis in a dose-dependent manner, associated with blockade of MMP-2 by AEP. Therefore, our study supports that <b>38u</b> might act as a potent and specific AEP inhibitor useful for cancer treatment.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer cell metastasis is a complex process that involves the tumor microenvironment, which is a large contributor to the increased invasiveness and migratory character of neoplastic cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Malignant cells typically interact with a surrounding ecosystem of cells, including myeloid cells, fibroblasts, tumor-associated macrophages, and endothelial cells, to promote angiogenesis, degradation of the extracellular matrix, and cell motility.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Throughout tumor progression, many extracellular proteases are known to contribute to the changes that occur in the tumor microenvironment and those most commonly associated with aberrant proliferation and metastasis are the matrix metalloproteinases (MMPs).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The zinc-dependent endopeptidases are involved in a variety of cellular processes, including cell signaling, tissue remodeling, organ development, and inflammatory response.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> However, the capability of this enzyme family to degrade the extracellular matrix has implicated it in cancer cell invasion and metastasis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> For many years, these enzymes were considered to be a promising cancer drug target and metalloproteinase inhibitors were found to be efficacious in animal models, but unfortunately, they proved to be unsuccessful in human clinical trials.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The clinical failure of metalloproteinase inhibitors is believed to be due to the important roles of the enzyme family in such a wide range of biological processes and their ability to act as tumor suppressors under certain conditions.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">It has been demonstated that MMP-2 contributes migration and invasion in human breast cancer MDA-MB-231 and MDA-MB-435 cells.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> Therefore, additional research of MMPs has focused on their regulation in an effort to identify other potential drug target candidates. Asparagine endopeptidase (AEP, legumain) was found to activate MMP-2 by proteolytic removal of an N-terminal propeptide.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> AEP is a lysosomal cysteine endoprotease and is the only mammalian enzyme that cleaves C-terminally to asparagine residues.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> While only a limited quantity of AEP is detected in normal tissues, the enzyme is overexpressed on the cell surface and in cytoplasmic vesicles of solid tumors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The endoprotease activity of AEP has been associated with increased invasive and aggressive behavior of several cancers, including breast, prostate, colorectal, and gastric carcinomas.<a onclick="showRef(event, 'ref11 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref11 ref16 ref17 ref18">(11, 16-18)</a> Thus, it is possible that AEP inhibitors may represent a more promising cancer therapeutic than the aforementioned metalloproteinase inhibitors.</div><div class="NLM_p last">The aberrant expression of AEP in cancer cells has made the enzyme a target for prodrug therapy.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> For instance, an inhibitor of α(v)β(3) integrin was conjugated to an asparagine-containing peptide to ensure that the prodrug was selectively activated by AEP in acidic tumors and tumor microenvironments.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Additionally, the common cancer drug, doxorubicin, has been coupled to peptide-based inhibitors of AEP, and the conjugate was observed to selectively accumulate in murine breast tumor tissue, as opposed to kidney or liver, and reduce the size of the tumor.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The demonstrated efficacy of AEP-targeted prodrugs validates the high degree of selectivity for tumor tissues that can be achieved by AEP-specific compounds, thereby decreasing potential side effects and toxicity. However, peptide-based compounds tend to be unfavorable drug candidates because of their limited stability and bioavailability. Thus, we have sought to identify small-molecule inhibitors that specifically target AEP and potently abrogate its activity. Herein, we describe the characterization of a lead compound, termed compound <b>38</b>, from a high throughput screen; we explore its mechanism of inhibition and optimize the positive hit via SAR studies, which led to a second-generation inhibitor with enhanced druggable characteristics. We go on to provide evidence of its ability to preclude invasion and migration in vitro and impede metastasis in vivo, presumably through its inhibition of MMP-2 activation.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Compound <b>38</b> Inhibits AEP Activity</h3><div class="NLM_p">To identify small-molecule inhibitors of AEP, we designed an AEP enzymatic activity assay for high-throughput screen using AEP-rich mouse kidney lysates as the enzyme source.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Following confirmatory assays with purified AEP, we identified top hits and subsequent triaging produced a lead compound, termed compound <b>38</b>. A kinetic analysis of the small-molecule inhibitor indicated that compound <b>38</b> competitively inhibits AEP activity strongly, <i>K</i><sub>I</sub> = 105 ± 37 nM (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A,B). Substrate reversibility and DTT/<span class="smallcaps smallerCapital">l</span>-cysteine reversibility assays further showed the competitive inhibitive feature of compound <b>38</b> toward AEP activity (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Figures 1 and 2">Figures 1 and 2</a>). Time course inactivation assays produced nonlinear curves, indicating that the compound is a slow-binding inhibitor of AEP; the secondary plot of the rate constants against each inhibitor concentration demonstrates that AEP is inactivated very rapidly and potently, as the second-order rate constant, <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub>, for compound <b>38</b> is 8.9 × 10<sup>5</sup> min<sup>–1</sup>·M<sup>–1</sup> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C,D)</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Kinetic analysis of compound <b>38</b> inhibition of AEP. (A) Michaelis–Menten plots displaying competitive inhibition of AEP. The inhibition constant, <i>K</i><sub>I</sub>, was determined from the globally fit data. (B) Double reciprocal Lineweaver–Burk plots also displaying competitive inhibition. (C) Nonlinear progress curves obtained from the time course inactivation experiments, indicating that compound <b>38</b> is a slow-binding inhibitor of AEP. (D) A plot of the corrected <i>k</i><sub>obs</sub> values obtained from each curve in (B) versus the concentration of compound <b>38</b>, which enabled the calculation of the second-order rate constant, <i>k</i><sub>inact</sub> /<i>K</i><sub>I</sub>, to be determined to measure the potency of the inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The xanthine-containing compound also exhibited favorable in vitro ADMET characteristics; it was found to be stable in liver microsomes in the presence or absence of NADPH and did not significantly inhibit any of the major cytochrome P450 isozymes.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, its Caco-2 cell permeability was minimal, suggesting that the compound may not be readily absorbed upon oral administration<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Caco-2 Cell Permeability of Tested Compounds<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">A → B <i>P</i>app (10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">A → B <i>P</i>app (10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char="."><i>R</i><sub>E</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ranitidine</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">warfarin</td><td class="colsep0 rowsep0" align="char" char=".">35.5</td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">talinolol</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">16.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">20.3</td><td class="colsep0 rowsep0" align="char" char=".">18.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38D</b>-<b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38D</b>-<b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38D</b>-<b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td><td class="colsep0 rowsep0" align="char" char=".">30.5</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Note: A → B <i>P</i> app, transport in direction of apical to basolateral; A → B <i>P</i>app, transport in direction of basolateral to apical; <i>R</i><sub>E</sub>, efflux ratio</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure–Activity Relationship (SAR) Analysis of Compound <b>38</b></h3><div class="NLM_p">In an effort to improve the druggability of the compound, structure–activity relationship studies were performed with various compound <b>38</b> derivatives. One μM of each compound was incubated with 50 nM purified, active AEP and 5 μM substrate peptide, and the percentage of residual enzyme activity was calculated compared to a control reaction. <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> displays the results of this analysis. Substitution at the R<sub>7</sub> position alone with smaller hydrophobic alkane chains did not seem to affect the activity of the parent molecule. Interestingly, compound <b>38u</b>, which contains an electron-donating methoxy group in place of the chloride of the parent compound, has similar reactivity as compound <b>38</b>, suggesting that the electron-withdrawing −Cl is not critical for the effective inhibition of AEP. However, there is greater than a 2-fold loss in activity when nothing is placed in the para- position of the benzene ring, as in the case of compound <b>38k</b>. There was also a 5–6-fold loss of activity of the parent compound, when a ketone or diol group was substituted at the R<sub>7</sub> position, demonstrating that although some manipulations at this position can be tolerated while others cannot (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). Nonetheless, the simultaneous addition of a methyl or benzyl group at the nitrogen at R<sub>1</sub> and substitution of a small alkyl group or a bulky benzene-containing group at R<sub>7</sub> did not seem to have any deleterious effects on the compound’s inhibitory activity (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). Conversely, all of the observed alterations made to the thiol group of compound <b>38</b> had profoundly adverse effects on its inhibitory activity (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C), indicating that the thiol group is critical for its inhibitory activity. In addition, we also carried out the rapid elimination of swill (REOS) and pan assay interference compounds (PAINS) filter analysis. None of the compound has PAINS structure, and those compounds were identified as REOS due to the presence of the thiol group. Although xanthine and its derivatives has been reported for other activities, such as A2BAdoR (G-protein coupled receptors) antagonists<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and DPP (dipeptidyl peptidase)-4 inhibitor,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> no bioactivity of the compound has been reported except for <b>38o</b> (caffeine). Altogether, these results demonstrate that the R<sub>1</sub> and R<sub>7</sub> positions can be manipulated to generate second-generation inhibitors of compound <b>38</b> with more favorable qualities and potentially enhanced potency.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The SAR analysis of compound <b>38</b>. (A) The structures and percentages of residual AEP activity of the compound <b>38</b> derivatives, in which substitutions were made to the nitrogen in the R<sub>7</sub> position. (B) The structures and percentages of residual AEP activity of the compound <b>38</b> derivatives, in which substitutions were made to the nitrogens at the R<sub>7</sub> and R<sub>1</sub> positions. (C) The structures and percentages of residual AEP activity of the compound <b>38</b> derivatives, in which substitutions were made at the R<sub>7</sub>, R<sub>1</sub>, and R<sub>6</sub> positions in the xanthine ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Compound <b>38u</b> displays Potent Caco-2 Permeability and Inhibition Specificity</h3><div class="NLM_p">On the basis of the above SAR analysis and chemical availability, three of the compound <b>38</b> derivatives, <b>38p</b>, <b>38u</b>, and <b>38v</b>, were chosen for further characterization. Addition of alkyl groups on the R1 position in the xanthine ring was believed to increase the hydrophobic character, leading to higher Caco-2 permeability. Moreover, these derivatives possess the inhibitory activities similar to that of the parent compound. As expected, Caco-2 permeability assays revealed that the derivatives displayed much higher permeability than the parent compound <b>38</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compound <b>38u</b> exhibited the most favorable efflux:influx ratio of all of the derivatives tested; thus it might be the most bioavailable derivative.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The inhibitory activity of the derivatives was also assessed in more depth to ensure that their inhibitory potential was indeed comparable to the parent compound; inhibition assays revealed that they possessed submicromolar IC<sub>50</sub> values and that they inhibited AEP with about 2-fold increased potency compared to compound <b>38</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The derivatives also had similar, and in some cases improved, selectivity for AEP over other major cysteine proteases. Just like compound <b>38</b>, compounds <b>38p</b>, <b>38u</b>, and <b>38v</b> had IC<sub>50</sub> values that were greater than 200 μM against cathepsin-S (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Although compounds <b>38p</b> and <b>38u</b> were able to inhibit cathepsin-L, they inhibited AEP 500-fold and 1000-fold, respectively, more selectively. All of the compound <b>38</b> derivatives were less potent inhibitors of caspase-3 and caspase-8 and were therefore more specific for AEP as compared to the parent compound <b>38</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>38u</b> specifically inhibits AEP. (A) Structures of compound <b>38</b> and its derivatives with increased hydrophobicity. (B) IC<sub>50</sub> curves for compound <b>38</b> and its derivatives against pure AEP. (C) Inhibition specificity assay. IC<sub>50</sub> values of compound <b>38</b> and its derivatives against AEP and other related major cysteine proteases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Compound <b>38u</b> Inhibits Breast Cancer Cell Invasion in Vitro</h3><div class="NLM_p">Becaused compound <b>38u</b> displayed favorable, druggable characteristics and was able to strongly inhibit AEP, its potential as an anticancer drug was assessed, initially in a cellular model. The moderately and highly metastatic human breast cancer cell lines, MDA-MB-231 and MDA-MB-435, respectively, were used to determine the efficacy of the compound <b>38</b> derivative toward the inhibition of cancer cell invasion and migration. Cell proliferation assays showed that compound <b>38u</b> was not cytotoxic to either cell line (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A,B). For the invasion assays, breast cancer cells were seeded in matrigel-coated inserts, which were placed above wells containing fetal bovine serum as the chemoattractant, and various concentrations of the inhibitor was added to each insert. After the number of invading cells was counted, it was apparent that compound <b>38u</b> was able to inhibit the invasion in a dose-dependent manner. At 2 μM, <b>38u</b> inhibited approximately 75% of cell invasion of both breast cancer cell types (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A,B). Similarly, <b>38u</b> was able to inhibit the migration of about 25% of the less metastatic breast cancer cells, MDA-MB-231, whereas it inhibited about 40% of the more detrimental MDA-MB-435 cells from migrating in vitro (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A,B). AEP activities from cells treated by <b>38u</b> were also suppressed in a dose-dependent manner (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). To confirm the role of AEP in <b>38u</b> induced inhibition of cell invasion, we carried out invasion assay with cells treated by AEP siRNA. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D, AEP knockdown decreased cell invasion significantly and abolished the inhibitive actions of <b>38u</b>. Hence, AEP inhibitors block cancer cell invasion without impinging on the cell viability.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>38u</b> inhibits invasion in vitro. (A) Effect of compound <b>38u</b> on cell proliferation, invasion, and migration of MDA-MB-231 cells. Cell proliferation was determined by MTT assay, following incubation with the compound. (B) Effect of compound <b>38u</b> on cell proliferation, invasion, and migration of MDA-MB-435 cells. Cell proliferation was determined by MTT assay, following incubation with the compound. (C) Effect of compound <b>38u</b> on AEP activity in MDA-MB-231 and MDA-MB-435 cells. AEP activity were examined with lysate of cells treated by <b>38u</b> (D) Effect of compound <b>38u</b> on invasion of MDA-MB-231 and MDA-MB-435 cells treated by control and AEP siRNA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Compound <b>38u</b> Inhibits Breast Cancer Metastasis in Vivo</h3><div class="NLM_p">Because compound <b>38u</b> successfully attenuated the invasion and migration of MDA-MB-231 and MDA-MB-435 cells in vitro, the compound’s ability to inhibit the metastasis of breast tumor cells in vivo was subsequently examined. A murine model of breast cancer metastasis was developed by subcutaneously injecting MDA-MB-231 cells into the mammary fat pad of nude mice.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> Compound <b>38u</b> was administered to the mice via oral gavage at doses of 3 or 10 mg/kg, or vehicle alone was given to the control group. After 42 days of treatment, the lungs were assessed for the presence of metastatic nodules; 3 mg/kg of compound <b>38u</b> significantly decreased the number of nodules present on the mice, while the 10 mg/kg dosage almost completely prevented lung metastasis (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). There was no significant difference between the mammary tumor weight or volume between the control and drug-treated mice (data not shown). The percentage of mice with metastatic nodules on their lungs was 100% for the control mice and decreased to 33% for the mice that received the 3 mg/kg and 17% for the mice that received 10 mg/kg (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Although treatment with compound <b>38u</b> impeded breast cancer metastasis, no significant toxicity was observed, as demonstrated by the similarity in body weight between the control group and drug-treated mice (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). Pathological examination of various major organs, such as kidney, liver, and bone marrow, did not exhibit any significant amount of toxicity (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Moreover, complete blood count (CBC) analysis revealed no significant difference between the drug- and vehicle-treated mice (Supporting Information, <a class="ref internalNav" href="#notes-2" aria-label="Table 1">Table 1</a>). Nonetheless, there was a slight increase in the size of the spleen in the drug-treated mice (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C), fitting with previous observations that knockout of AEP leads to the splenomegaly.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>38u</b> prevents breast-to-lung metastasis in vivo. (A) Representative mouse lungs of animals treated with vehicle control or 3 or 10 mg/kg compound <b>38u</b>. Bottom panel depicts IHC staining. (B) Quantification of metastasized cancer nodules found on the treated and untreated mouse lungs demonstrates that significantly less nodules are present in the lungs of the drug-treated mice. (C) The proportion of mice exhibiting metastatic nodules in lungs decreased as the drug treatment dosage increased.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>38u</b> does not exhibit toxic effects in mice. (A) IHC sections of bone marrow, kidney, liver, and spleen from animals treated with vehicle control or 3 or 10 mg/kg of compound <b>38u</b> show similar results in vehicle and drug-treated tissues. (B) There was no significant difference in body weight observed in mice treated with vehicle control or compound <b>38u</b>. (C) The size of the liver remained similar in vehicle and drug-treated animals, however, the spleen was slightly enlarged in drug-treated animals as compared to control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Compound <b>38u</b> Inhibits Cleavage of MMP-2 in Vitro and in Vivo</h3><div class="NLM_p">Because the AEP inhibitor was able to prevent mammary tumor metastasis to the lungs of mice, we wondered whether this observation was due to the inhibition of AEP-mediated cleavage of matrix metalloproteinase, MMP-2.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> The linkage between the overexpression of AEP and the increased invasive and metastatic potential of cancer cells, along with the observation that MMP-2 is a major substrate of AEP, suggests that AEP may exacerbate the migratory potential of tumor tissues through its cleavage of MMP-2. Therefore, we used gelatin zymography to assess whether the inhibition of AEP was concomitant with the inhibition of MMP-2 cleavage and mammary tumor metastasis. Initially, compound <b>38u</b> was found to inhibit MMP-2 cleavage in the presence of purified active AEP in vitro. As the AEP inhibitor concentration gradually increased, MMP-2 cleavage progressively decreased (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). Similarly, endogenous MMP-2 cleavage was inhibited in a dose-dependent manner in MDA-MD-231 breast cancer cells, however, the cell viability was not affected by the drug (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B,C). AEP activities from the cells treated by <b>38u</b> were inhibited in a dose-dependent manner (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>D). To rule out the off-target effect of <b>38u</b>, MMP-2 cleavages in AEP knockdown cells were also examined. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>E, following AEP knockdown, inhibition of MMP-2 conversion were abolished. Interestingly, the ratio of cleaved MMP-2 to full-length MMP-2 (pro-MMP-2) was observed to decrease in the mammary tumor tissue of mice treated with 3 or 10 mg/kg compound <b>38u</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>F). Collectively, our data support the conclusion that compound <b>38u</b> inhibits AEP, subsequently inhibiting MMP-2 from being cleaved by AEP, resulting in suppression of the metastasis of the mammary tumor cells.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>38u</b> inhibits AEP cleavage of MMP-2 in vitro and in vivo. (A) Gelatin zymography was used to demonstrate that in the presence of AEP, MMP-2 is cleaved when only vehicle control is added to the reaction. In the presence of only 1 μM compound <b>38u</b>, there is a significant decrease in the observed cleavage of MMP-2 and at the highest drug dose, 10 μM, MMP-2 cleavage returns to basal levels, as observed in the absence of AEP. (B) Compound <b>38u</b> was administered to MDA-MB-231 cells, and the inhibition of endogenous MMP-2 cleavage was observed in the presence of 1, 2, 5, and 10 μM compound. (C) The cell viability was not affected by the different doses of drug used in the experiment. (D) Effect of compound <b>38u</b> on AEP activity in MDA-MB-231 cells. Cells were treated with indicated concentrations of <b>38u</b>. AEP activity were examined with lysate of cells treated by <b>38u</b>. (E) Effect of compound <b>38u</b> on MMP-2 cleavage in MDA-MB-231 cells treated by AEP siRNA. Depletion of AEP abolished Pro-MMP-2 cleavage, and <b>38u</b> lost its inhibitory effect on MMP-2 cleavage. (F) The ratio of cleaved MMP-2 to full-length MMP-2 (pro-MMP-2) significantly decreased in drug-treated mammary tumor tissue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The aberrant expression of AEP in cancer cells and on the surface of tumor-associated macrophages has been linked to the enzyme’s involvement in tumor development and metastasis.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> There is a plethora of evidence suggesting that AEP is a viable drug target and a biomarker for the diagnosis and progression of various cancers.<a onclick="showRef(event, 'ref16 ref21 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref16 ref21 ref31 ref32 ref33">(16, 21, 31-33)</a> Recent studies suggest that legumain expression could be a prognostic factor in patients with colorectal cancer, breast cancer, and ovarian cancer as well as a potential target for tumor therapy.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34-36)</a> Although peptide-based AEP-targeted prodrugs have been generated to specifically target common cancer drugs to cancer cells,<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> no small molecular AEP inhibitors have been reported. Here, we have described the identification and optimization of an AEP-specific, small-molecule inhibitor, compound <b>38u</b>, which has favorable ADME and toxicity characteristics. The inhibitor was also found to inhibit the migration and invasion of MDA-MB-231 and MDA-MB-435 breast cancer cells in vitro; however, it did not impede the proliferation of the cells. This is consistent with a previous report which showed that AEP does not affect the proliferation of SGC7901 human gastric cancer cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Our observations suggest that the inhibition of AEP alone may not be sufficient to eradicate primary tumors. Nonetheless, the efficacious inhibition of mammary tumor metastasis exhibited by <b>38u</b> suggests that AEP inhibitors would be successful in containing a primary tumor in its original environment and preventing the spread of tumorous tissues to more vital tissues. Thus, the AEP inhibitor may be utilized in conjunction with other known cancer therapeutics to eradicate the tumor at the primary site and simultaneously prevent the migration of the tumor cells to a secondary site. There have been reports of peptide-based AEP inactivators that, when conjugated to a nanoparticle and the anticancer compound, doxorubicin, are able to specifically target doxorubicin to cancer cells, mitigating any systemic toxicity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In this case, the AEP inhibitor is used as a targeting molecule to direct the cancer drug specifically to cancer cells by exploiting the fact that AEP is extracellularly expressed on tumors and in tumor microenvironments; interestingly, the inhibitor conjugated nanoparticle alone is not sufficient to significantly decrease the size of the primary tumor.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> However, the small size of compound <b>38u</b> and its oral bioavailability would be advantageous in conjunction with other orally bioavailable anticancer agents, such as the breast cancer drug, lapatinib, which would decrease the discomfort of drug administration to cancer patients and concomitantly protect them from the formation of metastatic lesions.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">The in vivo mouse studies showed that the orally active AEP inhibitor does not cause any undesirable toxicity other than a slight enlargement of the spleen (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Nonetheless, pathological examination of the spleen sections and CBC (complete blood chemistry) analysis did not reveal any demonstrable abnormality. Conceivably, the limited animal numbers (6 mice/group) in each dose of drug treatment group may somehow overstate the variation. However, we still cannot definitively exclude the possibility that <b>38u</b> may incur some unknown minor side effects in the spleen. Finally, we also determined that the small molecular AEP inhibitor is likely imparting its effects by inhibiting the cleavage and activation of MMP-2 (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). The matrix metalloproteinase is a known substrate of AEP, which cleaves a propeptide from the N-terminus of MMP-2, thus enabling the enzyme to degrade the extracellular matrix and promote more aggressive and invasive tumor growth.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> It is reported that promoting the processing of pro-MMP-2 to MMP-2 by a artificial receptor for pro-MMP-2 enhances metastatic ability of U87 cells.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Chang et. al showed that epigallocatechingallate suppressed metastasis uveal melanoma cells and showed that secreted MMP-2 activity was dose-dependently inhibited by epigallocatechingallate, whereas the MMP-2 expression at protein and mRNA levels was not affected.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p last">Studies have shown that, similarly to AEP, there is an overexpression of MMPs in the majority of human cancers, which is associated with an increase in invasive and metastatic behavior and an overall poor prognosis because patients overexpressing these enzymes tend to have shorter survival rates.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Additionally, in gastric cancer, the enhanced expression of MMP-2 has been most strongly correlated with a poor prognosis in comparison to any of the other MMPs.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The inhibition of MMPs has not proven to be a successful strategy in cancer treatment because of the existence of multiple isozymes and their importance in various cellular processes.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> MMP-2 cleavage in MDA-MB-231 cells and mammary tissue was inhibited by compound <b>38u</b> in a dose-dependent manner (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), suggesting that the AEP inhibitor successfully regulates the activity of MMP-2. It has been shown before that legumain could degrade fibronection, the main component of extracellular matrix.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Conceivably, inhibition of AEP by its small inhibitors may potently block the breast-to-lung metastasis in mice. Therefore, we have described a novel approach to prevent breast tumor metastasis through the attenuation of MMP-2 activity by precluding its activation through the inhibition of AEP. These results suggest that it may be plausible to prevent cancer metastasis or even proliferation in different types of cancer, in which other AEP substrates are overexpressed.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Reagents, Compounds, and Cells</h3><div class="NLM_p last">Asparagine endopeptidase (AEP, legumain) was obtained from Sino Biological. Biocoat Matrigel Invasion Inserts were purchased from BD Biosciences. SiRNAs against AEP (sc-60930 and control scrambled siRNA (SC-37007) were from Santa Cruze ln. All the compounds were purchased and the purities (≥95%) were confirmed by the commercial vendors. HPLC and LC/MS were usually employed to determine the purity of the commercial compounds. Detailed information (company name, catalogue number) is listed below: Compounds <b>38a</b> (BAS 00162656), <b>38b</b> (BAS 00162658), <b>38d</b> (BAS 00162664), <b>38e</b> (BAS 00286887), <b>38j</b> (BAS 00964091), and <b>38l</b> (BAS 00458008) were from Asinex. Compounds <b>38</b> (R279900), <b>38c</b> (S990175), <b>38f</b> (S315095), <b>38h</b> (L216518), and <b>38o</b> (C0750) were purchased from Sigma. Compounds <b>38g</b> (9007265), <b>38k</b> (5647063), <b>38p</b> (5216008), <b>38r</b> (5994286), <b>38y</b> (5839553), and <b>38z</b> (7646613) were from ChemBridge. Compounds <b>38i</b> (D090–0126), and <b>38m</b> (C066–5678) were from ChemDiv. Compounds <b>38q</b> (STK869195), <b>38s</b> (STK868784), <b>38t</b> (STK834902), <b>38w</b> (STK834600), <b>38x</b> (STK760770), and <b>38aa</b> (STK357374) were from Vitas M Laboratories. Compounds <b>38u</b> (F3260–0907) and <b>38v</b> (F3260–0165) were from Life Chemicals. MDA-MB-231 and MDA-MB-435 cells were a gift from Dr. Lily Yang, Winship Cancer Institute, Emory University School of Medicine; the cells were cultured in DMEM (supplemented with 10% FBS, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin) and incubated at 37 °C with 5% CO<sub>2</sub> in a humidified incubator.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> IC<sub>50</sub> Assays</h3><div class="NLM_p last">Various concentrations of the appropriate compound were incubated with AEP reaction buffer (50 mM sodium citrate pH 5.5, 0.1% CHAPS, 60 mM Na<sub>2</sub>HPO<sub>4</sub>, 1 mM EDTA, final pH 6.0) and peptide substrate, 10 μM Cbz-Ala-Ala-Asn-AMC (Bachem). The reaction was initiated upon addition of 50 nM AEP, and fluorescent product formation was monitored over 15 min. The IC<sub>50</sub> values were calculated from the following equation: Fractional Enzymatic Activity = 1/(1 + ([I]/IC<sub>50</sub>)), in which [I] = inhibitor concentration and IC<sub>50</sub> = inhibitor concentration that yields half-maximal activity. Data were analyzed with GraFit version 5.0.11 software package.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Inhibition Kinetics Assays</h3><div class="NLM_p last">To determine the inhibition constants and the mechanism by which compound <b>38</b> inhibits AEP, the steady-state kinetic parameters for the hydrolysis of the peptide substrate, Z-AAN-AMC, were determined in the absence or presence of increasing concentrations of inhibitor. In these assays, specified concentrations of the inhibitor were preincubated with substrate for 10 min at 37 °C, then 50 nM AEP was added to initiate the reaction, which was quenched after 10 min. The RFU values of the reaction product were converted to micromolar values with an AMC standard curve, and the final reaction rates were plotted against substrate concentration and globally fit to equations representative of competitive inhibition (<a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>), noncompetitive inhibition (<a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>), mixed inhibition (<a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>), and uncompetitive inhibition (<a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>) using a nonlinear least fit squares approach by GraFit version 5.0.11.<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/jm-2017-00228n_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span><span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/jm-2017-00228n_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span><span class="NLM_disp-formula" id="eq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/jm-2017-00228n_m003.gif" alt="" /></img><span class="labelSpan">(3)</span></span><span class="NLM_disp-formula" id="eq4"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/jm-2017-00228n_m004.gif" alt="" /></img><span class="labelSpan">(4)</span></span>In the equations, <i>K</i><sub>ii</sub> is the intercept <i>K</i><sub>i</sub>, and <i>K</i><sub>is</sub> is the slope <i>K</i><sub>i</sub>. The mode of the inhibition induced by the compounds on AEP was determined by the best fit of the data to <a class="ref internalNav" href="#eq1" aria-label="eqs 1">eqs 1</a>–<a class="ref internalNav" href="#eq4" aria-label="4">4</a>. Visual inspection of the fits, and a comparison of the standard errors, was used to confirm these assignments.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Time Course Inactivation Assays</h3><div class="NLM_p last">Progress curves were generated by incubating 5 μM Z-AAN-AMC and the specified concentration of inhibitor in assay buffer at 37 °C for 10 min. The reaction was initiated by the addition of 50 nM AEP and quenched after 10 min. The concentration of the product was determined from an AMC standard curve, and the data was fit by nonlinear regression. Because the curves were nonlinear, they were fit to <a class="ref internalNav" href="#eq5" aria-label="eq 5">eq 5</a>, using the GraFit version 5.0.11 software package,<span class="NLM_disp-formula" id="eq5"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/jm-2017-00228n_m005.gif" alt="" /></img><span class="labelSpan">(5)</span></span>where <i>v</i><sub>i</sub> is the initial velocity, <i>k</i><sub>obs·app</sub> is the apparent pseudo-first-order rate constant for inactivation, and <i>t</i> is time. <a class="ref internalNav" href="#eq6" aria-label="Equation 6">Equation 6</a>,<span class="NLM_disp-formula" id="eq6"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/jm-2017-00228n_m006.gif" alt="" /></img><span class="labelSpan">(6)</span></span>was used to correct the apparent pseudo-first-order inactivation rate constants, obtained from this analysis, for substrate concentration and the pseudo-first-order inactivation rate constants, i.e., <i>k</i><sub>obs</sub>, thus obtained, were plotted against the tested inhibitor concentrations. As the data are consistent with a two-step mechanism of inactivation, they were fit to <a class="ref internalNav" href="#eq7" aria-label="eq 7">eq 7</a>,<span class="NLM_disp-formula" id="eq7"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/jm-2017-00228n_m007.gif" alt="" /></img><span class="labelSpan">(7)</span></span>using the GraFit version 5.0.11 software, where <i>K</i><sub>I</sub> is the concentration of inactivator that yields half-maximal inactivation, <i>k</i><sub>inact</sub> is the maximal rate of inactivation, and [I] is the concentration of inactivator.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Caco-2 Permeability Assay</h3><div class="NLM_p last">CaCo-2 cells grown in tissue culture flasks are trypsinized, suspended in medium, and the suspensions applied to wells of a Millipore 96-well Caco-2 plate. The cells were allowed to grow and differentiate for 3 weeks, feeding at 2-day intervals. For apical to basolateral (A → B) permeability, the test agent was added to the apical (A) side and amount of permeation was determined on the basolateral (B) side; for basolateral to apical (B > A) permeability, the test agent was added to the B side and the amount of permeation was determine on the A side. The A-side buffer contains 100 μM Lucifer yellow dye, in transport buffer (1.98 g/L glucose in 10 mM HEPES, 1× Hank’s Balanced Salt Solution), pH 6.5, and the B-side buffer is transport buffer, pH 7.4. CaCo-2 cells were incubated with these buffers for 2 h, and the receiver side buffer was removed for analysis by LC/MS/MS. Cells were incubated with 10 μM of each compound in buffer for 2 h, and the receiver side buffer was removed for analysis by LC/MS/MS. Efflux ratio <i>R</i><sub>E</sub> > 2 indicates a significant efflux activity and indication of potential substrate for PGP or other active transporters.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Cell Viability Assay</h3><div class="NLM_p last">Cells were seeded and cultured in 96-well plates (4000 cells/well). The next day, the medium was replaced with fresh medium containing different concentrations of the drugs or vehicle controls. The cells were then incubated at 37 °C for the indicated times. After treatment, the cells were incubated for another 4 h with 0.5 mg/mL MTT solution at 37 °C. The culture medium was discarded, and 0.1 mL DMSO was used to dissolve precipitate. The absorbance was measured at 570 nm using an automated microplated reader (Synergy 2, BioTek, VT, USA).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chamber Invasion and Migration Assay</h3><div class="NLM_p last">Invasion of cells through Matrigel was determined using a Transwell system (10 mm diameter, 8 μm pore size with polycarbonate membrane; Corning Costar). Briefly, cells (3 × 10<sup>4</sup>) were suspended in serum free medium with different concentrations of drug and seeded onto Matrigel-coated transwell chamber. Medium with 5% serum was used as a chemoattractant in the lower chambers. After desired times of incubation at 37 °C under 5% CO<sub>2</sub>/95% air atmosphere, medium was aspirated, and cells on the upper side of the membrane were removed with a cotton swab. The invading cells on the bottom of the filter were stained with 0.5% crystal violet in 25% methanol and quantified under invert microscope. In the transwell chamber migration assay, the BD Falcon Cell Culture Insert System containing membranes with 8 μm pore size was utilized in the assay; l.5 × 10<sup>4</sup> cells were suspended in serum free medium with different concentrations of drug and seeded onto 10 mm upper chamber of transwell system. Medium with 5% serum and same concentrations of drugs in corresponding upper chambers was added to the lower chamber. After a fixed time of incubation, the migration cells were stained and quantified as in the invasion assay.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vivo Spontaneous Metastasis Assay</h3><div class="NLM_p last">MDA-MB-231 cells were trypsinized and resuspended in serum free media at a density of 1 × 10<sup>7</sup>/mL and implanted into the mammary fat pad of the mice (200 μL/mouse). When the volumes of xenografts reached to 100 mm<sup>3</sup>, mice were randomized to receive vehicle control (12 mice per group) or tested compounds (six mice per group). Test compound or vehicle was then administered orally for 42 consecutive days. Tumor volume in mm<sup>3</sup> was determined using the formula (length × width<sup>2</sup>)/2, where length was the longest axis and width being the measurement at right angles to the length. Then 24 h after the last drug administration, the animals were sacrificed and tumors/orgns were collected for various experiments. Animals were maintained in a pathogen-freee environment, and procedures were operated in accordace with Emory Institutional Animal Care and Use Committee guidelines. For lung metastasis, after the mice were killed, the lungs were removed, washed, and fixed with Bouin’s solution for 24 h and the number of the tumor nodules on the whole surface of the lungs was counted under a dissecting microscope. Sections of the lungs were stained with hematoxylin and eosin (HE) to confirm the formation of metastases.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Gelatin Zymography Assay</h3><div class="NLM_p last">Gelatinase-containing samples were dissolved in Laemmli sample buffer in the absence of reducing agents and electrophoresed in 8% polyacrylamide SDS gels copolymerized with gelatin (1 mg/mL). Following electrophoresis, the gels were washed twice (30 min each time) and once in calcium assay buffer (40 mM Tris, 0.2 M NaCl, 10 mM CaCl<sub>2</sub>, pH 7.5) and then incubated in the calcium assay buffer at 37 °C for certain times with gently shaking. Gels were then fixed in 45% methanol/10% glacial acidic acid containing 0.5% Commassie Blue G-250 for 1 h, followed by destaining with 10% acetic acid, 10% methanol. Enzyme-digested regions were observed as white bands against a blue background. Zones of enzymatic activity were seen as negatively stained bands.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Statistical Analysis</h3><div class="NLM_p last">For statistical analysis, data shown in the study were obtained in at least two independent experiments performed in a parallel manner unless otherwise indicated, which are presented as mean ± SD. Statistical evaluation was carried out by Student’s <i>t</i> test or one-way ANOVA. Significance of difference was indicated as *<i>P</i> < 0.05 and **<i>P</i> < 0.01. The statistical analysis was performed by program Prism (GraphPad Software, La Jolla, CA).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00228">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00228" class="ext-link">10.1021/acs.jmedchem.7b00228</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Complete blood count (CBC) of vehicle and compound <b>38u</b> treated nude mice; substrate reversibility of compound <b>38</b> toward AEP; DTT and <span class="smallcaps smallerCapital">l</span>-cysteine reversiblitiy of compound <b>38</b> toward AEP (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00228/suppl_file/jm7b00228_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">(Molecular formula strings<a href="/doi/suppl/10.1021/acs.jmedchem.7b00228/suppl_file/jm7b00228_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00228/suppl_file/jm7b00228_si_001.pdf">jm7b00228_si_001.pdf (84.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00228/suppl_file/jm7b00228_si_002.csv">jm7b00228_si_002.csv (1.75 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00228" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keqiang Ye</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pathology and Laboratory Medicine ‡Department of Pharmacology, Emory
Chemical Biology Discovery Center Emory
University School of Medicine Atlanta, Georgia 30322, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7657-8154" title="Orcid link">http://orcid.org/0000-0002-7657-8154</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#177c6e7257727a78656e39727362"><span class="__cf_email__" data-cfemail="2f44564a6f4a42405d56014a4b5a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Qi</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pathology and Laboratory Medicine ‡Department of Pharmacology, Emory
Chemical Biology Discovery Center Emory
University School of Medicine Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Obiamaka Obianyo</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pathology and Laboratory Medicine ‡Department of Pharmacology, Emory
Chemical Biology Discovery Center Emory
University School of Medicine Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuhong Du</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pathology and Laboratory Medicine ‡Department of Pharmacology, Emory
Chemical Biology Discovery Center Emory
University School of Medicine Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haian Fu</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pathology and Laboratory Medicine ‡Department of Pharmacology, Emory
Chemical Biology Discovery Center Emory
University School of Medicine Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shiyong Li</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pathology and Laboratory Medicine ‡Department of Pharmacology, Emory
Chemical Biology Discovery Center Emory
University School of Medicine Atlanta, Georgia 30322, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Q.Q. and O.O. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e1907-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work is supported by a grant from National Institute of Health (RO1, CA186918) to K.Y. H.F. is a GRA/Georgia Cancer Coalition Distinguished Cancer Scholar. The high throughput screening was carried out at the Emory Chemical Biology Discovery Center.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> Abbreviations Used</h2><tr><td class="NLM_term">AEP</td><td class="NLM_def"><p class="first last">asparagine endopeptidase</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinases</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">REOS</td><td class="NLM_def"><p class="first last">rapid elimination of swill</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan assay interference compounds</p></td></tr><tr><td class="NLM_term">DPP</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">CBC</td><td class="NLM_def"><p class="first last">complete blood chemistry</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Coghlin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, G. I.</span><span> </span><span class="NLM_article-title">Current and emerging concepts in tumour metastasis</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1002/path.2727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1002%2Fpath.2727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=20681009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2010&pages=1-15&author=C.+Coghlinauthor=G.+I.+Murray&title=Current+and+emerging+concepts+in+tumour+metastasis&doi=10.1002%2Fpath.2727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current and emerging concepts in tumour metastasis</span></div><div class="casAuthors">Coghlin, Caroline; Murray, Graeme I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Disseminated cancer accounts for most deaths due to malignancy.  Despite this, research has focused predominantly on tumor development and progression at the primary site.  Recently, attention has shifted towards the field of tumor metastasis.  Several new and exciting concepts that have emerged in the past few years may shed light on this complex area.  The established canonical theory of tumor metastasis, as a process emerging from a stepwise accumulation of genetic events fuelled by clonal evolution, has been challenged.  New evidence suggests that malignant cells can disseminate at a much earlier stage than previously recognized in tumorigenesis.  These findings have direct relevance to clin. practice and shed new light on tumor biol.  Gene-profiling studies support this theory, suggesting that metastatic ability may be an innate property shared by the bulk of cells present early in a developing tumor mass.  There is a growing recognition of the importance of host factors outside the primary site in the development of metastatic disease.  The role of the 'pre-metastatic niche' is being defined and with this comes a new understanding of the function of bone marrow-derived progenitor cells in directing the dissemination of malignant cells to distant sites.  Current research has highlighted the crucial roles played by non-neoplastic host cells within the tumor microenvironment in regulating metastasis.  These new concepts have wide-ranging implications for our overall understanding of tumor metastasis and for the development of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMUNr7v0dAB7Vg90H21EOLACvtfcHk0lgqWgqd5vgUjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnurzO&md5=91ce24314a2f19849cc4213c656f0b6a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fpath.2727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2727%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlin%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DG.%2BI.%26atitle%3DCurrent%2520and%2520emerging%2520concepts%2520in%2520tumour%2520metastasis%26jtitle%3DJ.%2520Pathol.%26date%3D2010%26volume%3D222%26spage%3D1%26epage%3D15%26doi%3D10.1002%2Fpath.2727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Coussens, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">Inflammation and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.1038/nature01322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2Fnature01322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=12490959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFygtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2002&pages=860-867&author=L.+M.+Coussensauthor=Z.+Werb&title=Inflammation+and+cancer&doi=10.1038%2Fnature01322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and cancer</span></div><div class="casAuthors">Coussens, Lisa M.; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">6917</span>),
    <span class="NLM_cas:pages">860-867</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent data have expanded the concept that inflammation is a crit. component of tumor progression.  Many cancers arise from sites of infection, chronic irritation and inflammation.  It is now becoming clear that the tumor microenvironment, which is largely orchestrated by inflammatory cells, is an indispensable participant in the neoplastic process, fostering proliferation, survival and migration.  In addn., tumor cells have co-opted some of the signaling mols. of the innate immune system, such as selectins, chemokines and their receptors for invasion, migration and metastasis.  These insights are fostering new anti-inflammatory therapeutic approaches to cancer development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3OArXFf_lrVg90H21EOLACvtfcHk0lhKeVLONTac5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFygtb4%253D&md5=8861c61ab0c2ea67a1c853803c272412</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature01322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01322%26sid%3Dliteratum%253Aachs%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DInflammation%2520and%2520cancer%26jtitle%3DNature%26date%3D2002%26volume%3D420%26spage%3D860%26epage%3D867%26doi%3D10.1038%2Fnature01322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kessenbrock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plaks, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases: regulators of the tumor microenvironment</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.cell.2010.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=20371345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2010&pages=52-67&author=K.+Kessenbrockauthor=V.+Plaksauthor=Z.+Werb&title=Matrix+metalloproteinases%3A+regulators+of+the+tumor+microenvironment&doi=10.1016%2Fj.cell.2010.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: regulators of the tumor microenvironment</span></div><div class="casAuthors">Kessenbrock, Kai; Plaks, Vicki; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-67</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Extracellular proteolysis mediates tissue homeostasis.  In cancer, altered proteolysis leads to unregulated tumor growth, tissue remodeling, inflammation, tissue invasion, and metastasis.  The matrix metalloproteinases (MMPs) represent the most prominent family of proteinases assocd. with tumorigenesis.  Recent technol. developments have markedly advanced our understanding of MMPs as modulators of the tumor microenvironment.  In addn. to their role in extracellular matrix turnover and cancer cell migration, MMPs regulate signaling pathways that control cell growth, inflammation, or angiogenesis and may even work in a nonproteolytic manner.  These aspects of MMP function are reorienting our approaches to cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAwNenyy027LVg90H21EOLACvtfcHk0lhKeVLONTac5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgtb4%253D&md5=fb7ee4c41ef31db0310b985e87bcdb94</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DKessenbrock%26aufirst%3DK.%26aulast%3DPlaks%26aufirst%3DV.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DMatrix%2520metalloproteinases%253A%2520regulators%2520of%2520the%2520tumor%2520microenvironment%26jtitle%3DCell%26date%3D2010%26volume%3D141%26spage%3D52%26epage%3D67%26doi%3D10.1016%2Fj.cell.2010.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Husemann, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geigl, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musiani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghart, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eils, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riethmuller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C. A.</span><span> </span><span class="NLM_article-title">Systemic spread is an early step in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1016/j.ccr.2007.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.ccr.2007.12.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=58-68&author=Y.+Husemannauthor=J.+B.+Geiglauthor=F.+Schubertauthor=P.+Musianiauthor=M.+Meyerauthor=E.+Burghartauthor=G.+Forniauthor=R.+Eilsauthor=T.+Fehmauthor=G.+Riethmullerauthor=C.+A.+Klein&title=Systemic+spread+is+an+early+step+in+breast+cancer&doi=10.1016%2Fj.ccr.2007.12.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DHusemann%26aufirst%3DY.%26aulast%3DGeigl%26aufirst%3DJ.%2BB.%26aulast%3DSchubert%26aufirst%3DF.%26aulast%3DMusiani%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DBurghart%26aufirst%3DE.%26aulast%3DForni%26aufirst%3DG.%26aulast%3DEils%26aufirst%3DR.%26aulast%3DFehm%26aufirst%3DT.%26aulast%3DRiethmuller%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DC.%2BA.%26atitle%3DSystemic%2520spread%2520is%2520an%2520early%2520step%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D58%26epage%3D68%26doi%3D10.1016%2Fj.ccr.2007.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Liotta, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tryggvason, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbisa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafie, S.</span><span> </span><span class="NLM_article-title">Metastatic potential correlates with enzymatic degradation of basement membrane collagen</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1038/284067a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2F284067a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=6243750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaL3cXktVGmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1980&pages=67-68&author=L.+A.+Liottaauthor=K.+Tryggvasonauthor=S.+Garbisaauthor=I.+Hartauthor=C.+M.+Foltzauthor=S.+Shafie&title=Metastatic+potential+correlates+with+enzymatic+degradation+of+basement+membrane+collagen&doi=10.1038%2F284067a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metastatic potential correlates with enzymic degradation of basement membrane collagen</span></div><div class="casAuthors">Liotta, L. A.; Tryggvason, K.; Garbisa, S.; Hart, Ian; Foltz, C. M.; Shafie, S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">5751</span>),
    <span class="NLM_cas:pages">67-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The metastatic potential of variants of B16 melanoma and T241 sarcoma cell lines correlated with their ability to release sol. radioactivity from costar tissue culture cluster wells coated with 14C-proline-labeled type IV basement membrane collagen.  Metastatic potential was also correlated with the ability of trypsin-activated media from cultures of these tumors to enzymically digest labeled type IV collagen in soln.  Metastatic cells may differ quant. from normal cells in their formation of this collagenase, and its activity might therefore provide an in vitro marker for the metastatic potential of malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_1n5IN-gqD7Vg90H21EOLACvtfcHk0liNQuftKprm6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktVGmsbw%253D&md5=53353504bbe47d3390c02c34053d3ed6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F284067a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F284067a0%26sid%3Dliteratum%253Aachs%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26aulast%3DTryggvason%26aufirst%3DK.%26aulast%3DGarbisa%26aufirst%3DS.%26aulast%3DHart%26aufirst%3DI.%26aulast%3DFoltz%26aufirst%3DC.%2BM.%26aulast%3DShafie%26aufirst%3DS.%26atitle%3DMetastatic%2520potential%2520correlates%2520with%2520enzymatic%2520degradation%2520of%2520basement%2520membrane%2520collagen%26jtitle%3DNature%26date%3D1980%26volume%3D284%26spage%3D67%26epage%3D68%26doi%3D10.1038%2F284067a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Coussens, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fingleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisian, L. M.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase inhibitors and cancer: trials and tribulations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span><span class="refDoi"> DOI: 10.1126/science.1067100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1126%2Fscience.1067100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=11923519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD38XisFSmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=2387-2392&author=L.+M.+Coussensauthor=B.+Fingletonauthor=L.+M.+Matrisian&title=Matrix+metalloproteinase+inhibitors+and+cancer%3A+trials+and+tribulations&doi=10.1126%2Fscience.1067100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer therapy: matrix metalloproteinase inhibitors and cancer: trials and tribulations</span></div><div class="casAuthors">Coussens, Lisa M.; Fingleton, Barbara; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">5564</span>),
    <span class="NLM_cas:pages">2387-2392</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  For at least 30 yr, matrix metalloproteinases (MMPs) have been heralded as promising targets for cancer therapy on the basis of their massive up-regulation in malignant tissues and their unique ability to degrade all components of the extracellular matrix.  Preclin. studies testing the efficacy of MMP suppression in tumor models were so compelling that synthetic metalloproteinase inhibitors (MPI) were rapidly developed and routed into human clin. trials.  The results of these trials have been disappointing.  Here we review the studies that brought MPI into clin. testing and discuss the design and outcome of the trials in light of new information about the cellular source, substrates, and mode of action of MMPs at different stages of tumor progression.  The important lessons learned from the MPI experience may be of great value for future studies of MPI and for cancer drug development in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquzqvwAiv5frVg90H21EOLACvtfcHk0liNQuftKprm6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisFSmtb0%253D&md5=be0d4cfc46c6c451a2374e3545cb4ec6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1067100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1067100%26sid%3Dliteratum%253Aachs%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26aulast%3DFingleton%26aufirst%3DB.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DMatrix%2520metalloproteinase%2520inhibitors%2520and%2520cancer%253A%2520trials%2520and%2520tribulations%26jtitle%3DScience%26date%3D2002%26volume%3D295%26spage%3D2387%26epage%3D2392%26doi%3D10.1126%2Fscience.1067100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ukaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, K.</span><span> </span><span class="NLM_article-title">Inhibition of MMP-2-mediated cellular invasion by NF-kappaB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">485</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2017.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.bbrc.2017.02.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2017&pages=76-81&author=T.+Ukajiauthor=Y.+Linauthor=S.+Okadaauthor=K.+Umezawa&title=Inhibition+of+MMP-2-mediated+cellular+invasion+by+NF-kappaB+inhibitor+DHMEQ+in+3D+culture+of+breast+carcinoma+MDA-MB-231+cells%3A+A+model+for+early+phase+of+metastasis&doi=10.1016%2Fj.bbrc.2017.02.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2017.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2017.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DUkaji%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DUmezawa%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520MMP-2-mediated%2520cellular%2520invasion%2520by%2520NF-kappaB%2520inhibitor%2520DHMEQ%2520in%25203D%2520culture%2520of%2520breast%2520carcinoma%2520MDA-MB-231%2520cells%253A%2520A%2520model%2520for%2520early%2520phase%2520of%2520metastasis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D485%26spage%3D76%26epage%3D81%26doi%3D10.1016%2Fj.bbrc.2017.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, S.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase 2 regulates MDAMB231 breast cancer cell invasion induced by active mammalian diaphanous-related formin 1</span> <span class="citation_source-journal">Mol. Med. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.3892/mmr.2016.5282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.3892%2Fmmr.2016.5282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=27177153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFejtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=277-282&author=D.+Kimauthor=S.+Rhee&title=Matrix+metalloproteinase+2+regulates+MDAMB231+breast+cancer+cell+invasion+induced+by+active+mammalian+diaphanous-related+formin+1&doi=10.3892%2Fmmr.2016.5282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-2 regulates MDA-MB-231 breast cancer cell invasion induced by active mammalian diaphanous-related formin 1</span></div><div class="casAuthors">Kim, Daehwan; Rhee, Sangmyung</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Mammalian diaphanous-related formin 1 (mDia1) was initially identified as a Rho GTPase effector involved in the progression of various diseases, including types of cancer.  However, the precise underlying mol. mechanism of mDia1-mediated cancer cell invasion remains to be elucidated.  In the present study, mDia1 expression was demonstrated to be upregulated in tissues from a no. of cancer types, including kidney, prostate, and breast cancer using immunohistochem. anal.  Forced expression of a constitutively active (CA) form of mDia1 induces invasion, as measured by Transwell invasion assay, of MDA-MB-231 cells, which is a highly invasive breast cancer cell line, and this effect was markedly impaired by matrix metalloproteinase (MMP)-2 silencing.  Furthermore, the present study demonstrated that overexpression of the CA form of mDia1 leads to the induction of invasive ability in MCF-7 cells, which is a non-invasive breast cancer cell line, as a result of increased MMP-2 activity.  Thus, the results of the current study suggest that mDia1 is an important regulator of breast cancer cell invasion and that this effect may be mediated by MMP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkg0LNdh4EyrVg90H21EOLACvtfcHk0ljio9k4dhz6xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFejtLfE&md5=2033e637e174c1f102643976da607e67</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2016.5282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2016.5282%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DRhee%26aufirst%3DS.%26atitle%3DMatrix%2520metalloproteinase%25202%2520regulates%2520MDAMB231%2520breast%2520cancer%2520cell%2520invasion%2520induced%2520by%2520active%2520mammalian%2520diaphanous-related%2520formin%25201%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2016%26volume%3D14%26spage%3D277%26epage%3D282%26doi%3D10.3892%2Fmmr.2016.5282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Qi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span> </span><span class="NLM_article-title">Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis</span> <span class="citation_source-journal">J. Mol. Med. (Heidelberg, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span><span class="NLM_x">–</span> <span class="NLM_lpage">1377</span><span class="refDoi"> DOI: 10.1007/s00109-008-0398-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1007%2Fs00109-008-0398-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=18777017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCmsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=1367-1377&author=Q.+Qiauthor=H.+Guauthor=Y.+Yangauthor=N.+Luauthor=J.+Zhaoauthor=W.+Liuauthor=H.+Lingauthor=Q.+D.+Youauthor=X.+Wangauthor=Q.+Guo&title=Involvement+of+matrix+metalloproteinase+2+and+9+in+gambogic+acid+induced+suppression+of+MDA-MB-435+human+breast+carcinoma+cell+lung+metastasis&doi=10.1007%2Fs00109-008-0398-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis</span></div><div class="casAuthors">Qi, Qi; Gu, Hongyan; Yang, Yong; Lu, Na; Zhao, Jie; Liu, Wei; Ling, Hua; You, Qi-dong; Wang, Xiaotang; Guo, Qinglong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1367-1377</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cancer cell invasion is one of the crucial events in local spreading, growth, and metastasis of tumors.  The present study investigated the antiinvasive and antimetastatic action of gambogic acid (GA) in MDA-MB-435 human breast carcinoma cells.  GA caused a concn.-dependent suppression of cell invasion through Matrigel and significantly inhibited lung metastases of the cells transplanted in vivo.  The potent effects of GA have been attributed to its ability to reduce the expression of matrix metalloproteinases (MMP) 2 and 9 in vitro and in vivo both at the protein and mRNA levels, which were assocd. with protein kinase C (PKC) signaling pathway as supported by the diminished antiinvasive effect of GA in the presence of specific activator of the pathway.  Collectively, our data demonstrated that GA exhibited antiinvasion properties on highly invasive cancer cells via PKC mediated MMP-2/9 expression inhibition.  This indicated that GA can be served as a potential novel therapeutic candidate for the treatment of cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJMqc8YoYXgbVg90H21EOLACvtfcHk0ljio9k4dhz6xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCmsrzI&md5=a2b8992d1f2054b750d29c86464570c5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00109-008-0398-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-008-0398-z%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLing%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DQ.%26atitle%3DInvolvement%2520of%2520matrix%2520metalloproteinase%25202%2520and%25209%2520in%2520gambogic%2520acid%2520induced%2520suppression%2520of%2520MDA-MB-435%2520human%2520breast%2520carcinoma%2520cell%2520lung%2520metastasis%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2008%26volume%3D86%26spage%3D1367%26epage%3D1377%26doi%3D10.1007%2Fs00109-008-0398-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Munoz-Najar, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neurath, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vumbaca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, K. P.</span><span> </span><span class="NLM_article-title">Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2379</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span><span class="refDoi"> DOI: 10.1038/sj.onc.1209273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2Fsj.onc.1209273" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=2379-2392&author=U.+M.+Munoz-Najarauthor=K.+M.+Neurathauthor=F.+Vumbacaauthor=K.+P.+Claffey&title=Hypoxia+stimulates+breast+carcinoma+cell+invasion+through+MT1-MMP+and+MMP-2+activation&doi=10.1038%2Fsj.onc.1209273"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209273%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Najar%26aufirst%3DU.%2BM.%26aulast%3DNeurath%26aufirst%3DK.%2BM.%26aulast%3DVumbaca%26aufirst%3DF.%26aulast%3DClaffey%26aufirst%3DK.%2BP.%26atitle%3DHypoxia%2520stimulates%2520breast%2520carcinoma%2520cell%2520invasion%2520through%2520MT1-MMP%2520and%2520MMP-2%2520activation%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D2379%26epage%3D2392%26doi%3D10.1038%2Fsj.onc.1209273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gawenda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traub, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luck, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreipe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Wasielewski, R.</span><span> </span><span class="NLM_article-title">Legumain expression as a prognostic factor in breast cancer patients</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1007/s10549-006-9311-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1007%2Fs10549-006-9311-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=17028987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhslCltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=1-6&author=J.+Gawendaauthor=F.+Traubauthor=H.+J.+Luckauthor=H.+Kreipeauthor=R.+von+Wasielewski&title=Legumain+expression+as+a+prognostic+factor+in+breast+cancer+patients&doi=10.1007%2Fs10549-006-9311-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Legumain expression as a prognostic factor in breast cancer patients</span></div><div class="casAuthors">Gawenda, Jessica; Traub, Frank; Lueck, Hans J.; Kreipe, Hans; Wasielewski, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Invasive tumor cells and their microenvironments are enriched with a broad spectrum of different proteases.  Legumain, a novel asparaginyl endopeptidase, has been obsd. to be highly expressed in several types of solid tumors.  However, there is no data available identifying the relationship of legumain expression and clinicopathol. or biol. variables in invasive breast cancer.  For the first time, the prevalence of legumain expression in invasive breast cancer (n = 432) and non-neoplastic breast tissues (n = 128) was investigated by immunohistochem.  Three staining patterns were obsd. in the cytoplasm: diffuse positivity, tiny dots and vesicles.  Whereas vesicular positivity in the majority of tumor cells was significantly correlated to an adverse outcome, cytoplasmic and dot-like staining showed no prognostic effect.  Vesicular positivity was obsd. in 24% of carcinomas, but only in one case of non-neoplastic breast tissue (<1%; proliferative mastopathy).  This staining pattern was found to be independent of other factors analyzed as grading, nodal status or HER2 expression.  Besides being of prognostic value, legumain might prove to be an important predictive factor in breast cancer, since its unique cleavage specificity is already used in prodrug activation strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSNRkq-QU9RrVg90H21EOLACvtfcHk0ljio9k4dhz6xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhslCltrk%253D&md5=59791178784ce2c191c6eb79c5ba09e5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10549-006-9311-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-006-9311-z%26sid%3Dliteratum%253Aachs%26aulast%3DGawenda%26aufirst%3DJ.%26aulast%3DTraub%26aufirst%3DF.%26aulast%3DLuck%26aufirst%3DH.%2BJ.%26aulast%3DKreipe%26aufirst%3DH.%26aulast%3Dvon%2BWasielewski%26aufirst%3DR.%26atitle%3DLegumain%2520expression%2520as%2520a%2520prognostic%2520factor%2520in%2520breast%2520cancer%2520patients%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D102%26spage%3D1%26epage%3D6%26doi%3D10.1007%2Fs10549-006-9311-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortunato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span> </span><span class="NLM_article-title">Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1515/BC.2001.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1515%2FBC.2001.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=11517930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFSksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2001&pages=777-783&author=J.+M.+Chenauthor=M.+Fortunatoauthor=R.+A.+Stevensauthor=A.+J.+Barrett&title=Activation+of+progelatinase+A+by+mammalian+legumain%2C+a+recently+discovered+cysteine+proteinase&doi=10.1515%2FBC.2001.093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase</span></div><div class="casAuthors">Chen, Jinq-May; Fortunato, Mara; Stevens, Richard A. E.; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">777-783</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">The activation of progelatinase A to gelatinase A requires cleavage of an Asn bond to form the N-terminus of the mature enzyme.  The authors asked whether the activation could be mediated by legumain (3.4.22.34) (I), a recently discovered lysosomal cysteine proteinase that is specific for hydrolysis of Asn bonds.  The addn. of purified I to the concd. conditioned medium from HT1080 cell culture that contained both progelatinase A (II) and progelatinase B (III) caused the conversion of 72-kDa II to the 62-kDa form.  III in the medium was unaffected.  Incubation of recombinant II with I resulted in almost instantaneous activation as judged by the fluorometric assay with the specific gelatinase A substrate, Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.  I also activated II when it was in complex with TIMP-2.  Zymog. anal. and N-terminal sequencing revealed that I cleaved 72-kDa II between the Asn109-Tyr110 or Asn111-Phe112 bonds to produce the 62-kDa mature enzyme, and that further cleavage at Asn430 also occurred to generate a 36-kDa active form.  More 62-kDa gelatinase A was detected in cultures of C13 cells that overexpressed I than in those of the control HEK293 cells.  It was concluded that I is clearly capable of processing II to the active enzyme in vitro and in cultured cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK3gAlxuFOSrVg90H21EOLACvtfcHk0ljXPPtQuQlUZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFSksbo%253D&md5=50d9d0e5ee754d08132ffeda7ed4b69c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1515%2FBC.2001.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2001.093%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DFortunato%26aufirst%3DM.%26aulast%3DStevens%26aufirst%3DR.%2BA.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DActivation%2520of%2520progelatinase%2520A%2520by%2520mammalian%2520legumain%252C%2520a%2520recently%2520discovered%2520cysteine%2520proteinase%26jtitle%3DBiol.%2520Chem.%26date%3D2001%26volume%3D382%26spage%3D777%26epage%3D783%26doi%3D10.1515%2FBC.2001.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgington, T.</span><span> </span><span class="NLM_article-title">Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">2957</span><span class="NLM_x">–</span> <span class="NLM_lpage">2964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=12782603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1aitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2957-2964&author=C.+Liuauthor=C.+Sunauthor=H.+Huangauthor=K.+Jandaauthor=T.+Edgington&title=Overexpression+of+legumain+in+tumors+is+significant+for+invasion%2Fmetastasis+and+a+candidate+enzymatic+target+for+prodrug+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Legumain in Tumors Is Significant for Invasion/Metastasis and a Candidate Enzymatic Target for Prodrug Therapy</span></div><div class="casAuthors">Liu, Cheng; Sun, Chengzao; Huang, Haining; Janda, Kim; Edgington, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2957-2964</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of legumain, a novel asparaginyl endopeptidase, in tumors was identified from gene expression profiling and tumor tissue array anal.  Legumain was demonstrated in membrane-assocd. vesicles concd. at the invadopodia of tumor cells and on cell surfaces where it colocalized with integrins.  Legumain was demonstrated to activate progelatinase A.  Cells overexpressing legumain possessed increased migratory and invasive activity in vitro and adopted an invasive and metastatic phenotype in vivo, inferring significance of legumain in tumor invasion and metastasis.  A prodrug strategy incorporating a legumain-cleavable peptide substrate onto doxorubicin was developed.  The prototype compd., designated legubicin, exhibited reduced toxicity and was effectively tumoricidal in vivo in a murine colon carcinoma model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbzPhPINJ7zLVg90H21EOLACvtfcHk0ljXPPtQuQlUZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1aitL8%253D&md5=6088fb45e7f42d07a4101a5fa040e519</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJanda%26aufirst%3DK.%26aulast%3DEdgington%26aufirst%3DT.%26atitle%3DOverexpression%2520of%2520legumain%2520in%2520tumors%2520is%2520significant%2520for%2520invasion%252Fmetastasis%2520and%2520a%2520candidate%2520enzymatic%2520target%2520for%2520prodrug%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D2957%26epage%3D2964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dando, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span> </span><span class="NLM_article-title">Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">8090</span><span class="NLM_x">–</span> <span class="NLM_lpage">8098</span><span class="refDoi"> DOI: 10.1074/jbc.272.12.8090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1074%2Fjbc.272.12.8090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=9065484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaK2sXitFWrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=8090-8098&author=J.+M.+Chenauthor=P.+M.+Dandoauthor=N.+D.+Rawlingsauthor=M.+A.+Brownauthor=N.+E.+Youngauthor=R.+A.+Stevensauthor=E.+Hewittauthor=C.+Wattsauthor=A.+J.+Barrett&title=Cloning%2C+isolation%2C+and+characterization+of+mammalian+legumain%2C+an+asparaginyl+endopeptidase&doi=10.1074%2Fjbc.272.12.8090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, isolation, and characterization of mammalian legumain, and asparaginyl endopeptidase</span></div><div class="casAuthors">Chen, Jinq-May; Dando, Pam M.; Rawlings, Neil D.; Brown, Molly A.; Young, Nina E.; Stevens, Richard A.; Hewitt, Eric; Watts, Colin; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8090-8098</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Legumain is a cysteine endopeptidase that shows strict specificity for hydrolysis of asparaginyl bonds.  The enzyme belongs to peptidase family C13, and is thus unrelated to the better known cysteine peptidases of the papain family, C1 (Rawlings, N. D., and Barrett, A. J. (1994) Methods Enzymol. 244, 461-486).  To date, legumain has been described only from plants and a blood fluke, Schistosoma mansoni.  The authors now show that legumain is present in mammals.  The authors have cloned and sequenced human legumain and part of pig legumain.  The authors have also purified legumain to homogeneity (2200-fold, 8% yield) from pig kidney.  The mammalian sequences are clearly homologous with legumains from non-mammalian species.  Pig legumain is a glycoprotein of about 34 kDa, decreasing to 31 kDa on deglycosylation.  It is an asparaginyl endopeptidase, hydrolyzing A-Ala-Ala-Asn-7-(4-methyl)coumarylamide and benzoyl-Asn-p-nitroanilide.  Maximal activity is seen at pH 5.8 under normal assay conditions, and the enzyme is irreversibly denatured at pH 7 and above.  Mammalian legumain is a cysteine endopeptidase, inhibited by iodoacetamide and maleimides, but unaffected by compd. E64 (trans-epoxysuccinyl-L-leucylamideo-(4-guanidino)butane).  It is inhibited by ovocystatin (cystatin from chicken egg white) and human cystatin C with Ki values < 5 nM.  The authors discuss the significance of the discovery of a cysteine endopeptidase of a new family and distinctive specificity in man and other mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9BB-vOhPAyrVg90H21EOLACvtfcHk0ljXPPtQuQlUZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitFWrsbk%253D&md5=fbc20cfc8f745824027f01bbeacfe193</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.12.8090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.12.8090%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DDando%26aufirst%3DP.%2BM.%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26aulast%3DYoung%26aufirst%3DN.%2BE.%26aulast%3DStevens%26aufirst%3DR.%2BA.%26aulast%3DHewitt%26aufirst%3DE.%26aulast%3DWatts%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DCloning%252C%2520isolation%252C%2520and%2520characterization%2520of%2520mammalian%2520legumain%252C%2520an%2520asparaginyl%2520endopeptidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D8090%26epage%3D8098%26doi%3D10.1074%2Fjbc.272.12.8090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span> </span><span class="NLM_article-title">Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.1016/S0014-5793(98)01574-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2FS0014-5793%2898%2901574-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=9891971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaK1MXhslWltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=1998&pages=361-365&author=J.+M.+Chenauthor=N.+D.+Rawlingsauthor=R.+A.+Stevensauthor=A.+J.+Barrett&title=Identification+of+the+active+site+of+legumain+links+it+to+caspases%2C+clostripain+and+gingipains+in+a+new+clan+of+cysteine+endopeptidases&doi=10.1016%2FS0014-5793%2898%2901574-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases</span></div><div class="casAuthors">Chen, Jinq-May; Rawlings, Neil D.; Stevens, Richard A. E.; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-365</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We show by site-directed mutagenesis that the catalytic residues of mammalian legumain, a recently discovered lysosomal asparaginylcysteine endopeptidase, form a catalytic dyad in the motif His-Gly-spacer-Ala-Cys.  We note that the same motif is present in the caspases, aspartate-specific endopeptidases central to the process of apoptosis in animal cells, and also in the families of clostripain and gingipain which are arginyl/lysyl endopeptidases of pathogenic bacteria.  We propose that the four families have similar protein folds, are evolutionarily related in clan CD, and have common characteristics including substrate specificities dominated by the interactions of the S1 subsite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWGIM-diHwLVg90H21EOLACvtfcHk0ljlTjnkZMMR4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslWltQ%253D%253D&md5=437888ac750d2ae62e62fbb722c75f47</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2898%2901574-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252898%252901574-9%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26aulast%3DStevens%26aufirst%3DR.%2BA.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520the%2520active%2520site%2520of%2520legumain%2520links%2520it%2520to%2520caspases%252C%2520clostripain%2520and%2520gingipains%2520in%2520a%2520new%2520clan%2520of%2520cysteine%2520endopeptidases%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D441%26spage%3D361%26epage%3D365%26doi%3D10.1016%2FS0014-5793%2898%2901574-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, M.</span><span> </span><span class="NLM_article-title">Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness</span> <span class="citation_source-journal">World J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1007/s00345-012-0977-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1007%2Fs00345-012-0977-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23124822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsFyrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=359-364&author=Y.+Ohnoauthor=J.+Nakashimaauthor=M.+Izumiauthor=M.+Ohoriauthor=T.+Hashimotoauthor=M.+Tachibana&title=Association+of+legumain+expression+pattern+with+prostate+cancer+invasiveness+and+aggressiveness&doi=10.1007%2Fs00345-012-0977-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness</span></div><div class="casAuthors">Ohno, Yoshio; Nakashima, Jun; Izumi, Miki; Ohori, Makoto; Hashimoto, Takeshi; Tachibana, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Urology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-364</span>CODEN:
                <span class="NLM_cas:coden">WJURDJ</span>;
        ISSN:<span class="NLM_cas:issn">0724-4983</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Objectives: To investigate the clin. implication of legumain, an asparaginyl endopeptidase that is highly expressed in several types of cancer, expression in prostate cancer.  Methods: Legumain expression in prostate cancer cell lines was detd. by real-time reverse transcriptase PCR and Western blot.  Furthermore, legumain expression in 88 prostatectomy specimens was evaluated by immunohistochem.  The assocn. between legumain expression and clinicopathol. factors was analyzed.  Results: Legumain expression was confirmed at the mRNA and protein levels in all the cells.  Although all the cancer tissues were pos. for legumain, 2 staining patterns were obsd. in the cytoplasm: diffuse cytoplasmic and vesicular positivity.  The rates of Gleason score ≥8, extracapsular extension, and perineural invasion in the group with vesicular staining were significantly higher than those in the diffuse cytoplasmic group (p < 0.05).  The max. size of the tumor with vesicular staining was significantly greater than that of the tumor with diffuse cytoplasmic staining (p = 0.0302).  The 5-yr biochem. recurrence-free rate in the patients with vesicular legumain staining was 53.2 %; this rate was significantly lower than that (78.8 %) in the patients with diffuse cytoplasmic staining (p = 0.0269).  Conclusions: Tumors that showed a vesicular staining pattern of legumain had the potential of being highly invasive and aggressive in patients with prostate cancer who were treated with radical prostatectomy.  This suggests that legumain might contribute to the invasiveness and aggressiveness of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVq7_AfmqXwLVg90H21EOLACvtfcHk0ljlTjnkZMMR4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsFyrurY%253D&md5=067da9cb33f33c975cd027d542526886</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00345-012-0977-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00345-012-0977-z%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DY.%26aulast%3DNakashima%26aufirst%3DJ.%26aulast%3DIzumi%26aufirst%3DM.%26aulast%3DOhori%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DTachibana%26aufirst%3DM.%26atitle%3DAssociation%2520of%2520legumain%2520expression%2520pattern%2520with%2520prostate%2520cancer%2520invasiveness%2520and%2520aggressiveness%26jtitle%3DWorld%2520J.%2520Urol.%26date%3D2013%26volume%3D31%26spage%3D359%26epage%3D364%26doi%3D10.1007%2Fs00345-012-0977-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span> </span><span class="NLM_article-title">Effects of legumain as a potential prognostic factor on gastric cancers</span> <span class="citation_source-journal">Med. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="refDoi"> DOI: 10.1007/s12032-013-0621-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1007%2Fs12032-013-0621-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23740003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A280%3ADC%252BC3snpvFyquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=621&author=N.+Liauthor=Q.+Liuauthor=Q.+Suauthor=C.+Weiauthor=B.+Lanauthor=J.+Wangauthor=G.+Baoauthor=F.+Yanauthor=Y.+Yuauthor=B.+Pengauthor=J.+Qiuauthor=X.+Yanauthor=S.+Zhangauthor=F.+Guo&title=Effects+of+legumain+as+a+potential+prognostic+factor+on+gastric+cancers&doi=10.1007%2Fs12032-013-0621-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of legumain as a potential prognostic factor on gastric cancers</span></div><div class="casAuthors">Li Na; Liu Qiaoling; Su Qi; Wei Chongyang; Lan Bin; Wang Jianyong; Bao Guoqing; Yan Fei; Yu Ying; Peng Baowei; Qiu Ju; Yan Xiangming; Zhang Sheng; Guo Fang</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although legumain has been found to be a prognostic factor in both breast cancer and colorectal cancer, its effects on gastric cancer are unknown.  In this study, we investigated effects of legumain on gastric cancer and the correlation between legumain expression and prognosis of gastric cancer patients.  SGC7901 cells were transduced with legumain cDNA (SGC7901-hLeg) for overexpression of legumain or with legumain shRNA to knock down legumain.  In vitro tumor migration was examined by wound healing assay.  Furthermore, a tumorigenicity and metastasis mouse model was used to examine legumain function in vivo; asparaginyl endopeptidase inhibitor (AEPI, an inhibitor of legumain) was injected to the mice (i.p.) to evaluate its therapeutic effect.  Tissue microarray analysis from 112 gastric cancer patients was performed to evaluate the association between legumain expression and the cumulative survival time.  Legumain was highly expressed in gastric cancer patients and some gastric cancer cell lines.  Legumain promoted gastric cell migration in vitro and promoted gastric tumor growth and metastasis in vivo, and these effects were reversed by knockdown of legumain with shRNA or treated with AEPI.  In gastric cancer clinical samples, legumain expression in tumor was significantly higher than in non-tumor and was negatively associated with the cumulative survival rate.  In conclusion, legumain was highly expressed in gastric adenocarcinoma; legumain promoted gastric cancer tumorigenesis and metastasis in vitro and in vivo.  Legumain expression in tumor was a poor prognostic factor for gastric cancer patients, and legumain could be a potential target molecule for gastric cancer therapy in clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQt-Yoxz0IgQJotVjB3IRIyfW6udTcc2ebKNGlFthOXM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snpvFyquw%253D%253D&md5=d0b0d0655c6b1e4789d82bbfe5bfd0d3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs12032-013-0621-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-013-0621-9%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DQ.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DG.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DF.%26atitle%3DEffects%2520of%2520legumain%2520as%2520a%2520potential%2520prognostic%2520factor%2520on%2520gastric%2520cancers%26jtitle%3DMed.%2520Oncol.%26date%3D2013%26volume%3D30%26spage%3D621%26doi%3D10.1007%2Fs12032-013-0621-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Haugen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brix, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flatmark, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maelandsmo, G. M.</span><span> </span><span class="NLM_article-title">Nuclear legumain activity in colorectal cancer</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52980</span><span class="refDoi"> DOI: 10.1371/journal.pone.0052980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1371%2Fjournal.pone.0052980" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e52980&author=M.+H.+Haugenauthor=H.+T.+Johansenauthor=S.+J.+Pettersenauthor=R.+Solbergauthor=K.+Brixauthor=K.+Flatmarkauthor=G.+M.+Maelandsmo&title=Nuclear+legumain+activity+in+colorectal+cancer&doi=10.1371%2Fjournal.pone.0052980"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0052980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0052980%26sid%3Dliteratum%253Aachs%26aulast%3DHaugen%26aufirst%3DM.%2BH.%26aulast%3DJohansen%26aufirst%3DH.%2BT.%26aulast%3DPettersen%26aufirst%3DS.%2BJ.%26aulast%3DSolberg%26aufirst%3DR.%26aulast%3DBrix%26aufirst%3DK.%26aulast%3DFlatmark%26aufirst%3DK.%26aulast%3DMaelandsmo%26aufirst%3DG.%2BM.%26atitle%3DNuclear%2520legumain%2520activity%2520in%2520colorectal%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De52980%26doi%3D10.1371%2Fjournal.pone.0052980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Stern, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Many, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satchi-Fainaro, R.</span><span> </span><span class="NLM_article-title">A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">510</span><span class="refDoi"> DOI: 10.1021/bc800448u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc800448u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVyktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=500-510&author=L.+Sternauthor=R.+Perryauthor=P.+Ofekauthor=A.+Manyauthor=D.+Shabatauthor=R.+Satchi-Fainaro&title=A+novel+antitumor+prodrug+platform+designed+to+be+cleaved+by+the+endoprotease+legumain&doi=10.1021%2Fbc800448u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Antitumor Prodrug Platform Designed to Be Cleaved by the Endoprotease Legumain</span></div><div class="casAuthors">Stern, Liron; Perry, Rotem; Ofek, Paula; Many, Ariel; Shabat, Doron; Satchi-Fainaro, Ronit</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">500-510</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemotherapeutic treatment of neoplastic diseases is often restricted by adverse systemic toxicity, which limits the dose of drug that can be administered, or by the appearance of drug resistance.  Therefore, novel targeted therapeutic approaches are being developed to improve current conventional therapy in order to increase specificity and biocompatibility, and decrease toxicity.  Legumain represents a recently identified lysosomal protease that has been reported to be overexpressed in the majority of human solid tumors, to promote cell migration and is assocd. with enhanced tissue invasion and metastases.  Therefore, it serves as a promising candidate for prodrug therapy.  We synthesized a novel legumain-cleavable prodrug, carbobenzyloxy-alanine-alanine-asparagine-ethylenediamine-etoposide, which releases the chemotherapeutic agent, etoposide, as the active drug.  The prodrug was characterized and analyzed by 1H NMR and HPLC.  293 Human embryonic kidney (293 HEK) cells were stably transfected with human legumain, to achieve overexpression in vitro (293 HEK-Leg).  293 HEK-Leg cells expressed both active and inactive legumain and secreted it to the medium.  Legumain expression was found to be elevated because of serum starvation in both 293 HEK cells and PC3 human prostate carcinoma cells.  The com. substrate of legumain, carbobenzyloxy-alanine-alanine-asparagine-amino-4-Me coumarin (CBZ-Ala-Ala-Asn-AMC) and the synthesized prodrug were both cleaved by recombinant human legumain (rhlegumain) and legumain expressed in the 293 HEK-Leg cell lysate.  Upon cleavage by rhlegumain, the prodrug showed an inhibitory effect on the proliferation of 293 HEK and 293 HEK-Leg cells.  This study suggests a novel platform for prodrug therapy activated by legumain as a promising approach for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaEr0hM3i9UrVg90H21EOLACvtfcHk0liz-mW5yQ5oxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVyktrc%253D&md5=15a25647a8ffe0b4cd2bbb5d42565e33</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbc800448u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800448u%26sid%3Dliteratum%253Aachs%26aulast%3DStern%26aufirst%3DL.%26aulast%3DPerry%26aufirst%3DR.%26aulast%3DOfek%26aufirst%3DP.%26aulast%3DMany%26aufirst%3DA.%26aulast%3DShabat%26aufirst%3DD.%26aulast%3DSatchi-Fainaro%26aufirst%3DR.%26atitle%3DA%2520novel%2520antitumor%2520prodrug%2520platform%2520designed%2520to%2520be%2520cleaved%2520by%2520the%2520endoprotease%2520legumain%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26spage%3D500%26epage%3D510%26doi%3D10.1021%2Fbc800448u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjuri, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S. C.</span><span> </span><span class="NLM_article-title">Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1021/mp200434n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200434n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=168-175&author=Y.+Liuauthor=K.+M.+Bajjuriauthor=C.+Liuauthor=S.+C.+Sinha&title=Targeting+cell+surface+alpha%28v%29beta%283%29+integrin+increases+therapeutic+efficacies+of+a+legumain+protease-activated+auristatin+prodrug&doi=10.1021%2Fmp200434n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Cell Surface Alpha(v)beta(3) Integrin Increases Therapeutic Efficacies of a Legumain Protease-Activated Auristatin Prodrug</span></div><div class="casAuthors">Liu, Yuan; Bajjuri, Krishna Mohan; Liu, Cheng; Sinha, Subhash C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-175</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel monomethylauristatin E (MMAE) prodrug 8 was designed and prepd. that bound cell surface glycoprotein integrin αvβ3, and was activated using legumain protease as a catalyst.  Upon activation, prodrug 8 strongly induced the death of MDA-MB-435 cells that express integrin αvβ3 on cell surface.  Efficacies of prodrug 8 were also detd. in vivo using animal models of 4T1 murine breast cancer, D121 Lewis lung carcinoma, and MDA-MB-435 human breast cancer.  The results demonstrated that prodrug 8 decreased tumor growth and metastasis effectively.  In comparison to the parent cytotoxin, MMAE, and prodrug 3, prodrug 8 was less toxic to mouse white blood cells.  The latter caused no loss in wt. gain of mice at a dose 3 mg/kg, which is over 30 times in excess to MMAE (0.1 mg/kg).  We hypothesize that overexpression and colocalization of integrin αvβ3 and legumain protease on tumor cells, tumor vasculature, and/or tumor microenvironments can be exploited to enhance the efficacy and selectivity of potent cytotoxins, such as MMAE, which is otherwise too toxic to use for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0IT9GlanxCrVg90H21EOLACvtfcHk0liz-mW5yQ5oxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsbvO&md5=de275e0b82c4f4d6ad1f1f5e96c1975d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fmp200434n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200434n%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DBajjuri%26aufirst%3DK.%2BM.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSinha%26aufirst%3DS.%2BC.%26atitle%3DTargeting%2520cell%2520surface%2520alpha%2528v%2529beta%25283%2529%2520integrin%2520increases%2520therapeutic%2520efficacies%2520of%2520a%2520legumain%2520protease-activated%2520auristatin%2520prodrug%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D168%26epage%3D175%26doi%3D10.1021%2Fmp200434n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrasidlo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisfeld, R. A.</span><span> </span><span class="NLM_article-title">Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity</span> <span class="citation_source-journal">Nanomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1016/j.nano.2011.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.nano.2011.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=21419870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=665-673&author=D.+Liaoauthor=Z.+Liuauthor=W.+Wrasidloauthor=T.+Chenauthor=Y.+Luoauthor=R.+Xiangauthor=R.+A.+Reisfeld&title=Synthetic+enzyme+inhibitor%3A+a+novel+targeting+ligand+for+nanotherapeutic+drug+delivery+inhibiting+tumor+growth+without+systemic+toxicity&doi=10.1016%2Fj.nano.2011.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity</span></div><div class="casAuthors">Liao, Debbie; Liu, Ze; Wrasidlo, Wolfgang; Chen, Tingmei; Luo, Yunping; Xiang, Rong; Reisfeld, Ralph A.</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">665-673</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Unresolved problems assocd. with ligand-targeting of liposomal nanoparticles (NPs) to solid tumors include variable target receptor expression due to genetic heterogeneity and insufficient target specificity, leading to systemic toxicities.  This study addresses these issues by developing a novel ligand-targeting strategy for liposomal NPs using RR-11a, a synthetic enzyme inhibitor of Legumain, an asparaginyl endopeptidase.  Cell-surface expression of Legumain is driven by hypoxic stress, a hallmark of solid tumors.  Legumain-targeted RR-11a-coupled NPs revealed high ligand-receptor affinity, enhanced solid-tumor penetration and uptake by tumor cells.  Treatment of tumor-bearing mice with RR-11a-coupled NPs encapsulating doxorubicin resulted in improved tumor selectivity and drug sensitivity, leading to complete inhibition of tumor growth.  These antitumor effects were achieved while eliminating systemic drug toxicity.  Therefore, synthetic enzyme inhibitors, such as RR-11a, represent a new class of compds. that can be used for highly specific ligand-targeting of NPs to solid tumors.  From the Clin. Editor: This study addresses the problems assocd. with ligand-targeting of liposomal nanoparticles to solid tumors with variable target receptor expression.  A novel and efficacious targeting strategy has been developed towards a synthetic enzyme inhibitor of Legumain.  The authors demonstrate successful tumor growth inhibiting effect while eliminating systemic drug toxicity in an animal model using this strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpirlxsbelAJ7Vg90H21EOLACvtfcHk0lhvySV6aK64jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmtb4%253D&md5=038a043486a10d61e52d4caa88f21729</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2011.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2011.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWrasidlo%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DR.%26aulast%3DReisfeld%26aufirst%3DR.%2BA.%26atitle%3DSynthetic%2520enzyme%2520inhibitor%253A%2520a%2520novel%2520targeting%2520ligand%2520for%2520nanotherapeutic%2520drug%2520delivery%2520inhibiting%2520tumor%2520growth%2520without%2520systemic%2520toxicity%26jtitle%3DNanomedicine%26date%3D2011%26volume%3D7%26spage%3D665%26epage%3D673%26doi%3D10.1016%2Fj.nano.2011.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obianyo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandstetter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span> </span><span class="NLM_article-title">Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">14740</span><span class="refDoi"> DOI: 10.1038/ncomms14740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2Fncomms14740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=28345579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt12gu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14740&author=Z.+Zhangauthor=O.+Obianyoauthor=E.+Dallauthor=Y.+Duauthor=H.+Fuauthor=X.+Liuauthor=S.+S.+Kangauthor=M.+Songauthor=S.+P.+Yuauthor=C.+Cabreleauthor=M.+Schubertauthor=X.+Liauthor=J.+Z.+Wangauthor=H.+Brandstetterauthor=K.+Ye&title=Inhibition+of+delta-secretase+improves+cognitive+functions+in+mouse+models+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fncomms14740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease</span></div><div class="casAuthors">Zhang, Zhentao; Obianyo, Obiamaka; Dall, Elfriede; Du, Yuhong; Fu, Haian; Liu, Xia; Kang, Seong Su; Song, Mingke; Yu, Shan-Ping; Cabrele, Chiara; Schubert, Mario; Li, Xiaoguang; Wang, Jian-Zhi; Brandstetter, Hans; Ye, Keqiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14740</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">δ-Secretase, also known as asparagine endopeptidase (AEP) or legumain, is a lysosomal cysteine protease that cleaves both amyloid precursor protein (APP) and tau, mediating the amyloid-β and tau pathol. in Alzheimer's disease (AD).  Here we report the therapeutic effect of an orally bioactive and brain permeable δ-secretase inhibitor in mouse models of AD.  We performed a high-throughput screen and identified a non-toxic and selective δ-secretase inhibitor, termed compd. 11, that specifically blocks δ-secretase but not other related cysteine proteases.  Co-crystal structure anal. revealed a dual active site-directed and allosteric inhibition mode of this compd. class.  Chronic treatment of tau P301S and 5XFAD transgenic mice with this inhibitor reduces tau and APP cleavage, ameliorates synapse loss and augments long-term potentiation, resulting in protection of memory.  Therefore, these findings demonstrate that this δ-secretase inhibitor may be an effective clin. therapeutic agent towards AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ87LrkE00NbVg90H21EOLACvtfcHk0lhvySV6aK64jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt12gu7Y%253D&md5=8b7aea560cc7c4c4a05c825b3ab1d95b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fncomms14740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14740%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DObianyo%26aufirst%3DO.%26aulast%3DDall%26aufirst%3DE.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DS.%2BS.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DS.%2BP.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DSchubert%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DBrandstetter%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520delta-secretase%2520improves%2520cognitive%2520functions%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14740%26doi%3D10.1038%2Fncomms14740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Thomas, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocharski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surendran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoner, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span> </span><span class="NLM_article-title">The road map to oral bioavailability: an industrial perspective</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span><span class="refDoi"> DOI: 10.1517/17425255.2.4.591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1517%2F17425255.2.4.591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=16859407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1ahsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=591-608&author=V.+H.+Thomasauthor=S.+Bhattacharauthor=L.+Hitchinghamauthor=P.+Zocharskiauthor=M.+Naathauthor=N.+Surendranauthor=C.+L.+Stonerauthor=A.+El-Kattan&title=The+road+map+to+oral+bioavailability%3A+an+industrial+perspective&doi=10.1517%2F17425255.2.4.591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The road map to oral bioavailability: an industrial perspective</span></div><div class="casAuthors">Thomas, V. Hayden; Bhattachar, Shobha; Hitchingham, Linda; Zocharski, Philip; Naath, Maryanne; Surendran, Narayanan; Stoner, Chad L.; El-Kattan, Ayman</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">591-608</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Optimization of oral bioavailability is a continuing challenge for the pharmaceutical and biotechnol. industries.  The no. of potential drug candidates requiring in vivo evaluation has significantly increased with the advent of combinatorial chem.  In addn., drug discovery programs are increasingly forced into more lipophilic and lower soly. chem. space.  To aid in the use of in vitro and in silico tools as well as reduce the no. of in vivo studies required, a team-based discussion tool is proposed that provides a road map' to guide the selection of profiling assays that should be considered when optimizing oral bioavailability.  This road map divides the factors that contribute to poor oral bioavailability into two interrelated categories: absorption and metab.  This road map provides an interface for cross discipline discussions and a systematic approach to the experimentation that drives the drug discovery process towards a common goal - acceptable oral bioavailability using minimal resources in an acceptable time frame.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh7_zZKacXE7Vg90H21EOLACvtfcHk0lhvySV6aK64jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1ahsLs%253D&md5=79cf4cea1b89914bd3a8826b5d7360f9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F17425255.2.4.591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2.4.591%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DV.%2BH.%26aulast%3DBhattachar%26aufirst%3DS.%26aulast%3DHitchingham%26aufirst%3DL.%26aulast%3DZocharski%26aufirst%3DP.%26aulast%3DNaath%26aufirst%3DM.%26aulast%3DSurendran%26aufirst%3DN.%26aulast%3DStoner%26aufirst%3DC.%2BL.%26aulast%3DEl-Kattan%26aufirst%3DA.%26atitle%3DThe%2520road%2520map%2520to%2520oral%2520bioavailability%253A%2520an%2520industrial%2520perspective%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2006%26volume%3D2%26spage%3D591%26epage%3D608%26doi%3D10.1517%2F17425255.2.4.591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barawkar, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramdas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panmand, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naykodi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goswami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paliwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karande, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouduri, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palle, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookhtiar, K. A.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.ejmech.2017.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=28415011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFWntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=218-229&author=S.+Basuauthor=D.+A.+Barawkarauthor=V.+Ramdasauthor=M.+Patelauthor=Y.+Wamanauthor=A.+Panmandauthor=S.+Kumarauthor=S.+Thoratauthor=M.+Naykodiauthor=A.+Goswamiauthor=B.+S.+Reddyauthor=V.+Prasadauthor=S.+Chaturvediauthor=A.+Quraishiauthor=S.+Menonauthor=S.+Paliwalauthor=A.+Kulkarniauthor=V.+Karandeauthor=I.+Ghoshauthor=S.+Mustafaauthor=S.+Deauthor=V.+Jainauthor=E.+R.+Banerjeeauthor=S.+R.+Rouduriauthor=V.+P.+Palleauthor=A.+Chughauthor=K.+A.+Mookhtiar&title=Design+and+synthesis+of+novel+xanthine+derivatives+as+potent+and+selective+A2B+adenosine+receptor+antagonists+for+the+treatment+of+chronic+inflammatory+airway+diseases&doi=10.1016%2Fj.ejmech.2017.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases</span></div><div class="casAuthors">Basu, Sujay; Barawkar, Dinesh A.; Ramdas, Vidya; Patel, Meena; Waman, Yogesh; Panmand, Anil; Kumar, Santosh; Thorat, Sachin; Naykodi, Minakshi; Goswami, Arnab; Reddy, B. Srinivasa; Prasad, Vandna; Chaturvedi, Sandhya; Quraishi, Azfar; Menon, Suraj; Paliwal, Shalini; Kulkarni, Abhay; Karande, Vikas; Ghosh, Indraneel; Mustafa, Syed; De, Siddhartha; Jain, Vaibhav; Banerjee, Ena Ray; Rouduri, Sreekanth R.; Palle, Venkata P.; Chugh, Anita; Mookhtiar, Kasim A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">218-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The identification of novel, potent and selective A2B adenosine receptor (A2BAdoR) antagonists has been shown to be potentially beneficial for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).  Towards this effort, the authors explored several prop-2-ynylated C8-aryl or heteroaryl substitutions on xanthine chemotype and found that 1-prop-2-ynyl-1H-pyrazol-4-yl moiety was better tolerated at the C8 position.  Compd. I (R1 = H, R2 = n-Pr), exhibited binding affinity (Ki) of 62 nM but was non-selective for A2BAdoR over other AdoRs.  Incorporation of substituted Ph on the terminal acetylene increased the binding affinity (Ki) significantly to <10 nM.  Various substitutions on terminal Ph group and different alkyl substitutions on N-1 and N-3 were explored to improve the potency, selectivity for A2BAdoR and the soly.  In general, compds. with meta-substituted Ph provided better selectivity for A2BAdoR compared to that of para-substituted analogs.  Substitutions such as basic amines like pyrrolidine, piperidine, piperazine or cycloalkyls with polar group were tried on terminal acetylene, keeping in mind the poor soly. of xanthine analogs in general.  However, these substitutions led to a decrease in affinity compared to compd. I (R1 = H, R2 = n-Pr).  Subsequent SAR optimization resulted in identification of compd. I [R1 = 3-(CF3O)C6H4, R2 = Et(II)] with high human A2BAdoR affinity (Ki = 13 nM), selectivity against other AdoR subtypes and with good pharmacokinetic properties.  It was found to be a potent functional A2BAdoR antagonist with a Ki of 8 nM in cAMP assay in hA2B-HEK293 cells and an IC50 of 107 nM in IL6 assay in NIH-3T3 cells.  Docking study was performed to rationalize the obsd. affinity data.  Structure-activity relationship (SAR) studies also led to identification of compd. I (R1 = 3-HO2CC6H4, R2 = n-Pr) as a potent A2BAdoR antagonist with Ki of 1.8 nM in cAMP assay and good aq. soly. of 529 μM at neutral pH.  Compd. II was further tested for in vivo efficacy and found to be efficacious in ovalbumin-induced allergic asthma model in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8O-mETdHU7LVg90H21EOLACvtfcHk0ljIZRLQoel7Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFWntrc%253D&md5=208780bfe877de2b9d9457b8e9d74376</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBarawkar%26aufirst%3DD.%2BA.%26aulast%3DRamdas%26aufirst%3DV.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DWaman%26aufirst%3DY.%26aulast%3DPanmand%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DThorat%26aufirst%3DS.%26aulast%3DNaykodi%26aufirst%3DM.%26aulast%3DGoswami%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DPrasad%26aufirst%3DV.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DQuraishi%26aufirst%3DA.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DKarande%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DI.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DBanerjee%26aufirst%3DE.%2BR.%26aulast%3DRouduri%26aufirst%3DS.%2BR.%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DChugh%26aufirst%3DA.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520xanthine%2520derivatives%2520as%2520potent%2520and%2520selective%2520A2B%2520adenosine%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520chronic%2520inflammatory%2520airway%2520diseases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D218%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2017.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of process-related impurities of antidiabetic drug linagliptin</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="refDoi"> DOI: 10.3390/molecules21081041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.3390%2Fmolecules21081041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1041&author=Y.+Huangauthor=X.+Heauthor=T.+Wuauthor=F.+Zhang&title=Synthesis+and+characterization+of+process-related+impurities+of+antidiabetic+drug+linagliptin&doi=10.3390%2Fmolecules21081041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21081041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21081041%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520process-related%2520impurities%2520of%2520antidiabetic%2520drug%2520linagliptin%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D1041%26doi%3D10.3390%2Fmolecules21081041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljIZRLQoel7Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span> </span><span class="NLM_article-title">Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer</span> <span class="citation_source-journal">OncoTargets Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.2147/OTT.S44564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.2147%2FOTT.S44564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23874108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFymtL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=861-867&author=Y.+Huangauthor=Y.+Heauthor=S.+Yeauthor=X.+Liauthor=Q.+Zhongauthor=Z.+Chenauthor=X.+Jin&title=Combined+use+of+cyclophosphamide+and+Chalone+19-peptide+in+experimental+breast+cancer&doi=10.2147%2FOTT.S44564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer</span></div><div class="casAuthors">Huang, Yuanxi; He, Yan; Ye, Shengqian; Li, Xiaomei; Zhong, Qingqi; Chen, Zhuo; Jin, Xiaoming</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">861-867</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Cyclophosphamide is a potent anticancer drug, but its clin. utility is limited because of its severe side effects, in particular liver damage.  Chalone 19-peptide induces apoptosis of tumor cells and inhibits tumor growth.  The present study investigated the antitumor effects of a combination of cyclophosphamide and Chalone 19-peptide in exptl. breast cancer.  Methods: An animal model of breast cancer was developed, consisting of an MDA-MB-231 cell line implanted in the nude mouse.  Eight doses of a combination of cyclophosphamide 50 mg/kg or 100 mg/kg and Chalone 19-peptide 6.6 mg/kg were administered, and the mice were euthanized 28 days after the final drug injection.  Histopathol. anal. of tumor size, metastasis, and apoptosis of cancer cells was performed.  Control mice were injected i.p. with either cyclophosphamide alone or the same vol. of solvent.  Results: Tumor sizes in the treatment groups were smaller than in the controls.  No metastasis was found in the groups treated with cyclophosphamide and Chalone 19-peptide, but lung metastasis was found in controls.  Liver damage in the groups treated with cyclophosphamide was more serious than in the other groups.  Conclusion: Addn. of Chalone 19-peptide can improve the ability of cyclophosphamide to inhibit tumor growth and also reduces side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoedhkaCKDXH7Vg90H21EOLACvtfcHk0liMrNWs_Cn0WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFymtL%252FN&md5=9fa706152b1652f76fe329c28c0be3dc</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2147%2FOTT.S44564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S44564%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DX.%26atitle%3DCombined%2520use%2520of%2520cyclophosphamide%2520and%2520Chalone%252019-peptide%2520in%2520experimental%2520breast%2520cancer%26jtitle%3DOncoTargets%2520Ther.%26date%3D2013%26volume%3D6%26spage%3D861%26epage%3D867%26doi%3D10.2147%2FOTT.S44564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span> </span><span class="NLM_article-title">Inhibition of breast cancer metastases by a novel inhibitor of TGFbeta receptor 1</span> <span class="citation_source-journal">J. Natl. Cancer. Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1093/jnci/djs485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1093%2Fjnci%2Fdjs485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23178439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns12luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2013&pages=47-58&author=Y.+Fangauthor=Y.+Chenauthor=L.+Yuauthor=C.+Zhengauthor=Y.+Qiauthor=Z.+Liauthor=Z.+Yangauthor=Y.+Zhangauthor=T.+Shiauthor=J.+Luoauthor=M.+Liu&title=Inhibition+of+breast+cancer+metastases+by+a+novel+inhibitor+of+TGFbeta+receptor+1&doi=10.1093%2Fjnci%2Fdjs485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Breast Cancer Metastases by a Novel Inhibitor of TGFβ Receptor 1</span></div><div class="casAuthors">Fang, Yuanzhang; Chen, Yihua; Yu, Linxi; Zheng, Cong; Qi, Ya; Li, Zhenxi; Yang, Zhengfeng; Zhang, Yong; Shi, Tieliu; Luo, Jian; Liu, Mingyao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-58</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Transforming growth factor beta (TGFβ), which is implicated in metastasis to various organs in breast cancer, is a potential target for new antitumor metastasis drugs.  Methods To identify specific inhibitors of TGFβ receptor 1 (TGFβR1) in breast cancer metastasis, a virtual library of more than 400000 different compds. was screened by mol. docking modeling and confirmed with Smad-binding element luciferase and TGFβR1 kinase assays.  Affymetrix GeneChip expression anal. of mRNA levels and real-time polymerase chain reaction were performed to det. expression changes of TGFβ-mediated, metastasis-assocd. genes in breast cancer cells after treatment with the small-mol. inhibitor YR-290.  YR-290 was also examd. for its effects on breast cancer migration, invasion, and metastasis using transwell and epithelial-to-mesenchymal transition (EMT) assays in vitro and three different mouse (BALB/c and NU/NU nude) models (n = 10 per group).  Kaplan-Meier analyses were used to assess survival.  All statistical tests were two-sided.  Results YR-290 interacted with the kinase domain of TGFβR1, abrogated kinase activity (half maximal inhibitory concn. = 137nM, 95% confidence interval = 126.4 to 147.6nM) and inhibited the TGFβ-mediated downstream signaling pathway and metastasis-assocd. genes in breast cancer cells.  YR-290 inhibited TGFβ-modulated breast cancer cell migration and invasion.  In tumor metastasis mouse models, YR-290 almost completely blocked cancer metastasis.  Nos. of lung tumor nodules of mice treated with 1mg/kg and 5mg/kg YR-290 were reduced by 74.93% (95% confidence interval = 61.45% to 88.41%) and 94.93% (95% confidence interval = 82.13% to 100%), resp., compared with control mice.  Treatment with YR-290 also statistically significantly prolonged the survival of tumor-bearing mice.  Conclusions YR-290 is a novel inhibitor of tumor metastasis that works by blocking TGFβ signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH3nni105UT7Vg90H21EOLACvtfcHk0liMrNWs_Cn0WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns12luw%253D%253D&md5=54b2149c87d7fe897b21a5c4b267d734</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjs485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjs485%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520breast%2520cancer%2520metastases%2520by%2520a%2520novel%2520inhibitor%2520of%2520TGFbeta%2520receptor%25201%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D2013%26volume%3D105%26spage%3D47%26epage%3D58%26doi%3D10.1093%2Fjnci%2Fdjs485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chan, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henter, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeths, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordenskjold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara-Nishimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span> </span><span class="NLM_article-title">Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1073/pnas.0809824105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1073%2Fpnas.0809824105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=468-473&author=C.+B.+Chanauthor=M.+Abeauthor=N.+Hashimotoauthor=C.+Haoauthor=I.+R.+Williamsauthor=X.+Liuauthor=S.+Nakaoauthor=A.+Yamamotoauthor=C.+Zhengauthor=J.+I.+Henterauthor=M.+Meethsauthor=M.+Nordenskjoldauthor=S.+Y.+Liauthor=I.+Hara-Nishimuraauthor=M.+Asanoauthor=K.+Ye&title=Mice+lacking+asparaginyl+endopeptidase+develop+disorders+resembling+hemophagocytic+syndrome&doi=10.1073%2Fpnas.0809824105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0809824105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0809824105%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%2BB.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DI.%2BR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNakao%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DHenter%26aufirst%3DJ.%2BI.%26aulast%3DMeeths%26aufirst%3DM.%26aulast%3DNordenskjold%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DS.%2BY.%26aulast%3DHara-Nishimura%26aufirst%3DI.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DK.%26atitle%3DMice%2520lacking%2520asparaginyl%2520endopeptidase%2520develop%2520disorders%2520resembling%2520hemophagocytic%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D468%26epage%3D473%26doi%3D10.1073%2Fpnas.0809824105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span> </span><span class="NLM_article-title">Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span><span class="refDoi"> DOI: 10.1111/cas.12202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1111%2Fcas.12202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23691974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2013&pages=1217-1225&author=Y.+Linauthor=C.+Weiauthor=Y.+Liuauthor=Y.+Qiuauthor=C.+Liuauthor=F.+Guo&title=Selective+ablation+of+tumor-associated+macrophages+suppresses+metastasis+and+angiogenesis&doi=10.1111%2Fcas.12202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis</span></div><div class="casAuthors">Lin, Yingying; Wei, Chongyang; Liu, Yuan; Qiu, Yongming; Liu, Cheng; Guo, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1217-1225</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tumor-assocd. macrophages (TAM) play a crit. role in promoting tumor development and metastasis.  In the present study, we found that legumain, an asparaginyl endopeptidase, was highly expressed on the surface of TAM.  A doxorubicin-based prodrug specifically activated by legumain selectively ablated TAM and resulted in a significant redn. of angiogenic factors and related tumor vessel growth.  Treatment with the prodrug also suppressed circulating tumor cells and myeloid immune suppressor Gr-1+/CD11b+ cells in tumor-bearing animals.  After selective ablation of TAM using the prodrug, tumor growth and metastases were greatly inhibited in murine tumor models.  These results indicate that legumain-activated prodrugs targeting TAM in tumors might represent a novel anticancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5sVq-e_eymLVg90H21EOLACvtfcHk0liMrNWs_Cn0WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrtr7I&md5=683c2be4ef76cd6e4d1d5a74c7d0f20a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fcas.12202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12202%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DF.%26atitle%3DSelective%2520ablation%2520of%2520tumor-associated%2520macrophages%2520suppresses%2520metastasis%2520and%2520angiogenesis%26jtitle%3DCancer%2520Sci.%26date%3D2013%26volume%3D104%26spage%3D1217%26epage%3D1225%26doi%3D10.1111%2Fcas.12202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Reisfeld, R. A.</span><span> </span><span class="NLM_article-title">The tumor microenvironment: a target for combination therapy of breast cancer</span> <span class="citation_source-journal">Crit. Rev. Oncog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1615/CritRevOncog.v18.i1-2.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1615%2FCritRevOncog.v18.i1-2.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23237555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A280%3ADC%252BC3s3hslCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=115-133&author=R.+A.+Reisfeld&title=The+tumor+microenvironment%3A+a+target+for+combination+therapy+of+breast+cancer&doi=10.1615%2FCritRevOncog.v18.i1-2.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The tumor microenvironment: a target for combination therapy of breast cancer</span></div><div class="casAuthors">Reisfeld Ralph A</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncogenesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">115-33</span>
        ISSN:<span class="NLM_cas:issn">0893-9675</span>.
    </div><div class="casAbstract">Cancer immunotherapy is in the midst of a major paradigm shift from an approach primarily focused on attacking tumor cells to a strategy also targeting the tumor microenvironment (TME).  This strategy is designed for the use of combination therapies, several of which are reviewed here.  Particular emphasis is placed on targeting such components of the TME as tumor-associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs) overexpressing specific therapy targets such as Legumain, an asparaginyl endopeptidase, proto-oncogene  Fra-1, transcription factor Stat3 and fibroblast activation protein (FAP) as well as HER-2, respectively.  The use of DNA vaccines directed against some of these targets overexpressed on both breast tumor cells as well as TAMs and CAFs in the TME results in the elimination of tumor growth, progression, metastasis and recurrence in mouse tumor models.  This type of cancer therapy is significantly improved in efficacy by a strategy specifically designed to combine immunotherapies, including DNA vaccines, with a novel chemotherapy featuring highly effective nanoparticle-mediated drug delivery, specifically targeted to tumor cells as well as key components of the TME, leading to its modulation and subsequent elimination of tumor growth, metastasis, and, most importantly, suppression of tumor recurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqeuE8ZX7crbZpSb_XWfMrfW6udTcc2ea98o0wq2kIZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3hslCjsA%253D%253D&md5=ef484eda32092e3d2cc1622b572009db</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1615%2FCritRevOncog.v18.i1-2.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevOncog.v18.i1-2.70%26sid%3Dliteratum%253Aachs%26aulast%3DReisfeld%26aufirst%3DR.%2BA.%26atitle%3DThe%2520tumor%2520microenvironment%253A%2520a%2520target%2520for%2520combination%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DCrit.%2520Rev.%2520Oncog.%26date%3D2013%26volume%3D18%26spage%3D115%26epage%3D133%26doi%3D10.1615%2FCritRevOncog.v18.i1-2.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupack, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, R.</span><span> </span><span class="NLM_article-title">Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2679</span><span class="NLM_x">–</span> <span class="NLM_lpage">2686</span><span class="refDoi"> DOI: 10.1002/jcb.24143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1002%2Fjcb.24143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2012&pages=2679-2686&author=L.+Wangauthor=S.+Chenauthor=M.+Zhangauthor=N.+Liauthor=Y.+Chenauthor=W.+Suauthor=Y.+Liuauthor=D.+Luauthor=S.+Liauthor=Y.+Yangauthor=Z.+Liauthor=D.+Stupackauthor=P.+Quauthor=H.+Huauthor=R.+Xiang&title=Legumain%3A+a+biomarker+for+diagnosis+and+prognosis+of+human+ovarian+cancer&doi=10.1002%2Fjcb.24143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjcb.24143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.24143%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DStupack%26aufirst%3DD.%26aulast%3DQu%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DR.%26atitle%3DLegumain%253A%2520a%2520biomarker%2520for%2520diagnosis%2520and%2520prognosis%2520of%2520human%2520ovarian%2520cancer%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2012%26volume%3D113%26spage%3D2679%26epage%3D2686%26doi%3D10.1002%2Fjcb.24143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Edgington, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdoes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withana, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachmann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span> </span><span class="NLM_article-title">Functional imaging of legumain in cancer using a new quenched activity-based probe</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span><span class="refDoi"> DOI: 10.1021/ja307083b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja307083b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSqsbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=174-182&author=L.+E.+Edgingtonauthor=M.+Verdoesauthor=A.+Ortegaauthor=N.+P.+Withanaauthor=J.+Leeauthor=S.+Syedauthor=M.+H.+Bachmannauthor=G.+Blumauthor=M.+Bogyo&title=Functional+imaging+of+legumain+in+cancer+using+a+new+quenched+activity-based+probe&doi=10.1021%2Fja307083b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Imaging of Legumain in Cancer Using a New Quenched Activity-Based Probe</span></div><div class="casAuthors">Edgington, Laura E.; Verdoes, Martijn; Ortega, Alberto; Withana, Nimali P.; Lee, Jiyoun; Syed, Salahuddin; Bachmann, Michael H.; Blum, Galia; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-182</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Legumain is a lysosomal cysteine protease whose biol. function remains poorly defined.  Legumain activity is up-regulated in most human cancers and inflammatory diseases most likely as the result of high expression in populations of activated macrophages.  Within the tumor microenvironment, legumain activity is thought to promote tumorigenesis.  To obtain a greater understanding of the role of legumain activity during cancer progression and inflammation, we developed an activity-based probe that becomes fluorescent only upon binding active legumain.  This probe is highly selective for legumain, even in the context of whole cells and tissues, and is also a more effective label of legumain than previously reported probes.  Here we present the synthesis and application of our probe to the anal. of legumain activity in primary macrophages and in two mouse models of cancer.  We find that legumain activity is highly correlated with macrophage activation and furthermore that it is an ideal marker for primary tumor inflammation and early stage metastatic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmBlI6e_DeMbVg90H21EOLACvtfcHk0lhqmNBlmvjJDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSqsbvP&md5=51830cee1df9b60aef194be32d4ae310</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja307083b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja307083b%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSyed%26aufirst%3DS.%26aulast%3DBachmann%26aufirst%3DM.%2BH.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DFunctional%2520imaging%2520of%2520legumain%2520in%2520cancer%2520using%2520a%2520new%2520quenched%2520activity-based%2520probe%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D174%26epage%3D182%26doi%3D10.1021%2Fja307083b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Murthy, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roodman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X. F.</span><span> </span><span class="NLM_article-title">Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2293</span><span class="NLM_x">–</span> <span class="NLM_lpage">2299</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-1642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1158%2F1078-0432.CCR-04-1642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=15788679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFaju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2293-2299&author=R.+V.+Murthyauthor=G.+Arbmanauthor=J.+Gaoauthor=G.+D.+Roodmanauthor=X.+F.+Sun&title=Legumain+expression+in+relation+to+clinicopathologic+and+biological+variables+in+colorectal+cancer&doi=10.1158%2F1078-0432.CCR-04-1642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer</span></div><div class="casAuthors">Murthy, Raghavendra Vasudeva; Arbman, Gunnar; Gao, Jingfang; Roodman, G. David; Sun, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2293-2299</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Legumain, a novel asparaginyl endopeptidase, has been obsd. to be highly expressed in several types of tumors including colorectal cancer.  However, there is no study examg. the relationship of legumain expression to clinocopathol. and biol. variables in colorectal cancers.  We investigated legumain expression in 164 primary colorectal cancers, 34 corresponding distant normal mucosa samples, 89 adjacent normal mucosa samples, and 33 lymph node metastases using immunohistochem.  We also did Western blotting anal. on three addnl. colorectal cancers and three colonic cell lines.  Legumain expression was increased in primary tumors compared with distant or adjacent normal mucosa (P < 0.05), but there was no significant change between primary tumors and metastases (P > 0.05).  Legumain expression was pos. related to poorer differentiation/mucinous carcinoma (P = 0.04), higher degree of necrosis (P = 0.03) and apoptosis (P < 0.0001), pos. proliferating cell nuclear antigen (P < 0.0001) and p53 expression (P = 0.049), and had a pos. tendency towards stromelysin 3 (P = 0.058) and PINCH positivity (P = 0.05).  The patients with tumors that showed both weak and lower percentage of the legumain expression, either in tumor (P = 0.01) or in stroma (P = 0.04), had a better prognosis.  The legumain expression may be involved in colorectal cancer development and have a prognostic value in the patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo799TIWPiXeLVg90H21EOLACvtfcHk0ljwfnfBdWPhlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFaju7g%253D&md5=e33df863890fd6521b44ba2462dbf188</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1642%26sid%3Dliteratum%253Aachs%26aulast%3DMurthy%26aufirst%3DR.%2BV.%26aulast%3DArbman%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26aulast%3DSun%26aufirst%3DX.%2BF.%26atitle%3DLegumain%2520expression%2520in%2520relation%2520to%2520clinicopathologic%2520and%2520biological%2520variables%2520in%2520colorectal%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2293%26epage%3D2299%26doi%3D10.1158%2F1078-0432.CCR-04-1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janda, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgington, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span> </span><span class="NLM_article-title">Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">980</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1158%2F0008-5472.CAN-05-2591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=16424032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=970-980&author=W.+Wuauthor=Y.+Luoauthor=C.+Sunauthor=Y.+Liuauthor=P.+Kuoauthor=J.+Vargaauthor=R.+Xiangauthor=R.+Reisfeldauthor=K.+D.+Jandaauthor=T.+S.+Edgingtonauthor=C.+Liu&title=Targeting+cell-impermeable+prodrug+activation+to+tumor+microenvironment+eradicates+multiple+drug-resistant+neoplasms&doi=10.1158%2F0008-5472.CAN-05-2591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Cell-Impermeable Prodrug Activation to Tumor Microenvironment Eradicates Multiple Drug-Resistant Neoplasms</span></div><div class="casAuthors">Wu, Wenyuan; Luo, Yunping; Sun, Chengzao; Liu, Yuan; Kuo, Paul; Varga, Janos; Xiang, Rong; Reisfeld, Ralph; Janda, Kim D.; Edgington, Thomas S.; Liu, Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">970-980</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The tumor microenvironment is notably enriched with a broad spectrum of proteases.  The proteolytic specificities of peptide substrates provide modular chem. tools for the rational design of cell-impermeable prodrugs that are specifically activated by proteases extracellularly in the tumor microenvironment.  Targeting cell-impermeable prodrug activation to tumor microenvironment will significantly reduce drug toxicity to normal tissues.  The activated prodrug attacks both tumor and stroma cells through a "bystander effect" without selectively deleting target-producing cells, therefore further minimizing resistance and toxicity.  Here, we showed that legumain, the only asparaginyl endopeptidase of the mammalian genome, is highly expressed by neoplastic, stromal, and endothelial cells in solid tumors.  Legumain is present extracellularly in the tumor microenvironment, assocd. with matrix as well as cell surfaces and functional locally in the reduced pH of the tumor microenvironment.  A novel legumain-activated, cell-impermeable doxorubicin prodrug LEG-3 was designed to be activated exclusively in the tumor microenvironment.  Upon administration, there is a profound increase of the end-product doxorubicin in nuclei of cells in tumors but little in other tissues.  This tumor microenvironment-activated prodrug completely arrested growth of a variety of neoplasms, including multidrug-resistant tumor in vivo and significantly extended survival without evidence of myelosuppression or cardiac toxicity.  The tumor microenvironment-activated prodrug design can be extended to other proteases and chemotherapeutic compds. and provides new potentials for the rational development of more effective functionally targeted cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolEhvAaZUXc7Vg90H21EOLACvtfcHk0ljwfnfBdWPhlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFyjsA%253D%253D&md5=bc75cb0d30aca3de6ab5c73005bdeee1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2591%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DP.%26aulast%3DVarga%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DR.%26aulast%3DReisfeld%26aufirst%3DR.%26aulast%3DJanda%26aufirst%3DK.%2BD.%26aulast%3DEdgington%26aufirst%3DT.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DTargeting%2520cell-impermeable%2520prodrug%2520activation%2520to%2520tumor%2520microenvironment%2520eradicates%2520multiple%2520drug-resistant%2520neoplasms%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D970%26epage%3D980%26doi%3D10.1158%2F0008-5472.CAN-05-2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisfeld, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, R.</span><span> </span><span class="NLM_article-title">Targeting tumor-associated macrophages as a novel strategy against breast cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">2132</span><span class="NLM_x">–</span> <span class="NLM_lpage">2141</span><span class="refDoi"> DOI: 10.1172/JCI27648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1172%2FJCI27648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=2132-2141&author=Y.+Luoauthor=H.+Zhouauthor=J.+Kruegerauthor=C.+Kaplanauthor=S.+H.+Leeauthor=C.+Dolmanauthor=D.+Markowitzauthor=W.+Wuauthor=C.+Liuauthor=R.+A.+Reisfeldauthor=R.+Xiang&title=Targeting+tumor-associated+macrophages+as+a+novel+strategy+against+breast+cancer&doi=10.1172%2FJCI27648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1172%2FJCI27648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI27648%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKrueger%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DDolman%26aufirst%3DC.%26aulast%3DMarkowitz%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DReisfeld%26aufirst%3DR.%2BA.%26aulast%3DXiang%26aufirst%3DR.%26atitle%3DTargeting%2520tumor-associated%2520macrophages%2520as%2520a%2520novel%2520strategy%2520against%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D2132%26epage%3D2141%26doi%3D10.1172%2FJCI27648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ovat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muindi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sojka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopacek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. C.</span><span> </span><span class="NLM_article-title">Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7192</span><span class="NLM_x">–</span> <span class="NLM_lpage">7210</span><span class="refDoi"> DOI: 10.1021/jm900849h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900849h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7192-7210&author=A.+Ovatauthor=F.+Muindiauthor=C.+Faganauthor=M.+Brounerauthor=E.+Hansellauthor=J.+Dvorakauthor=D.+Sojkaauthor=P.+Kopacekauthor=J.+H.+McKerrowauthor=C.+R.+Caffreyauthor=J.+C.+Powers&title=Aza-peptidyl+Michael+acceptor+and+epoxide+inhibitors%2D%2Dpotent+and+selective+inhibitors+of+Schistosoma+mansoni+and+Ixodes+ricinus+legumains+%28asparaginyl+endopeptidases%29&doi=10.1021%2Fjm900849h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm900849h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900849h%26sid%3Dliteratum%253Aachs%26aulast%3DOvat%26aufirst%3DA.%26aulast%3DMuindi%26aufirst%3DF.%26aulast%3DFagan%26aufirst%3DC.%26aulast%3DBrouner%26aufirst%3DM.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DDvorak%26aufirst%3DJ.%26aulast%3DSojka%26aufirst%3DD.%26aulast%3DKopacek%26aufirst%3DP.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DAza-peptidyl%2520Michael%2520acceptor%2520and%2520epoxide%2520inhibitors--potent%2520and%2520selective%2520inhibitors%2520of%2520Schistosoma%2520mansoni%2520and%2520Ixodes%2520ricinus%2520legumains%2520%2528asparaginyl%2520endopeptidases%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7192%26epage%3D7210%26doi%3D10.1021%2Fjm900849h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Loak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoury, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, C.</span><span> </span><span class="NLM_article-title">Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">1239</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span><span class="refDoi"> DOI: 10.1515/BC.2003.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1515%2FBC.2003.136" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=1239-1246&author=K.+Loakauthor=D.+N.+Liauthor=B.+Manouryauthor=J.+Billsonauthor=F.+Mortonauthor=E.+Hewittauthor=C.+Watts&title=Novel+cell-permeable+acyloxymethylketone+inhibitors+of+asparaginyl+endopeptidase&doi=10.1515%2FBC.2003.136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.136%26sid%3Dliteratum%253Aachs%26aulast%3DLoak%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DD.%2BN.%26aulast%3DManoury%26aufirst%3DB.%26aulast%3DBillson%26aufirst%3DJ.%26aulast%3DMorton%26aufirst%3DF.%26aulast%3DHewitt%26aufirst%3DE.%26aulast%3DWatts%26aufirst%3DC.%26atitle%3DNovel%2520cell-permeable%2520acyloxymethylketone%2520inhibitors%2520of%2520asparaginyl%2520endopeptidase%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D1239%26epage%3D1246%26doi%3D10.1515%2FBC.2003.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Guan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSilvio, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arpornwirat, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorvidhaya, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newstat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, H.</span><span> </span><span class="NLM_article-title">Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1947</span><span class="NLM_x">–</span> <span class="NLM_lpage">1953</span><span class="refDoi"> DOI: 10.1200/JCO.2011.40.5241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1200%2FJCO.2011.40.5241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23509322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=1947-1953&author=Z.+Guanauthor=B.+Xuauthor=M.+L.+DeSilvioauthor=Z.+Shenauthor=W.+Arpornwiratauthor=Z.+Tongauthor=V.+Lorvidhayaauthor=Z.+Jiangauthor=J.+Yangauthor=A.+Makhsonauthor=W.+L.+Leungauthor=M.+W.+Russoauthor=B.+Newstatauthor=L.+Wangauthor=G.+Chenauthor=C.+Olivaauthor=H.+Gomez&title=Randomized+trial+of+lapatinib+versus+placebo+added+to+paclitaxel+in+the+treatment+of+human+epidermal+growth+factor+receptor+2-overexpressing+metastatic+breast+cancer&doi=10.1200%2FJCO.2011.40.5241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer</span></div><div class="casAuthors">Guan, Zhongzhen; Xu, Binghe; DeSilvio, Michelle L.; Shen, Zhenzhou; Arpornwirat, Wichit; Tong, Zhongsheng; Lorvidhaya, Vicharn; Jiang, Zefei; Yang, Junlan; Makhson, Anatoly; Leung, Wai Lim; Russo, Mark W.; Newstat, Beth; Wang, Li; Chen, George; Oliva, Cristina; Gomez, Henry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1947-1953</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Lapatinib is an oral small-mol. tyrosine kinase inhibitor of both epidermal growth factor receptor and human epidermal growth factor receptor 2 (HER2).  This study is designed to test whether the addn. of lapatinib to paclitaxel improves overall survival (OS) compared with placebo plus paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).  Patients and Methods This phase III, randomized, double-blind study assessed the efficacy and safety of lapatinib plus paclitaxel compared with placebo plus paclitaxel in patients with newly diagnosed HER2-pos. MBC.  The primary end point was OS.  Secondary end points included progression-free survival (PFS), overall response rate (ORR), clin. benefit rate, and safety.  Results The addn. of lapatinib to paclitaxel significantly improved OS vs. paclitaxel (treatment hazard ratio [HR], 0.74; 95% CI, 0.58 to 0.94; P = .0124); median OS was 27.8 vs. 20.5 mo, resp.  Median PFS was prolonged by 3.2 mo, from 6.5 mo with placebo plus paclitaxel to 9.7 mo with lapatinib plus paclitaxel (HR, 0.52; 95% CI, 0.42 to 0.64; stratified log-rank P < .001).  ORR was significantly higher with lapatinib plus paclitaxel compared with placebo plus paclitaxel (69% v 50%, resp.; P < .001).  The incidence of grades 3 and 4 diarrhea and neutropenia was higher in the lapatinib plus paclitaxel arm.  Only 4% of patients in this group reported febrile neutropenia.  Cardiac events were low grade, asymptomatic, and mostly reversible.  The incidence of hepatic events was similar in both arms.  There were no fatal adverse events in the lapatinib plus paclitaxel arm.  Conclusion This trial demonstrated that lapatinib combined with paclitaxel offers a significant and clin. meaningful survival advantage over paclitaxel alone in patients with HER2-pos. MBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEaOVfMRSDwbVg90H21EOLACvtfcHk0lgGxQm0YsrEQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbvE&md5=3940987cd66b39ae75bf0f071c8473b6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.40.5241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.40.5241%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DDeSilvio%26aufirst%3DM.%2BL.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DArpornwirat%26aufirst%3DW.%26aulast%3DTong%26aufirst%3DZ.%26aulast%3DLorvidhaya%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMakhson%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DW.%2BL.%26aulast%3DRusso%26aufirst%3DM.%2BW.%26aulast%3DNewstat%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DOliva%26aufirst%3DC.%26aulast%3DGomez%26aufirst%3DH.%26atitle%3DRandomized%2520trial%2520of%2520lapatinib%2520versus%2520placebo%2520added%2520to%2520paclitaxel%2520in%2520the%2520treatment%2520of%2520human%2520epidermal%2520growth%2520factor%2520receptor%25202-overexpressing%2520metastatic%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D1947%26epage%3D1953%26doi%3D10.1200%2FJCO.2011.40.5241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Proteases associated with invadopodia, and their role in degradation of extracellular matrix</span> <span class="citation_source-journal">Enzyme Protein</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1159%2F000468616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=8796997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaK28XjvVGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=59-71&author=W.+T.+Chen&title=Proteases+associated+with+invadopodia%2C+and+their+role+in+degradation+of+extracellular+matrix"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases associated with invadopodia, and their role in degradation of extracellular matrix</span></div><div class="casAuthors">Chen, Wen-Tien</div><div class="citationInfo"><span class="NLM_cas:title">Enzyme & Protein</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">59-71</span>CODEN:
                <span class="NLM_cas:coden">EPROEA</span>;
        ISSN:<span class="NLM_cas:issn">1019-6773</span>.
    
            (<span class="NLM_cas:orgname">Karger</span>)
        </div><div class="casAbstract">A review with 83 refs.  Metastasizing cancer cells invade the extracellular matrix using plasma membrane protrusions (invadopodia) that contact and dissolve the matrix.  Evidence suggests that membrane-assocd. proteases, 170 kDa gelatinase (seprase) and Gelatinase A, exert their mechanisms of action on invadopodia.  Potential roles that other metallo- and serine-types of membrane proteases, including membrane-type matrix metalloprotease, meprin, dipeptidyl peptidase IV, fibroblast activation protein α and guanidinobenzoatase, play in the cell surface proteolysis are also discussed.  It is proposed that formation of a structurally and functionally linked protease complex on invadopodia allows the invasion of cancer cells into the extracellular matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor4TlhjNwOL7Vg90H21EOLACvtfcHk0lgGxQm0YsrEQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVGjtbw%253D&md5=b01332439c1460660374409cbf646ab9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1159%2F000468616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000468616%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DProteases%2520associated%2520with%2520invadopodia%252C%2520and%2520their%2520role%2520in%2520degradation%2520of%2520extracellular%2520matrix%26jtitle%3DEnzyme%2520Protein%26date%3D1996%26volume%3D49%26spage%3D59%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Corcoran, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiner, D. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetler-Stevenson, W. G.</span><span> </span><span class="NLM_article-title">MMP-2: expression, activation and inhibition</span> <span class="citation_source-journal">Enzyme Protein</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1159%2F000468613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=8796994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaK28XjvVGjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=7-19&author=M.+L.+Corcoranauthor=R.+E.+Hewittauthor=D.+E.+Kleinerauthor=W.+G.+Stetler-Stevenson&title=MMP-2%3A+expression%2C+activation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-2: expression, activation and inhibition</span></div><div class="casAuthors">Corcoran, Marta L.; Hewitt, Robert E.; Kleiner, David E.; Stetler-Stevenson, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Enzyme & Protein</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">7-19</span>CODEN:
                <span class="NLM_cas:coden">EPROEA</span>;
        ISSN:<span class="NLM_cas:issn">1019-6773</span>.
    
            (<span class="NLM_cas:orgname">Karger</span>)
        </div><div class="casAbstract">A review with 79 refs.  Remodeling of the extracellular matrix (ECM), which occurs during many physiol. and pathol. processes, is one of the requisite events of cellular invasion.  The matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases that are responsible for proteolytic degrdn. of specific ECM components.  Regulating the activity of the MMPs at both mRNA and/or protein levels modulates the degrdn. of the ECM components which in turn alter cellular invasion.  Although most MMPs are regulated via similar mechanisms at the mRNA and protein levels, the modulation of gelatinase A is unique.  Understanding the mechanisms that regulate gelatinase A is important since expression and activation of this particular MMP is consistently correlated with a majority of malignant phenotypes.  In this report, the authors will contrast the mechanisms that regulate the expression, activation and inhibition of gelatinase A with the mechanisms that modulate the rest the MMP family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXXrF9bojru7Vg90H21EOLACvtfcHk0lgZO547sADoYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVGjtLc%253D&md5=f12bf21fe14215bbed2979540eceedba</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1159%2F000468613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000468613%26sid%3Dliteratum%253Aachs%26aulast%3DCorcoran%26aufirst%3DM.%2BL.%26aulast%3DHewitt%26aufirst%3DR.%2BE.%26aulast%3DKleiner%26aufirst%3DD.%2BE.%26aulast%3DStetler-Stevenson%26aufirst%3DW.%2BG.%26atitle%3DMMP-2%253A%2520expression%252C%2520activation%2520and%2520inhibition%26jtitle%3DEnzyme%2520Protein%26date%3D1996%26volume%3D49%26spage%3D7%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Nishida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span> </span><span class="NLM_article-title">Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">9096</span><span class="NLM_x">–</span> <span class="NLM_lpage">9104</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-2522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1158%2F0008-5472.CAN-08-2522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=18974156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSkur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9096-9104&author=Y.+Nishidaauthor=H.+Miyamoriauthor=E.+W.+Thompsonauthor=T.+Takinoauthor=Y.+Endoauthor=H.+Sato&title=Activation+of+matrix+metalloproteinase-2+%28MMP-2%29+by+membrane+type+1+matrix+metalloproteinase+through+an+artificial+receptor+for+proMMP-2+generates+active+MMP-2&doi=10.1158%2F0008-5472.CAN-08-2522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Matrix Metalloproteinase-2 (MMP-2) by Membrane Type 1 Matrix Metalloproteinase through an Artificial Receptor for ProMMP-2 Generates Active MMP-2</span></div><div class="casAuthors">Nishida, Yuki; Miyamori, Hisashi; Thompson, Erik W.; Takino, Takahisa; Endo, Yoshio; Sato, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9096-9104</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The suggested model for pro-matrix metalloproteinase-2 (proMMP-2) activation by membrane type 1 MMP (MT1-MMP) implicates the complex between MT1-MMP and tissue inhibitor of MMP-2 (TIMP-2) as a receptor for proMMP-2.  To dissect this model and assess the pathol. significance of MMP-2 activation, an artificial receptor for proMMP-2 was created by replacing the signal sequence of TIMP-2 with cytoplasmic/transmembrane domain of type II transmembrane mosaic serine protease (MSP-T2).  Unlike TIMP-2, MSP-T2 served as a receptor for proMMP-2 without inhibiting MT1-MMP, and generated TIMP-2-free active MMP-2 even at a low level of MT1-MMP.  Thus, MSP-T2 did not affect direct cleavage of the substrate testican-1 by MT1-MMP, whereas TIMP-2 inhibited it even at the level that stimulates proMMP-2 processing.  Expression of MSP-T2 in HT1080 cells enhanced MMP-2 activation by endogenous MT1-MMP and caused intensive hydrolysis of collagen gel.  Expression of MSP-T2 in U87 glioma cells, which express a trace level of endogenous MT1-MMP, induced MMP-2 activation and enhanced cell-assocd. protease activity, activation of extracellular signal-regulated kinase, and metastatic ability into chick embryonic liver and lung.  MT1-MMP can exert both max. MMP-2 activation and direct cleavage of substrates with MSP-T2, which cannot be achieved with TIMP-2.  These results suggest that MMP-2 activation by MT1-MMP potentially amplifies protease activity, and combination with direct cleavage of substrate causes effective tissue degrdn. and enhances tumor invasion and metastasis, which highlights the complex role of TIMP-2.  MSP-T2 is a unique tool to analyze physiol. and pathol. roles of MMP-2 and MT1-MMP in comparison with TIMP-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6nTjTSAlkrLVg90H21EOLACvtfcHk0lgZO547sADoYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSkur3F&md5=66043bb711e9d0e7bbed01a42689f461</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2522%26sid%3Dliteratum%253Aachs%26aulast%3DNishida%26aufirst%3DY.%26aulast%3DMiyamori%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DE.%2BW.%26aulast%3DTakino%26aufirst%3DT.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DH.%26atitle%3DActivation%2520of%2520matrix%2520metalloproteinase-2%2520%2528MMP-2%2529%2520by%2520membrane%2520type%25201%2520matrix%2520metalloproteinase%2520through%2520an%2520artificial%2520receptor%2520for%2520proMMP-2%2520generates%2520active%2520MMP-2%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D9096%26epage%3D9104%26doi%3D10.1158%2F0008-5472.CAN-08-2522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Chang, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D. N.</span><span> </span><span class="NLM_article-title">Epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and ERK1/2 pathway</span> <span class="citation_source-journal">Biomed. Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">141582</span><span class="refDoi"> DOI: 10.1155/2014/141582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1155%2F2014%2F141582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=25184134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FnvVCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=141582&author=C.+W.+Changauthor=Y.+H.+Hsiehauthor=W.+E.+Yangauthor=S.+F.+Yangauthor=Y.+Chenauthor=D.+N.+Hu&title=Epigallocatechingallate+inhibits+migration+of+human+uveal+melanoma+cells+via+downregulation+of+matrix+metalloproteinase-2+activity+and+ERK1%2F2+pathway&doi=10.1155%2F2014%2F141582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and ERK1/2 pathway</span></div><div class="casAuthors">Chang Chi-Wu; Hsieh Yi-Hsien; Yang Wei-En; Yang Shun-Fa; Chen Yueqin; Hu Dan-Ning</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141582</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The effects of epigallocatechingallate (EGCG) on the migration and expression of MMP-2 of uveal melanoma cells have not been reported.  We studied this effect and relevant signaling pathways in a human uveal melanoma cell line (M17).  MTT study found that EGCG did not affect the cell viability of M17 cells up to 100 μM.  Wound-healing assay showed that EGCG significantly reduced the migration of melanoma cells in a dose-dependent manner from 20 to 100 μM.  Gelatin zymography showed that secreted MMP-2 activity was dose-dependently inhibited by EGCG, whereas the MMP-2 expression at protein and mRNA levels was not affected as determined by western blot and RT-PCR analysis.  EGCG significantly increased the expressions of MMP-2 endogenous inhibitors (TIMP-2 and RECK) in M17 cells.  Western blot analysis of MAPK signal pathways showed that EGCG significantly decreased phosphorylated ERK1/2 levels, but not p38 and JNK levels, in melanoma cells.  ERK1/2 inhibitors also reduced the migration and activity of MMP-2 in M17 cells.  The present study suggested EGCG at nontoxic levels could inhibit migration of melanoma cells via downregulation of activities of secreted MMP-2 through the inhibition of the ERK1/2 phosphorylation.  Therefore, EGCG may be a promising agent to be explored for the prevention of metastasis of uveal melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPQjDyJ_luQrjnyZkbE8yXfW6udTcc2eY9wougxbnER7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FnvVCitg%253D%253D&md5=daadb8d33b4477800578094263592ce3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1155%2F2014%2F141582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F141582%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BW.%26aulast%3DHsieh%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DW.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DD.%2BN.%26atitle%3DEpigallocatechingallate%2520inhibits%2520migration%2520of%2520human%2520uveal%2520melanoma%2520cells%2520via%2520downregulation%2520of%2520matrix%2520metalloproteinase-2%2520activity%2520and%2520ERK1%252F2%2520pathway%26jtitle%3DBiomed.%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D141582%26doi%3D10.1155%2F2014%2F141582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kubben, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sier, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duijn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffioen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanemaaijer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Velde, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Krieken, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verspaget, H. W.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6603041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2Fsj.bjc.6603041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=16538217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=1035-1040&author=F.+J.+Kubbenauthor=C.+F.+Sierauthor=W.+van+Duijnauthor=G.+Griffioenauthor=R.+Hanemaaijerauthor=C.+J.+van+de+Veldeauthor=J.+H.+van+Kriekenauthor=C.+B.+Lamersauthor=H.+W.+Verspaget&title=Matrix+metalloproteinase-2+is+a+consistent+prognostic+factor+in+gastric+cancer&doi=10.1038%2Fsj.bjc.6603041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer</span></div><div class="casAuthors">Kubben, F. J. G. M.; Sier, C. F. M.; van Duijn, W.; Griffioen, G.; Hanemaaijer, R.; van de Velde, C. J. H.; van Krieken, J. H. J. M.; Lamers, C. B. H. W.; Verspaget, H. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1035-1040</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In a pioneer study, we showed 10 years ago that enhanced tissue levels of the matrix metalloproteinases (MMPs) MMP-2 and MMP-9 in gastric cancers, as detd. by zymog., were related with worse overall survival of the patients.  To corroborate these observations, we now assessed MMP-2 and MMP-9 with new techniques in an expanded group of gastric cancer patients (n=81) and included for comparison MMP-7, MMP-8 and the tissue inhibitors of MMPs, TIMP-1 and -2.  All MMPs and TIMP-1 were significantly increased in tumor tissue compared to normal gastric mucosa.  Matrix metalloproteinase-7, -8 and -9, and the TIMPs showed some correlations with the clinicopathol. parameters TNM, WHO and Lauren classification, but their levels were not related with survival.  Regardless of the detn. method used, i.e., ELISA or bioactivity assay, an enhanced tumor MMP-2 level did not show a significant correlation with any of the clinicopathol. parameters, but was confirmed to be an independent prognostic factor in gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSS3LO-2iEirVg90H21EOLACvtfcHk0lh_tjHmuNobZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7o%253D&md5=2031b65f44b50d3d00af0c259f67f301</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603041%26sid%3Dliteratum%253Aachs%26aulast%3DKubben%26aufirst%3DF.%2BJ.%26aulast%3DSier%26aufirst%3DC.%2BF.%26aulast%3Dvan%2BDuijn%26aufirst%3DW.%26aulast%3DGriffioen%26aufirst%3DG.%26aulast%3DHanemaaijer%26aufirst%3DR.%26aulast%3Dvan%2Bde%2BVelde%26aufirst%3DC.%2BJ.%26aulast%3Dvan%2BKrieken%26aufirst%3DJ.%2BH.%26aulast%3DLamers%26aufirst%3DC.%2BB.%26aulast%3DVerspaget%26aufirst%3DH.%2BW.%26atitle%3DMatrix%2520metalloproteinase-2%2520is%2520a%2520consistent%2520prognostic%2520factor%2520in%2520gastric%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D1035%26epage%3D1040%26doi%3D10.1038%2Fsj.bjc.6603041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Morita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahama-Noda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara-Nishimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, I.</span><span> </span><span class="NLM_article-title">Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1424</span><span class="refDoi"> DOI: 10.1016/j.febslet.2007.02.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.febslet.2007.02.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=17350006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVWnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=1417-1424&author=Y.+Moritaauthor=H.+Arakiauthor=T.+Sugimotoauthor=K.+Takeuchiauthor=T.+Yamaneauthor=T.+Maedaauthor=Y.+Yamamotoauthor=K.+Nishiauthor=M.+Asanoauthor=K.+Shirahama-Nodaauthor=M.+Nishimuraauthor=T.+Uzuauthor=I.+Hara-Nishimuraauthor=D.+Koyaauthor=A.+Kashiwagiauthor=I.+Ohkubo&title=Legumain%2Fasparaginyl+endopeptidase+controls+extracellular+matrix+remodeling+through+the+degradation+of+fibronectin+in+mouse+renal+proximal+tubular+cells&doi=10.1016%2Fj.febslet.2007.02.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells</span></div><div class="casAuthors">Morita, Yoshikata; Araki, Hisazumi; Sugimoto, Toshiro; Takeuchi, Keisuke; Yamane, Takuya; Maeda, Toshinaga; Yamamoto, Yoshio; Nishi, Katsuji; Asano, Masahide; Shirahama-Noda, Kanae; Nishimura, Mikio; Uzu, Takashi; Hara-Nishimura, Ikuko; Koya, Daisuke; Kashiwagi, Atsunori; Ohkubo, Iwao</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1417-1424</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Legumain/asparaginyl endopeptidase (EC 3.4.22.34) is a novel cysteine protease that is abundantly expressed in the late endosomes and lysosomes of renal proximal tubular cells.  Recently, emerging evidence has indicated that legumain might play an important role in control of extracellular matrix turnover in various pathol. conditions such as tumor growth/metastasis and progression of atherosclerosis.  We initially found that purified legumain can directly degrade fibronectin, one of the main components of the extracellular matrix, in vitro.  Therefore, we examd. the effect of legumain on fibronectin degrdn. in cultured mouse renal proximal tubular cells.  Fibronectin processing can be inhibited by chloroquine, an inhibitor of lysosomal degrdn., and can be enhanced by the overexpression of legumain, indicating that fibronectin degrdn. occurs in the presence of legumain in lysosomes from renal proximal tubular cells.  Furthermore, in legumain-deficient mice, unilateral ureteral obstruction (UUO)-induced renal interstitial protein accumulation of fibronectin and renal interstitial fibrosis were markedly enhanced.  These findings indicate that legumain might have an important role in extracellular matrix remodeling via the degrdn. of fibronectin in renal proximal tubular cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3Nj7LQTaaLVg90H21EOLACvtfcHk0lh_tjHmuNobZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVWnsLs%253D&md5=d6fda469791a3ab8971c20e1046f2201</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2007.02.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2007.02.064%26sid%3Dliteratum%253Aachs%26aulast%3DMorita%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DH.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DYamane%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DNishi%26aufirst%3DK.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DShirahama-Noda%26aufirst%3DK.%26aulast%3DNishimura%26aufirst%3DM.%26aulast%3DUzu%26aufirst%3DT.%26aulast%3DHara-Nishimura%26aufirst%3DI.%26aulast%3DKoya%26aufirst%3DD.%26aulast%3DKashiwagi%26aufirst%3DA.%26aulast%3DOhkubo%26aufirst%3DI.%26atitle%3DLegumain%252Fasparaginyl%2520endopeptidase%2520controls%2520extracellular%2520matrix%2520remodeling%2520through%2520the%2520degradation%2520of%2520fibronectin%2520in%2520mouse%2520renal%2520proximal%2520tubular%2520cells%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D1417%26epage%3D1424%26doi%3D10.1016%2Fj.febslet.2007.02.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Zhao</span>, <span class="hlFld-ContribAuthor ">Yujie  Liu</span>, <span class="hlFld-ContribAuthor ">Yanfei  Hao</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Tao</span>, <span class="hlFld-ContribAuthor ">Dong  Wang</span>, <span class="hlFld-ContribAuthor ">Yuyin  Li</span>, <span class="hlFld-ContribAuthor ">Zhenxing  Liu</span>, <span class="hlFld-ContribAuthor ">Edward A  McKenzie</span>, <span class="hlFld-ContribAuthor ">Qing  Zhao</span>, <span class="hlFld-ContribAuthor ">Aipo  Diao</span>. </span><span class="cited-content_cbyCitation_article-title">Esomeprazole inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2021,</strong> <em>39 </em>
                                    (2)
                                     , 337-347. <a href="https://doi.org/10.1007/s10637-020-01011-3" title="DOI URL">https://doi.org/10.1007/s10637-020-01011-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-020-01011-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-020-01011-3%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DEsomeprazole%252Binhibits%252Bthe%252Blysosomal%252Bcysteine%252Bprotease%252Blegumain%252Bto%252Bprevent%252Bcancer%252Bmetastasis%26aulast%3DZhao%26aufirst%3DTian%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D2%26spage%3D337%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richa  Gupta</span>, <span class="hlFld-ContribAuthor ">Gaurav  Kumar</span>, <span class="hlFld-ContribAuthor ">Buddhi Prakash  Jain</span>, <span class="hlFld-ContribAuthor ">Sunandini  Chandra</span>, <span class="hlFld-ContribAuthor ">Shyamal K.  Goswami</span>. </span><span class="cited-content_cbyCitation_article-title">Ectopic expression of 35 kDa and knocking down of 78 kDa SG2NAs induce cytoskeletal reorganization, alter membrane sialylation, and modulate the markers of EMT. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biochemistry</span><span> <strong>2021,</strong> <em>476 </em>
                                    (2)
                                     , 633-648. <a href="https://doi.org/10.1007/s11010-020-03932-2" title="DOI URL">https://doi.org/10.1007/s11010-020-03932-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11010-020-03932-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11010-020-03932-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biochemistry%26atitle%3DEctopic%252Bexpression%252Bof%252B35%2525C2%2525A0kDa%252Band%252Bknocking%252Bdown%252Bof%252B78%2525C2%2525A0kDa%252BSG2NAs%252Binduce%252Bcytoskeletal%252Breorganization%25252C%252Balter%252Bmembrane%252Bsialylation%25252C%252Band%252Bmodulate%252Bthe%252Bmarkers%252Bof%252BEMT%26aulast%3DGupta%26aufirst%3DRicha%26date%3D2021%26date%3D2020%26volume%3D476%26issue%3D2%26spage%3D633%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariane A.D.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Marcela V.  Pimenta</span>, <span class="hlFld-ContribAuthor ">Iris M.  Costa</span>, <span class="hlFld-ContribAuthor ">Priscila P.  Zenatti</span>, <span class="hlFld-ContribAuthor ">Natacha A.  Migita</span>, <span class="hlFld-ContribAuthor ">José A.  Yunes</span>, <span class="hlFld-ContribAuthor ">Carlota O.  Rangel-Yagui</span>, <span class="hlFld-ContribAuthor ">Matheus M.  de Sá</span>, <span class="hlFld-ContribAuthor ">Adalberto  Pessoa</span>, <span class="hlFld-ContribAuthor ">Tales A.  Costa-Silva</span>, <span class="hlFld-ContribAuthor ">Marcos H.  Toyama</span>, <span class="hlFld-ContribAuthor ">Carlos A.  Breyer</span>, <span class="hlFld-ContribAuthor ">Marcos A.  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Veronica F.  Santiago</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Palmisano</span>, <span class="hlFld-ContribAuthor ">Christiano M.V.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Cristina B.  Hebeda</span>, <span class="hlFld-ContribAuthor ">Sandra H.P.  Farsky</span>, <span class="hlFld-ContribAuthor ">Gisele  Monteiro</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of lysosomal protease sensitivity in the immunogenicity of the antitumor biopharmaceutical asparaginase. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>182 </em>, 114230. <a href="https://doi.org/10.1016/j.bcp.2020.114230" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114230%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DInfluence%252Bof%252Blysosomal%252Bprotease%252Bsensitivity%252Bin%252Bthe%252Bimmunogenicity%252Bof%252Bthe%252Bantitumor%252Bbiopharmaceutical%252Basparaginase%26aulast%3DRodrigues%26aufirst%3DMariane%2BA.D.%26date%3D2020%26volume%3D182%26spage%3D114230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kecheng  Lei</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Gu</span>, <span class="hlFld-ContribAuthor ">Alvaro G.  Alvarado</span>, <span class="hlFld-ContribAuthor ">Yuhong  Du</span>, <span class="hlFld-ContribAuthor ">Shilin  Luo</span>, <span class="hlFld-ContribAuthor ">Eun Hee  Ahn</span>, <span class="hlFld-ContribAuthor ">Seong Su  Kang</span>, <span class="hlFld-ContribAuthor ">Bing  Ji</span>, <span class="hlFld-ContribAuthor ">Xia  Liu</span>, <span class="hlFld-ContribAuthor ">Hui  Mao</span>, <span class="hlFld-ContribAuthor ">Haian  Fu</span>, <span class="hlFld-ContribAuthor ">Harley I.  Kornblum</span>, <span class="hlFld-ContribAuthor ">Lingjing  Jin</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Keqiang  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2020,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-020-00979-y" title="DOI URL">https://doi.org/10.1186/s13045-020-00979-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-020-00979-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-020-00979-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DDiscovery%252Bof%252Ba%252Bdual%252Binhibitor%252Bof%252BNQO1%252Band%252BGSTP1%252Bfor%252Btreating%252Bglioblastoma%26aulast%3DLei%26aufirst%3DKecheng%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayasree S.  Kanathasan</span>, <span class="hlFld-ContribAuthor ">Diivananthan  Gunasagaram</span>, <span class="hlFld-ContribAuthor ">Shafi Ullah  Khan</span>, <span class="hlFld-ContribAuthor ">Uma D.  Palanisamy</span>, <span class="hlFld-ContribAuthor ">Ammu Kutty  Radhakrishnan</span>, <span class="hlFld-ContribAuthor ">Nafees  Ahemad</span>, <span class="hlFld-ContribAuthor ">Varghese  Swamy</span>. </span><span class="cited-content_cbyCitation_article-title">Linear versus Branched Peptide with Same Amino Acid Sequence for Legumain‐Targeting in Macrophages: Targeting Efficiency and Bioimaging Potential. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (32)
                                     , 9911-9919. <a href="https://doi.org/10.1002/slct.202002161" title="DOI URL">https://doi.org/10.1002/slct.202002161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002161%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DLinear%252Bversus%252BBranched%252BPeptide%252Bwith%252BSame%252BAmino%252BAcid%252BSequence%252Bfor%252BLegumain%2525E2%252580%252590Targeting%252Bin%252BMacrophages%25253A%252BTargeting%252BEfficiency%252Band%252BBioimaging%252BPotential%26aulast%3DKanathasan%26aufirst%3DJayasree%2BS.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D32%26spage%3D9911%26epage%3D9919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi  Li</span>, <span class="hlFld-ContribAuthor ">Qingzhu  Liu</span>, <span class="hlFld-ContribAuthor ">Siqin  Ye</span>, <span class="hlFld-ContribAuthor ">Shijie  Wang</span>, <span class="hlFld-ContribAuthor ">Ke  Li</span>, <span class="hlFld-ContribAuthor ">Gaochao  Lv</span>, <span class="hlFld-ContribAuthor ">Ying  Peng</span>, <span class="hlFld-ContribAuthor ">Ling  Qiu</span>, <span class="hlFld-ContribAuthor ">Jianguo  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">A protease‐responsive fluorescent probe for sensitive imaging of legumain activity in living tumor cells. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>272 </em><a href="https://doi.org/10.1111/cbdd.13530" title="DOI URL">https://doi.org/10.1111/cbdd.13530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13530%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DA%252Bprotease%2525E2%252580%252590responsive%252Bfluorescent%252Bprobe%252Bfor%252Bsensitive%252Bimaging%252Bof%252Blegumain%252Bactivity%252Bin%252Bliving%252Btumor%252Bcells%26aulast%3DLi%26aufirst%3DXi%26date%3D2019%26date%3D2019%26volume%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nana  Ozawa</span>, <span class="hlFld-ContribAuthor ">Yuki  Sato</span>, <span class="hlFld-ContribAuthor ">Yukari  Mori</span>, <span class="hlFld-ContribAuthor ">Hiroko  Masuda</span>, <span class="hlFld-ContribAuthor ">Mao  Yamane</span>, <span class="hlFld-ContribAuthor ">Yuka  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Remina  Shirai</span>, <span class="hlFld-ContribAuthor ">Rena  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kengo  Sato</span>, <span class="hlFld-ContribAuthor ">Yusaku  Mori</span>, <span class="hlFld-ContribAuthor ">Tsutomu  Hirano</span>, <span class="hlFld-ContribAuthor ">Takuya  Watanabe</span>. </span><span class="cited-content_cbyCitation_article-title">Legumain Promotes Atherosclerotic Vascular Remodeling. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (9)
                                     , 2195. <a href="https://doi.org/10.3390/ijms20092195" title="DOI URL">https://doi.org/10.3390/ijms20092195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20092195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20092195%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DLegumain%252BPromotes%252BAtherosclerotic%252BVascular%252BRemodeling%26aulast%3DOzawa%26aufirst%3DNana%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D9%26spage%3D2195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatjana  Bosnjak</span>, <span class="hlFld-ContribAuthor ">Rigmor  Solberg</span>, <span class="hlFld-ContribAuthor ">Paya Diana  Hemati</span>, <span class="hlFld-ContribAuthor ">Abbas  Jafari</span>, <span class="hlFld-ContribAuthor ">Moustapha  Kassem</span>, <span class="hlFld-ContribAuthor ">Harald Thidemann  Johansen</span>. </span><span class="cited-content_cbyCitation_article-title">Lansoprazole inhibits the cysteine protease legumain by binding to the active site. </span><span class="cited-content_cbyCitation_journal-name">Basic & Clinical Pharmacology & Toxicology</span><span> <strong>2019,</strong> <em>11 </em><a href="https://doi.org/10.1111/bcpt.13230" title="DOI URL">https://doi.org/10.1111/bcpt.13230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcpt.13230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcpt.13230%26sid%3Dliteratum%253Aachs%26jtitle%3DBasic%2520%2526%2520Clinical%2520Pharmacology%2520%2526%2520Toxicology%26atitle%3DLansoprazole%252Binhibits%252Bthe%252Bcysteine%252Bprotease%252Blegumain%252Bby%252Bbinding%252Bto%252Bthe%252Bactive%252Bsite%26aulast%3DBosnjak%26aufirst%3DTatjana%26date%3D2019%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peiyuan  Bai</span>, <span class="hlFld-ContribAuthor ">Luheng  Lyu</span>, <span class="hlFld-ContribAuthor ">Tingting  Yu</span>, <span class="hlFld-ContribAuthor ">Caojian  Zuo</span>, <span class="hlFld-ContribAuthor ">Jie  Fu</span>, <span class="hlFld-ContribAuthor ">Yuhu  He</span>, <span class="hlFld-ContribAuthor ">Qiangyou  Wan</span>, <span class="hlFld-ContribAuthor ">Naifu  Wan</span>, <span class="hlFld-ContribAuthor ">Daile  Jia</span>, <span class="hlFld-ContribAuthor ">Ankang  Lyu</span>. </span><span class="cited-content_cbyCitation_article-title">Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-β1 Signaling. </span><span class="cited-content_cbyCitation_journal-name">Arteriosclerosis, Thrombosis, and Vascular Biology</span><span> <strong>2019,</strong> <em>39 </em>
                                    (4)
                                     <a href="https://doi.org/10.1161/ATVBAHA.118.312254" title="DOI URL">https://doi.org/10.1161/ATVBAHA.118.312254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/ATVBAHA.118.312254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FATVBAHA.118.312254%26sid%3Dliteratum%253Aachs%26jtitle%3DArteriosclerosis%252C%2520Thrombosis%252C%2520and%2520Vascular%2520Biology%26atitle%3DMacrophage-Derived%252BLegumain%252BPromotes%252BPulmonary%252BHypertension%252Bby%252BActivating%252Bthe%252BMMP%252B%252528Matrix%252BMetalloproteinase%252529-2%25252FTGF%252B%252528Transforming%252BGrowth%252BFactor%252529-%2525CE%2525B21%252BSignaling%26aulast%3DBai%26aufirst%3DPeiyuan%26date%3D2019%26volume%3D39%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong-Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Fa-Qian  Shen</span>, <span class="hlFld-ContribAuthor ">Meng-Ru  Yang</span>, <span class="hlFld-ContribAuthor ">Ling-Xia  You</span>, <span class="hlFld-ContribAuthor ">Li-Zhi  Chen</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>, <span class="hlFld-ContribAuthor ">Ya-Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Fan-Lei  Kong</span>, <span class="hlFld-ContribAuthor ">Ming-Hua  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (23-24)
                                     , 3816-3821. <a href="https://doi.org/10.1016/j.bmcl.2018.05.004" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDihydropyrazothiazole%252Bderivatives%252Bas%252Bpotential%252BMMP-2%25252FMMP-8%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DWang%26aufirst%3DZhong-Chang%26date%3D2018%26volume%3D28%26issue%3D23-24%26spage%3D3816%26epage%3D3821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Shi</span>, <span class="hlFld-ContribAuthor ">Bin  Lan</span>, <span class="hlFld-ContribAuthor ">Baowei  Peng</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Wang</span>, <span class="hlFld-ContribAuthor ">Ganggang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Li</span>, <span class="hlFld-ContribAuthor ">Fang  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Combination therapy with BH3 mimetic and hyperthermia tends to be more effective on anti-melanoma treatment. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2018,</strong> <em>503 </em>
                                    (1)
                                     , 249-256. <a href="https://doi.org/10.1016/j.bbrc.2018.06.010" title="DOI URL">https://doi.org/10.1016/j.bbrc.2018.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2018.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2018.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DCombination%252Btherapy%252Bwith%252BBH3%252Bmimetic%252Band%252Bhyperthermia%252Btends%252Bto%252Bbe%252Bmore%252Beffective%252Bon%252Banti-melanoma%252Btreatment%26aulast%3DShi%26aufirst%3DZhen%26date%3D2018%26volume%3D503%26issue%3D1%26spage%3D249%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Wanqiang  Wu</span>, <span class="hlFld-ContribAuthor ">Seong Su  Kang</span>, <span class="hlFld-ContribAuthor ">Xia  Liu</span>, <span class="hlFld-ContribAuthor ">Zhiping  Wu</span>, <span class="hlFld-ContribAuthor ">Junmin  Peng</span>, <span class="hlFld-ContribAuthor ">Shan Ping  Yu</span>, <span class="hlFld-ContribAuthor ">Fredric P.  Manfredsson</span>, <span class="hlFld-ContribAuthor ">Ivette M.  Sandoval</span>, <span class="hlFld-ContribAuthor ">Xuebo  Liu</span>, <span class="hlFld-ContribAuthor ">Jian-Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Keqiang  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">BDNF inhibits neurodegenerative disease–associated asparaginyl endopeptidase activity via phosphorylation by AKT. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2018,</strong> <em>3 </em>
                                    (16)
                                     <a href="https://doi.org/10.1172/jci.insight.99007" title="DOI URL">https://doi.org/10.1172/jci.insight.99007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.99007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.99007%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DBDNF%252Binhibits%252Bneurodegenerative%252Bdisease%2525E2%252580%252593associated%252Basparaginyl%252Bendopeptidase%252Bactivity%252Bvia%252Bphosphorylation%252Bby%252BAKT%26aulast%3DWang%26aufirst%3DZhi-Hao%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Junchun  Tang</span>, <span class="hlFld-ContribAuthor ">Yi-yi  Li</span>, <span class="hlFld-ContribAuthor ">YanXia  Gu</span>, <span class="hlFld-ContribAuthor ">Ying  Yu</span>, <span class="hlFld-ContribAuthor ">Jing  Xiong</span>, <span class="hlFld-ContribAuthor ">Xueqing  Zhao</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Ting-ting  Li</span>, <span class="hlFld-ContribAuthor ">Jutao  Chen</span>, <span class="hlFld-ContribAuthor ">Qi  Wan</span>, <span class="hlFld-ContribAuthor ">Zhaohui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic acid induces neuronal cell death via activation of asparagine endopeptidase in cerebral ischemia-reperfusion injury. </span><span class="cited-content_cbyCitation_journal-name">Experimental Neurology</span><span> <strong>2018,</strong> <em>306 </em>, 1-9. <a href="https://doi.org/10.1016/j.expneurol.2018.04.010" title="DOI URL">https://doi.org/10.1016/j.expneurol.2018.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.expneurol.2018.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.expneurol.2018.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Neurology%26atitle%3DLysophosphatidic%252Bacid%252Binduces%252Bneuronal%252Bcell%252Bdeath%252Bvia%252Bactivation%252Bof%252Basparagine%252Bendopeptidase%252Bin%252Bcerebral%252Bischemia-reperfusion%252Binjury%26aulast%3DWang%26aufirst%3DChao%26date%3D2018%26volume%3D306%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Kinetic analysis of compound <b>38</b> inhibition of AEP. (A) Michaelis–Menten plots displaying competitive inhibition of AEP. The inhibition constant, <i>K</i><sub>I</sub>, was determined from the globally fit data. (B) Double reciprocal Lineweaver–Burk plots also displaying competitive inhibition. (C) Nonlinear progress curves obtained from the time course inactivation experiments, indicating that compound <b>38</b> is a slow-binding inhibitor of AEP. (D) A plot of the corrected <i>k</i><sub>obs</sub> values obtained from each curve in (B) versus the concentration of compound <b>38</b>, which enabled the calculation of the second-order rate constant, <i>k</i><sub>inact</sub> /<i>K</i><sub>I</sub>, to be determined to measure the potency of the inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The SAR analysis of compound <b>38</b>. (A) The structures and percentages of residual AEP activity of the compound <b>38</b> derivatives, in which substitutions were made to the nitrogen in the R<sub>7</sub> position. (B) The structures and percentages of residual AEP activity of the compound <b>38</b> derivatives, in which substitutions were made to the nitrogens at the R<sub>7</sub> and R<sub>1</sub> positions. (C) The structures and percentages of residual AEP activity of the compound <b>38</b> derivatives, in which substitutions were made at the R<sub>7</sub>, R<sub>1</sub>, and R<sub>6</sub> positions in the xanthine ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>38u</b> specifically inhibits AEP. (A) Structures of compound <b>38</b> and its derivatives with increased hydrophobicity. (B) IC<sub>50</sub> curves for compound <b>38</b> and its derivatives against pure AEP. (C) Inhibition specificity assay. IC<sub>50</sub> values of compound <b>38</b> and its derivatives against AEP and other related major cysteine proteases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>38u</b> inhibits invasion in vitro. (A) Effect of compound <b>38u</b> on cell proliferation, invasion, and migration of MDA-MB-231 cells. Cell proliferation was determined by MTT assay, following incubation with the compound. (B) Effect of compound <b>38u</b> on cell proliferation, invasion, and migration of MDA-MB-435 cells. Cell proliferation was determined by MTT assay, following incubation with the compound. (C) Effect of compound <b>38u</b> on AEP activity in MDA-MB-231 and MDA-MB-435 cells. AEP activity were examined with lysate of cells treated by <b>38u</b> (D) Effect of compound <b>38u</b> on invasion of MDA-MB-231 and MDA-MB-435 cells treated by control and AEP siRNA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>38u</b> prevents breast-to-lung metastasis in vivo. (A) Representative mouse lungs of animals treated with vehicle control or 3 or 10 mg/kg compound <b>38u</b>. Bottom panel depicts IHC staining. (B) Quantification of metastasized cancer nodules found on the treated and untreated mouse lungs demonstrates that significantly less nodules are present in the lungs of the drug-treated mice. (C) The proportion of mice exhibiting metastatic nodules in lungs decreased as the drug treatment dosage increased.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>38u</b> does not exhibit toxic effects in mice. (A) IHC sections of bone marrow, kidney, liver, and spleen from animals treated with vehicle control or 3 or 10 mg/kg of compound <b>38u</b> show similar results in vehicle and drug-treated tissues. (B) There was no significant difference in body weight observed in mice treated with vehicle control or compound <b>38u</b>. (C) The size of the liver remained similar in vehicle and drug-treated animals, however, the spleen was slightly enlarged in drug-treated animals as compared to control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/medium/jm-2017-00228n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>38u</b> inhibits AEP cleavage of MMP-2 in vitro and in vivo. (A) Gelatin zymography was used to demonstrate that in the presence of AEP, MMP-2 is cleaved when only vehicle control is added to the reaction. In the presence of only 1 μM compound <b>38u</b>, there is a significant decrease in the observed cleavage of MMP-2 and at the highest drug dose, 10 μM, MMP-2 cleavage returns to basal levels, as observed in the absence of AEP. (B) Compound <b>38u</b> was administered to MDA-MB-231 cells, and the inhibition of endogenous MMP-2 cleavage was observed in the presence of 1, 2, 5, and 10 μM compound. (C) The cell viability was not affected by the different doses of drug used in the experiment. (D) Effect of compound <b>38u</b> on AEP activity in MDA-MB-231 cells. Cells were treated with indicated concentrations of <b>38u</b>. AEP activity were examined with lysate of cells treated by <b>38u</b>. (E) Effect of compound <b>38u</b> on MMP-2 cleavage in MDA-MB-231 cells treated by AEP siRNA. Depletion of AEP abolished Pro-MMP-2 cleavage, and <b>38u</b> lost its inhibitory effect on MMP-2 cleavage. (F) The ratio of cleaved MMP-2 to full-length MMP-2 (pro-MMP-2) significantly decreased in drug-treated mammary tumor tissue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00228/20170908/images/large/jm-2017-00228n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00228&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Coghlin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, G. I.</span><span> </span><span class="NLM_article-title">Current and emerging concepts in tumour metastasis</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1002/path.2727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1002%2Fpath.2727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=20681009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2010&pages=1-15&author=C.+Coghlinauthor=G.+I.+Murray&title=Current+and+emerging+concepts+in+tumour+metastasis&doi=10.1002%2Fpath.2727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current and emerging concepts in tumour metastasis</span></div><div class="casAuthors">Coghlin, Caroline; Murray, Graeme I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Disseminated cancer accounts for most deaths due to malignancy.  Despite this, research has focused predominantly on tumor development and progression at the primary site.  Recently, attention has shifted towards the field of tumor metastasis.  Several new and exciting concepts that have emerged in the past few years may shed light on this complex area.  The established canonical theory of tumor metastasis, as a process emerging from a stepwise accumulation of genetic events fuelled by clonal evolution, has been challenged.  New evidence suggests that malignant cells can disseminate at a much earlier stage than previously recognized in tumorigenesis.  These findings have direct relevance to clin. practice and shed new light on tumor biol.  Gene-profiling studies support this theory, suggesting that metastatic ability may be an innate property shared by the bulk of cells present early in a developing tumor mass.  There is a growing recognition of the importance of host factors outside the primary site in the development of metastatic disease.  The role of the 'pre-metastatic niche' is being defined and with this comes a new understanding of the function of bone marrow-derived progenitor cells in directing the dissemination of malignant cells to distant sites.  Current research has highlighted the crucial roles played by non-neoplastic host cells within the tumor microenvironment in regulating metastasis.  These new concepts have wide-ranging implications for our overall understanding of tumor metastasis and for the development of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMUNr7v0dAB7Vg90H21EOLACvtfcHk0lg2GBbFbSg65w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnurzO&md5=91ce24314a2f19849cc4213c656f0b6a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fpath.2727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2727%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlin%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DG.%2BI.%26atitle%3DCurrent%2520and%2520emerging%2520concepts%2520in%2520tumour%2520metastasis%26jtitle%3DJ.%2520Pathol.%26date%3D2010%26volume%3D222%26spage%3D1%26epage%3D15%26doi%3D10.1002%2Fpath.2727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Coussens, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">Inflammation and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.1038/nature01322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2Fnature01322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=12490959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFygtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2002&pages=860-867&author=L.+M.+Coussensauthor=Z.+Werb&title=Inflammation+and+cancer&doi=10.1038%2Fnature01322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and cancer</span></div><div class="casAuthors">Coussens, Lisa M.; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">6917</span>),
    <span class="NLM_cas:pages">860-867</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent data have expanded the concept that inflammation is a crit. component of tumor progression.  Many cancers arise from sites of infection, chronic irritation and inflammation.  It is now becoming clear that the tumor microenvironment, which is largely orchestrated by inflammatory cells, is an indispensable participant in the neoplastic process, fostering proliferation, survival and migration.  In addn., tumor cells have co-opted some of the signaling mols. of the innate immune system, such as selectins, chemokines and their receptors for invasion, migration and metastasis.  These insights are fostering new anti-inflammatory therapeutic approaches to cancer development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3OArXFf_lrVg90H21EOLACvtfcHk0lg2GBbFbSg65w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFygtb4%253D&md5=8861c61ab0c2ea67a1c853803c272412</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature01322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01322%26sid%3Dliteratum%253Aachs%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DInflammation%2520and%2520cancer%26jtitle%3DNature%26date%3D2002%26volume%3D420%26spage%3D860%26epage%3D867%26doi%3D10.1038%2Fnature01322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kessenbrock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plaks, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases: regulators of the tumor microenvironment</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.cell.2010.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=20371345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2010&pages=52-67&author=K.+Kessenbrockauthor=V.+Plaksauthor=Z.+Werb&title=Matrix+metalloproteinases%3A+regulators+of+the+tumor+microenvironment&doi=10.1016%2Fj.cell.2010.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: regulators of the tumor microenvironment</span></div><div class="casAuthors">Kessenbrock, Kai; Plaks, Vicki; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-67</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Extracellular proteolysis mediates tissue homeostasis.  In cancer, altered proteolysis leads to unregulated tumor growth, tissue remodeling, inflammation, tissue invasion, and metastasis.  The matrix metalloproteinases (MMPs) represent the most prominent family of proteinases assocd. with tumorigenesis.  Recent technol. developments have markedly advanced our understanding of MMPs as modulators of the tumor microenvironment.  In addn. to their role in extracellular matrix turnover and cancer cell migration, MMPs regulate signaling pathways that control cell growth, inflammation, or angiogenesis and may even work in a nonproteolytic manner.  These aspects of MMP function are reorienting our approaches to cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAwNenyy027LVg90H21EOLACvtfcHk0ljoKVYCpLokcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgtb4%253D&md5=fb7ee4c41ef31db0310b985e87bcdb94</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DKessenbrock%26aufirst%3DK.%26aulast%3DPlaks%26aufirst%3DV.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DMatrix%2520metalloproteinases%253A%2520regulators%2520of%2520the%2520tumor%2520microenvironment%26jtitle%3DCell%26date%3D2010%26volume%3D141%26spage%3D52%26epage%3D67%26doi%3D10.1016%2Fj.cell.2010.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Husemann, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geigl, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musiani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghart, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eils, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riethmuller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C. A.</span><span> </span><span class="NLM_article-title">Systemic spread is an early step in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1016/j.ccr.2007.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.ccr.2007.12.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=58-68&author=Y.+Husemannauthor=J.+B.+Geiglauthor=F.+Schubertauthor=P.+Musianiauthor=M.+Meyerauthor=E.+Burghartauthor=G.+Forniauthor=R.+Eilsauthor=T.+Fehmauthor=G.+Riethmullerauthor=C.+A.+Klein&title=Systemic+spread+is+an+early+step+in+breast+cancer&doi=10.1016%2Fj.ccr.2007.12.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DHusemann%26aufirst%3DY.%26aulast%3DGeigl%26aufirst%3DJ.%2BB.%26aulast%3DSchubert%26aufirst%3DF.%26aulast%3DMusiani%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DBurghart%26aufirst%3DE.%26aulast%3DForni%26aufirst%3DG.%26aulast%3DEils%26aufirst%3DR.%26aulast%3DFehm%26aufirst%3DT.%26aulast%3DRiethmuller%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DC.%2BA.%26atitle%3DSystemic%2520spread%2520is%2520an%2520early%2520step%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D58%26epage%3D68%26doi%3D10.1016%2Fj.ccr.2007.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Liotta, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tryggvason, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbisa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafie, S.</span><span> </span><span class="NLM_article-title">Metastatic potential correlates with enzymatic degradation of basement membrane collagen</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1038/284067a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2F284067a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=6243750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaL3cXktVGmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1980&pages=67-68&author=L.+A.+Liottaauthor=K.+Tryggvasonauthor=S.+Garbisaauthor=I.+Hartauthor=C.+M.+Foltzauthor=S.+Shafie&title=Metastatic+potential+correlates+with+enzymatic+degradation+of+basement+membrane+collagen&doi=10.1038%2F284067a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metastatic potential correlates with enzymic degradation of basement membrane collagen</span></div><div class="casAuthors">Liotta, L. A.; Tryggvason, K.; Garbisa, S.; Hart, Ian; Foltz, C. M.; Shafie, S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">5751</span>),
    <span class="NLM_cas:pages">67-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The metastatic potential of variants of B16 melanoma and T241 sarcoma cell lines correlated with their ability to release sol. radioactivity from costar tissue culture cluster wells coated with 14C-proline-labeled type IV basement membrane collagen.  Metastatic potential was also correlated with the ability of trypsin-activated media from cultures of these tumors to enzymically digest labeled type IV collagen in soln.  Metastatic cells may differ quant. from normal cells in their formation of this collagenase, and its activity might therefore provide an in vitro marker for the metastatic potential of malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_1n5IN-gqD7Vg90H21EOLACvtfcHk0ljoKVYCpLokcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktVGmsbw%253D&md5=53353504bbe47d3390c02c34053d3ed6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F284067a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F284067a0%26sid%3Dliteratum%253Aachs%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26aulast%3DTryggvason%26aufirst%3DK.%26aulast%3DGarbisa%26aufirst%3DS.%26aulast%3DHart%26aufirst%3DI.%26aulast%3DFoltz%26aufirst%3DC.%2BM.%26aulast%3DShafie%26aufirst%3DS.%26atitle%3DMetastatic%2520potential%2520correlates%2520with%2520enzymatic%2520degradation%2520of%2520basement%2520membrane%2520collagen%26jtitle%3DNature%26date%3D1980%26volume%3D284%26spage%3D67%26epage%3D68%26doi%3D10.1038%2F284067a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Coussens, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fingleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisian, L. M.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase inhibitors and cancer: trials and tribulations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span><span class="refDoi"> DOI: 10.1126/science.1067100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1126%2Fscience.1067100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=11923519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD38XisFSmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=2387-2392&author=L.+M.+Coussensauthor=B.+Fingletonauthor=L.+M.+Matrisian&title=Matrix+metalloproteinase+inhibitors+and+cancer%3A+trials+and+tribulations&doi=10.1126%2Fscience.1067100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer therapy: matrix metalloproteinase inhibitors and cancer: trials and tribulations</span></div><div class="casAuthors">Coussens, Lisa M.; Fingleton, Barbara; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">5564</span>),
    <span class="NLM_cas:pages">2387-2392</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  For at least 30 yr, matrix metalloproteinases (MMPs) have been heralded as promising targets for cancer therapy on the basis of their massive up-regulation in malignant tissues and their unique ability to degrade all components of the extracellular matrix.  Preclin. studies testing the efficacy of MMP suppression in tumor models were so compelling that synthetic metalloproteinase inhibitors (MPI) were rapidly developed and routed into human clin. trials.  The results of these trials have been disappointing.  Here we review the studies that brought MPI into clin. testing and discuss the design and outcome of the trials in light of new information about the cellular source, substrates, and mode of action of MMPs at different stages of tumor progression.  The important lessons learned from the MPI experience may be of great value for future studies of MPI and for cancer drug development in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquzqvwAiv5frVg90H21EOLACvtfcHk0liHoBGrbZTMAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisFSmtb0%253D&md5=be0d4cfc46c6c451a2374e3545cb4ec6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1067100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1067100%26sid%3Dliteratum%253Aachs%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26aulast%3DFingleton%26aufirst%3DB.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DMatrix%2520metalloproteinase%2520inhibitors%2520and%2520cancer%253A%2520trials%2520and%2520tribulations%26jtitle%3DScience%26date%3D2002%26volume%3D295%26spage%3D2387%26epage%3D2392%26doi%3D10.1126%2Fscience.1067100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ukaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, K.</span><span> </span><span class="NLM_article-title">Inhibition of MMP-2-mediated cellular invasion by NF-kappaB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">485</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2017.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.bbrc.2017.02.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2017&pages=76-81&author=T.+Ukajiauthor=Y.+Linauthor=S.+Okadaauthor=K.+Umezawa&title=Inhibition+of+MMP-2-mediated+cellular+invasion+by+NF-kappaB+inhibitor+DHMEQ+in+3D+culture+of+breast+carcinoma+MDA-MB-231+cells%3A+A+model+for+early+phase+of+metastasis&doi=10.1016%2Fj.bbrc.2017.02.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2017.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2017.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DUkaji%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DUmezawa%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520MMP-2-mediated%2520cellular%2520invasion%2520by%2520NF-kappaB%2520inhibitor%2520DHMEQ%2520in%25203D%2520culture%2520of%2520breast%2520carcinoma%2520MDA-MB-231%2520cells%253A%2520A%2520model%2520for%2520early%2520phase%2520of%2520metastasis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D485%26spage%3D76%26epage%3D81%26doi%3D10.1016%2Fj.bbrc.2017.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, S.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase 2 regulates MDAMB231 breast cancer cell invasion induced by active mammalian diaphanous-related formin 1</span> <span class="citation_source-journal">Mol. Med. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.3892/mmr.2016.5282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.3892%2Fmmr.2016.5282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=27177153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFejtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=277-282&author=D.+Kimauthor=S.+Rhee&title=Matrix+metalloproteinase+2+regulates+MDAMB231+breast+cancer+cell+invasion+induced+by+active+mammalian+diaphanous-related+formin+1&doi=10.3892%2Fmmr.2016.5282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-2 regulates MDA-MB-231 breast cancer cell invasion induced by active mammalian diaphanous-related formin 1</span></div><div class="casAuthors">Kim, Daehwan; Rhee, Sangmyung</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Mammalian diaphanous-related formin 1 (mDia1) was initially identified as a Rho GTPase effector involved in the progression of various diseases, including types of cancer.  However, the precise underlying mol. mechanism of mDia1-mediated cancer cell invasion remains to be elucidated.  In the present study, mDia1 expression was demonstrated to be upregulated in tissues from a no. of cancer types, including kidney, prostate, and breast cancer using immunohistochem. anal.  Forced expression of a constitutively active (CA) form of mDia1 induces invasion, as measured by Transwell invasion assay, of MDA-MB-231 cells, which is a highly invasive breast cancer cell line, and this effect was markedly impaired by matrix metalloproteinase (MMP)-2 silencing.  Furthermore, the present study demonstrated that overexpression of the CA form of mDia1 leads to the induction of invasive ability in MCF-7 cells, which is a non-invasive breast cancer cell line, as a result of increased MMP-2 activity.  Thus, the results of the current study suggest that mDia1 is an important regulator of breast cancer cell invasion and that this effect may be mediated by MMP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkg0LNdh4EyrVg90H21EOLACvtfcHk0liHoBGrbZTMAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFejtLfE&md5=2033e637e174c1f102643976da607e67</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2016.5282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2016.5282%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DRhee%26aufirst%3DS.%26atitle%3DMatrix%2520metalloproteinase%25202%2520regulates%2520MDAMB231%2520breast%2520cancer%2520cell%2520invasion%2520induced%2520by%2520active%2520mammalian%2520diaphanous-related%2520formin%25201%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2016%26volume%3D14%26spage%3D277%26epage%3D282%26doi%3D10.3892%2Fmmr.2016.5282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Qi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span> </span><span class="NLM_article-title">Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis</span> <span class="citation_source-journal">J. Mol. Med. (Heidelberg, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span><span class="NLM_x">–</span> <span class="NLM_lpage">1377</span><span class="refDoi"> DOI: 10.1007/s00109-008-0398-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1007%2Fs00109-008-0398-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=18777017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCmsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=1367-1377&author=Q.+Qiauthor=H.+Guauthor=Y.+Yangauthor=N.+Luauthor=J.+Zhaoauthor=W.+Liuauthor=H.+Lingauthor=Q.+D.+Youauthor=X.+Wangauthor=Q.+Guo&title=Involvement+of+matrix+metalloproteinase+2+and+9+in+gambogic+acid+induced+suppression+of+MDA-MB-435+human+breast+carcinoma+cell+lung+metastasis&doi=10.1007%2Fs00109-008-0398-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis</span></div><div class="casAuthors">Qi, Qi; Gu, Hongyan; Yang, Yong; Lu, Na; Zhao, Jie; Liu, Wei; Ling, Hua; You, Qi-dong; Wang, Xiaotang; Guo, Qinglong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1367-1377</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cancer cell invasion is one of the crucial events in local spreading, growth, and metastasis of tumors.  The present study investigated the antiinvasive and antimetastatic action of gambogic acid (GA) in MDA-MB-435 human breast carcinoma cells.  GA caused a concn.-dependent suppression of cell invasion through Matrigel and significantly inhibited lung metastases of the cells transplanted in vivo.  The potent effects of GA have been attributed to its ability to reduce the expression of matrix metalloproteinases (MMP) 2 and 9 in vitro and in vivo both at the protein and mRNA levels, which were assocd. with protein kinase C (PKC) signaling pathway as supported by the diminished antiinvasive effect of GA in the presence of specific activator of the pathway.  Collectively, our data demonstrated that GA exhibited antiinvasion properties on highly invasive cancer cells via PKC mediated MMP-2/9 expression inhibition.  This indicated that GA can be served as a potential novel therapeutic candidate for the treatment of cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJMqc8YoYXgbVg90H21EOLACvtfcHk0liHoBGrbZTMAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCmsrzI&md5=a2b8992d1f2054b750d29c86464570c5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00109-008-0398-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-008-0398-z%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLing%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DQ.%26atitle%3DInvolvement%2520of%2520matrix%2520metalloproteinase%25202%2520and%25209%2520in%2520gambogic%2520acid%2520induced%2520suppression%2520of%2520MDA-MB-435%2520human%2520breast%2520carcinoma%2520cell%2520lung%2520metastasis%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2008%26volume%3D86%26spage%3D1367%26epage%3D1377%26doi%3D10.1007%2Fs00109-008-0398-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Munoz-Najar, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neurath, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vumbaca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, K. P.</span><span> </span><span class="NLM_article-title">Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2379</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span><span class="refDoi"> DOI: 10.1038/sj.onc.1209273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2Fsj.onc.1209273" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=2379-2392&author=U.+M.+Munoz-Najarauthor=K.+M.+Neurathauthor=F.+Vumbacaauthor=K.+P.+Claffey&title=Hypoxia+stimulates+breast+carcinoma+cell+invasion+through+MT1-MMP+and+MMP-2+activation&doi=10.1038%2Fsj.onc.1209273"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209273%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Najar%26aufirst%3DU.%2BM.%26aulast%3DNeurath%26aufirst%3DK.%2BM.%26aulast%3DVumbaca%26aufirst%3DF.%26aulast%3DClaffey%26aufirst%3DK.%2BP.%26atitle%3DHypoxia%2520stimulates%2520breast%2520carcinoma%2520cell%2520invasion%2520through%2520MT1-MMP%2520and%2520MMP-2%2520activation%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D2379%26epage%3D2392%26doi%3D10.1038%2Fsj.onc.1209273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gawenda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traub, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luck, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreipe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Wasielewski, R.</span><span> </span><span class="NLM_article-title">Legumain expression as a prognostic factor in breast cancer patients</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1007/s10549-006-9311-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1007%2Fs10549-006-9311-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=17028987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhslCltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=1-6&author=J.+Gawendaauthor=F.+Traubauthor=H.+J.+Luckauthor=H.+Kreipeauthor=R.+von+Wasielewski&title=Legumain+expression+as+a+prognostic+factor+in+breast+cancer+patients&doi=10.1007%2Fs10549-006-9311-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Legumain expression as a prognostic factor in breast cancer patients</span></div><div class="casAuthors">Gawenda, Jessica; Traub, Frank; Lueck, Hans J.; Kreipe, Hans; Wasielewski, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Invasive tumor cells and their microenvironments are enriched with a broad spectrum of different proteases.  Legumain, a novel asparaginyl endopeptidase, has been obsd. to be highly expressed in several types of solid tumors.  However, there is no data available identifying the relationship of legumain expression and clinicopathol. or biol. variables in invasive breast cancer.  For the first time, the prevalence of legumain expression in invasive breast cancer (n = 432) and non-neoplastic breast tissues (n = 128) was investigated by immunohistochem.  Three staining patterns were obsd. in the cytoplasm: diffuse positivity, tiny dots and vesicles.  Whereas vesicular positivity in the majority of tumor cells was significantly correlated to an adverse outcome, cytoplasmic and dot-like staining showed no prognostic effect.  Vesicular positivity was obsd. in 24% of carcinomas, but only in one case of non-neoplastic breast tissue (<1%; proliferative mastopathy).  This staining pattern was found to be independent of other factors analyzed as grading, nodal status or HER2 expression.  Besides being of prognostic value, legumain might prove to be an important predictive factor in breast cancer, since its unique cleavage specificity is already used in prodrug activation strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSNRkq-QU9RrVg90H21EOLACvtfcHk0ljsS1C0w9jgnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhslCltrk%253D&md5=59791178784ce2c191c6eb79c5ba09e5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10549-006-9311-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-006-9311-z%26sid%3Dliteratum%253Aachs%26aulast%3DGawenda%26aufirst%3DJ.%26aulast%3DTraub%26aufirst%3DF.%26aulast%3DLuck%26aufirst%3DH.%2BJ.%26aulast%3DKreipe%26aufirst%3DH.%26aulast%3Dvon%2BWasielewski%26aufirst%3DR.%26atitle%3DLegumain%2520expression%2520as%2520a%2520prognostic%2520factor%2520in%2520breast%2520cancer%2520patients%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D102%26spage%3D1%26epage%3D6%26doi%3D10.1007%2Fs10549-006-9311-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortunato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span> </span><span class="NLM_article-title">Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1515/BC.2001.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1515%2FBC.2001.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=11517930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFSksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2001&pages=777-783&author=J.+M.+Chenauthor=M.+Fortunatoauthor=R.+A.+Stevensauthor=A.+J.+Barrett&title=Activation+of+progelatinase+A+by+mammalian+legumain%2C+a+recently+discovered+cysteine+proteinase&doi=10.1515%2FBC.2001.093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase</span></div><div class="casAuthors">Chen, Jinq-May; Fortunato, Mara; Stevens, Richard A. E.; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">777-783</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">The activation of progelatinase A to gelatinase A requires cleavage of an Asn bond to form the N-terminus of the mature enzyme.  The authors asked whether the activation could be mediated by legumain (3.4.22.34) (I), a recently discovered lysosomal cysteine proteinase that is specific for hydrolysis of Asn bonds.  The addn. of purified I to the concd. conditioned medium from HT1080 cell culture that contained both progelatinase A (II) and progelatinase B (III) caused the conversion of 72-kDa II to the 62-kDa form.  III in the medium was unaffected.  Incubation of recombinant II with I resulted in almost instantaneous activation as judged by the fluorometric assay with the specific gelatinase A substrate, Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.  I also activated II when it was in complex with TIMP-2.  Zymog. anal. and N-terminal sequencing revealed that I cleaved 72-kDa II between the Asn109-Tyr110 or Asn111-Phe112 bonds to produce the 62-kDa mature enzyme, and that further cleavage at Asn430 also occurred to generate a 36-kDa active form.  More 62-kDa gelatinase A was detected in cultures of C13 cells that overexpressed I than in those of the control HEK293 cells.  It was concluded that I is clearly capable of processing II to the active enzyme in vitro and in cultured cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK3gAlxuFOSrVg90H21EOLACvtfcHk0ljsS1C0w9jgnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFSksbo%253D&md5=50d9d0e5ee754d08132ffeda7ed4b69c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1515%2FBC.2001.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2001.093%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DFortunato%26aufirst%3DM.%26aulast%3DStevens%26aufirst%3DR.%2BA.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DActivation%2520of%2520progelatinase%2520A%2520by%2520mammalian%2520legumain%252C%2520a%2520recently%2520discovered%2520cysteine%2520proteinase%26jtitle%3DBiol.%2520Chem.%26date%3D2001%26volume%3D382%26spage%3D777%26epage%3D783%26doi%3D10.1515%2FBC.2001.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgington, T.</span><span> </span><span class="NLM_article-title">Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">2957</span><span class="NLM_x">–</span> <span class="NLM_lpage">2964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=12782603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1aitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2957-2964&author=C.+Liuauthor=C.+Sunauthor=H.+Huangauthor=K.+Jandaauthor=T.+Edgington&title=Overexpression+of+legumain+in+tumors+is+significant+for+invasion%2Fmetastasis+and+a+candidate+enzymatic+target+for+prodrug+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Legumain in Tumors Is Significant for Invasion/Metastasis and a Candidate Enzymatic Target for Prodrug Therapy</span></div><div class="casAuthors">Liu, Cheng; Sun, Chengzao; Huang, Haining; Janda, Kim; Edgington, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2957-2964</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of legumain, a novel asparaginyl endopeptidase, in tumors was identified from gene expression profiling and tumor tissue array anal.  Legumain was demonstrated in membrane-assocd. vesicles concd. at the invadopodia of tumor cells and on cell surfaces where it colocalized with integrins.  Legumain was demonstrated to activate progelatinase A.  Cells overexpressing legumain possessed increased migratory and invasive activity in vitro and adopted an invasive and metastatic phenotype in vivo, inferring significance of legumain in tumor invasion and metastasis.  A prodrug strategy incorporating a legumain-cleavable peptide substrate onto doxorubicin was developed.  The prototype compd., designated legubicin, exhibited reduced toxicity and was effectively tumoricidal in vivo in a murine colon carcinoma model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbzPhPINJ7zLVg90H21EOLACvtfcHk0ljsS1C0w9jgnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1aitL8%253D&md5=6088fb45e7f42d07a4101a5fa040e519</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJanda%26aufirst%3DK.%26aulast%3DEdgington%26aufirst%3DT.%26atitle%3DOverexpression%2520of%2520legumain%2520in%2520tumors%2520is%2520significant%2520for%2520invasion%252Fmetastasis%2520and%2520a%2520candidate%2520enzymatic%2520target%2520for%2520prodrug%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D2957%26epage%3D2964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dando, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span> </span><span class="NLM_article-title">Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">8090</span><span class="NLM_x">–</span> <span class="NLM_lpage">8098</span><span class="refDoi"> DOI: 10.1074/jbc.272.12.8090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1074%2Fjbc.272.12.8090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=9065484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaK2sXitFWrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=8090-8098&author=J.+M.+Chenauthor=P.+M.+Dandoauthor=N.+D.+Rawlingsauthor=M.+A.+Brownauthor=N.+E.+Youngauthor=R.+A.+Stevensauthor=E.+Hewittauthor=C.+Wattsauthor=A.+J.+Barrett&title=Cloning%2C+isolation%2C+and+characterization+of+mammalian+legumain%2C+an+asparaginyl+endopeptidase&doi=10.1074%2Fjbc.272.12.8090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, isolation, and characterization of mammalian legumain, and asparaginyl endopeptidase</span></div><div class="casAuthors">Chen, Jinq-May; Dando, Pam M.; Rawlings, Neil D.; Brown, Molly A.; Young, Nina E.; Stevens, Richard A.; Hewitt, Eric; Watts, Colin; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8090-8098</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Legumain is a cysteine endopeptidase that shows strict specificity for hydrolysis of asparaginyl bonds.  The enzyme belongs to peptidase family C13, and is thus unrelated to the better known cysteine peptidases of the papain family, C1 (Rawlings, N. D., and Barrett, A. J. (1994) Methods Enzymol. 244, 461-486).  To date, legumain has been described only from plants and a blood fluke, Schistosoma mansoni.  The authors now show that legumain is present in mammals.  The authors have cloned and sequenced human legumain and part of pig legumain.  The authors have also purified legumain to homogeneity (2200-fold, 8% yield) from pig kidney.  The mammalian sequences are clearly homologous with legumains from non-mammalian species.  Pig legumain is a glycoprotein of about 34 kDa, decreasing to 31 kDa on deglycosylation.  It is an asparaginyl endopeptidase, hydrolyzing A-Ala-Ala-Asn-7-(4-methyl)coumarylamide and benzoyl-Asn-p-nitroanilide.  Maximal activity is seen at pH 5.8 under normal assay conditions, and the enzyme is irreversibly denatured at pH 7 and above.  Mammalian legumain is a cysteine endopeptidase, inhibited by iodoacetamide and maleimides, but unaffected by compd. E64 (trans-epoxysuccinyl-L-leucylamideo-(4-guanidino)butane).  It is inhibited by ovocystatin (cystatin from chicken egg white) and human cystatin C with Ki values < 5 nM.  The authors discuss the significance of the discovery of a cysteine endopeptidase of a new family and distinctive specificity in man and other mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9BB-vOhPAyrVg90H21EOLACvtfcHk0lg3cV2ZUq9npg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitFWrsbk%253D&md5=fbc20cfc8f745824027f01bbeacfe193</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.12.8090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.12.8090%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DDando%26aufirst%3DP.%2BM.%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26aulast%3DYoung%26aufirst%3DN.%2BE.%26aulast%3DStevens%26aufirst%3DR.%2BA.%26aulast%3DHewitt%26aufirst%3DE.%26aulast%3DWatts%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DCloning%252C%2520isolation%252C%2520and%2520characterization%2520of%2520mammalian%2520legumain%252C%2520an%2520asparaginyl%2520endopeptidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D8090%26epage%3D8098%26doi%3D10.1074%2Fjbc.272.12.8090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. J.</span><span> </span><span class="NLM_article-title">Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.1016/S0014-5793(98)01574-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2FS0014-5793%2898%2901574-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=9891971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaK1MXhslWltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=1998&pages=361-365&author=J.+M.+Chenauthor=N.+D.+Rawlingsauthor=R.+A.+Stevensauthor=A.+J.+Barrett&title=Identification+of+the+active+site+of+legumain+links+it+to+caspases%2C+clostripain+and+gingipains+in+a+new+clan+of+cysteine+endopeptidases&doi=10.1016%2FS0014-5793%2898%2901574-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases</span></div><div class="casAuthors">Chen, Jinq-May; Rawlings, Neil D.; Stevens, Richard A. E.; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-365</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We show by site-directed mutagenesis that the catalytic residues of mammalian legumain, a recently discovered lysosomal asparaginylcysteine endopeptidase, form a catalytic dyad in the motif His-Gly-spacer-Ala-Cys.  We note that the same motif is present in the caspases, aspartate-specific endopeptidases central to the process of apoptosis in animal cells, and also in the families of clostripain and gingipain which are arginyl/lysyl endopeptidases of pathogenic bacteria.  We propose that the four families have similar protein folds, are evolutionarily related in clan CD, and have common characteristics including substrate specificities dominated by the interactions of the S1 subsite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWGIM-diHwLVg90H21EOLACvtfcHk0lg3cV2ZUq9npg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslWltQ%253D%253D&md5=437888ac750d2ae62e62fbb722c75f47</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2898%2901574-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252898%252901574-9%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26aulast%3DStevens%26aufirst%3DR.%2BA.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520the%2520active%2520site%2520of%2520legumain%2520links%2520it%2520to%2520caspases%252C%2520clostripain%2520and%2520gingipains%2520in%2520a%2520new%2520clan%2520of%2520cysteine%2520endopeptidases%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D441%26spage%3D361%26epage%3D365%26doi%3D10.1016%2FS0014-5793%2898%2901574-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, M.</span><span> </span><span class="NLM_article-title">Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness</span> <span class="citation_source-journal">World J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1007/s00345-012-0977-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1007%2Fs00345-012-0977-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23124822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsFyrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=359-364&author=Y.+Ohnoauthor=J.+Nakashimaauthor=M.+Izumiauthor=M.+Ohoriauthor=T.+Hashimotoauthor=M.+Tachibana&title=Association+of+legumain+expression+pattern+with+prostate+cancer+invasiveness+and+aggressiveness&doi=10.1007%2Fs00345-012-0977-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness</span></div><div class="casAuthors">Ohno, Yoshio; Nakashima, Jun; Izumi, Miki; Ohori, Makoto; Hashimoto, Takeshi; Tachibana, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Urology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-364</span>CODEN:
                <span class="NLM_cas:coden">WJURDJ</span>;
        ISSN:<span class="NLM_cas:issn">0724-4983</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Objectives: To investigate the clin. implication of legumain, an asparaginyl endopeptidase that is highly expressed in several types of cancer, expression in prostate cancer.  Methods: Legumain expression in prostate cancer cell lines was detd. by real-time reverse transcriptase PCR and Western blot.  Furthermore, legumain expression in 88 prostatectomy specimens was evaluated by immunohistochem.  The assocn. between legumain expression and clinicopathol. factors was analyzed.  Results: Legumain expression was confirmed at the mRNA and protein levels in all the cells.  Although all the cancer tissues were pos. for legumain, 2 staining patterns were obsd. in the cytoplasm: diffuse cytoplasmic and vesicular positivity.  The rates of Gleason score ≥8, extracapsular extension, and perineural invasion in the group with vesicular staining were significantly higher than those in the diffuse cytoplasmic group (p < 0.05).  The max. size of the tumor with vesicular staining was significantly greater than that of the tumor with diffuse cytoplasmic staining (p = 0.0302).  The 5-yr biochem. recurrence-free rate in the patients with vesicular legumain staining was 53.2 %; this rate was significantly lower than that (78.8 %) in the patients with diffuse cytoplasmic staining (p = 0.0269).  Conclusions: Tumors that showed a vesicular staining pattern of legumain had the potential of being highly invasive and aggressive in patients with prostate cancer who were treated with radical prostatectomy.  This suggests that legumain might contribute to the invasiveness and aggressiveness of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVq7_AfmqXwLVg90H21EOLACvtfcHk0lg3cV2ZUq9npg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsFyrurY%253D&md5=067da9cb33f33c975cd027d542526886</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00345-012-0977-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00345-012-0977-z%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DY.%26aulast%3DNakashima%26aufirst%3DJ.%26aulast%3DIzumi%26aufirst%3DM.%26aulast%3DOhori%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DTachibana%26aufirst%3DM.%26atitle%3DAssociation%2520of%2520legumain%2520expression%2520pattern%2520with%2520prostate%2520cancer%2520invasiveness%2520and%2520aggressiveness%26jtitle%3DWorld%2520J.%2520Urol.%26date%3D2013%26volume%3D31%26spage%3D359%26epage%3D364%26doi%3D10.1007%2Fs00345-012-0977-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span> </span><span class="NLM_article-title">Effects of legumain as a potential prognostic factor on gastric cancers</span> <span class="citation_source-journal">Med. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="refDoi"> DOI: 10.1007/s12032-013-0621-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1007%2Fs12032-013-0621-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23740003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A280%3ADC%252BC3snpvFyquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=621&author=N.+Liauthor=Q.+Liuauthor=Q.+Suauthor=C.+Weiauthor=B.+Lanauthor=J.+Wangauthor=G.+Baoauthor=F.+Yanauthor=Y.+Yuauthor=B.+Pengauthor=J.+Qiuauthor=X.+Yanauthor=S.+Zhangauthor=F.+Guo&title=Effects+of+legumain+as+a+potential+prognostic+factor+on+gastric+cancers&doi=10.1007%2Fs12032-013-0621-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of legumain as a potential prognostic factor on gastric cancers</span></div><div class="casAuthors">Li Na; Liu Qiaoling; Su Qi; Wei Chongyang; Lan Bin; Wang Jianyong; Bao Guoqing; Yan Fei; Yu Ying; Peng Baowei; Qiu Ju; Yan Xiangming; Zhang Sheng; Guo Fang</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although legumain has been found to be a prognostic factor in both breast cancer and colorectal cancer, its effects on gastric cancer are unknown.  In this study, we investigated effects of legumain on gastric cancer and the correlation between legumain expression and prognosis of gastric cancer patients.  SGC7901 cells were transduced with legumain cDNA (SGC7901-hLeg) for overexpression of legumain or with legumain shRNA to knock down legumain.  In vitro tumor migration was examined by wound healing assay.  Furthermore, a tumorigenicity and metastasis mouse model was used to examine legumain function in vivo; asparaginyl endopeptidase inhibitor (AEPI, an inhibitor of legumain) was injected to the mice (i.p.) to evaluate its therapeutic effect.  Tissue microarray analysis from 112 gastric cancer patients was performed to evaluate the association between legumain expression and the cumulative survival time.  Legumain was highly expressed in gastric cancer patients and some gastric cancer cell lines.  Legumain promoted gastric cell migration in vitro and promoted gastric tumor growth and metastasis in vivo, and these effects were reversed by knockdown of legumain with shRNA or treated with AEPI.  In gastric cancer clinical samples, legumain expression in tumor was significantly higher than in non-tumor and was negatively associated with the cumulative survival rate.  In conclusion, legumain was highly expressed in gastric adenocarcinoma; legumain promoted gastric cancer tumorigenesis and metastasis in vitro and in vivo.  Legumain expression in tumor was a poor prognostic factor for gastric cancer patients, and legumain could be a potential target molecule for gastric cancer therapy in clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQt-Yoxz0IgQJotVjB3IRIyfW6udTcc2eZHbf2zV1Ypdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snpvFyquw%253D%253D&md5=d0b0d0655c6b1e4789d82bbfe5bfd0d3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs12032-013-0621-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-013-0621-9%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DQ.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DG.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DF.%26atitle%3DEffects%2520of%2520legumain%2520as%2520a%2520potential%2520prognostic%2520factor%2520on%2520gastric%2520cancers%26jtitle%3DMed.%2520Oncol.%26date%3D2013%26volume%3D30%26spage%3D621%26doi%3D10.1007%2Fs12032-013-0621-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Haugen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brix, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flatmark, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maelandsmo, G. M.</span><span> </span><span class="NLM_article-title">Nuclear legumain activity in colorectal cancer</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52980</span><span class="refDoi"> DOI: 10.1371/journal.pone.0052980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1371%2Fjournal.pone.0052980" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e52980&author=M.+H.+Haugenauthor=H.+T.+Johansenauthor=S.+J.+Pettersenauthor=R.+Solbergauthor=K.+Brixauthor=K.+Flatmarkauthor=G.+M.+Maelandsmo&title=Nuclear+legumain+activity+in+colorectal+cancer&doi=10.1371%2Fjournal.pone.0052980"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0052980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0052980%26sid%3Dliteratum%253Aachs%26aulast%3DHaugen%26aufirst%3DM.%2BH.%26aulast%3DJohansen%26aufirst%3DH.%2BT.%26aulast%3DPettersen%26aufirst%3DS.%2BJ.%26aulast%3DSolberg%26aufirst%3DR.%26aulast%3DBrix%26aufirst%3DK.%26aulast%3DFlatmark%26aufirst%3DK.%26aulast%3DMaelandsmo%26aufirst%3DG.%2BM.%26atitle%3DNuclear%2520legumain%2520activity%2520in%2520colorectal%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De52980%26doi%3D10.1371%2Fjournal.pone.0052980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Stern, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Many, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satchi-Fainaro, R.</span><span> </span><span class="NLM_article-title">A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">510</span><span class="refDoi"> DOI: 10.1021/bc800448u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc800448u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVyktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=500-510&author=L.+Sternauthor=R.+Perryauthor=P.+Ofekauthor=A.+Manyauthor=D.+Shabatauthor=R.+Satchi-Fainaro&title=A+novel+antitumor+prodrug+platform+designed+to+be+cleaved+by+the+endoprotease+legumain&doi=10.1021%2Fbc800448u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Antitumor Prodrug Platform Designed to Be Cleaved by the Endoprotease Legumain</span></div><div class="casAuthors">Stern, Liron; Perry, Rotem; Ofek, Paula; Many, Ariel; Shabat, Doron; Satchi-Fainaro, Ronit</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">500-510</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemotherapeutic treatment of neoplastic diseases is often restricted by adverse systemic toxicity, which limits the dose of drug that can be administered, or by the appearance of drug resistance.  Therefore, novel targeted therapeutic approaches are being developed to improve current conventional therapy in order to increase specificity and biocompatibility, and decrease toxicity.  Legumain represents a recently identified lysosomal protease that has been reported to be overexpressed in the majority of human solid tumors, to promote cell migration and is assocd. with enhanced tissue invasion and metastases.  Therefore, it serves as a promising candidate for prodrug therapy.  We synthesized a novel legumain-cleavable prodrug, carbobenzyloxy-alanine-alanine-asparagine-ethylenediamine-etoposide, which releases the chemotherapeutic agent, etoposide, as the active drug.  The prodrug was characterized and analyzed by 1H NMR and HPLC.  293 Human embryonic kidney (293 HEK) cells were stably transfected with human legumain, to achieve overexpression in vitro (293 HEK-Leg).  293 HEK-Leg cells expressed both active and inactive legumain and secreted it to the medium.  Legumain expression was found to be elevated because of serum starvation in both 293 HEK cells and PC3 human prostate carcinoma cells.  The com. substrate of legumain, carbobenzyloxy-alanine-alanine-asparagine-amino-4-Me coumarin (CBZ-Ala-Ala-Asn-AMC) and the synthesized prodrug were both cleaved by recombinant human legumain (rhlegumain) and legumain expressed in the 293 HEK-Leg cell lysate.  Upon cleavage by rhlegumain, the prodrug showed an inhibitory effect on the proliferation of 293 HEK and 293 HEK-Leg cells.  This study suggests a novel platform for prodrug therapy activated by legumain as a promising approach for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaEr0hM3i9UrVg90H21EOLACvtfcHk0lhaD8SPo8lIpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVyktrc%253D&md5=15a25647a8ffe0b4cd2bbb5d42565e33</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbc800448u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800448u%26sid%3Dliteratum%253Aachs%26aulast%3DStern%26aufirst%3DL.%26aulast%3DPerry%26aufirst%3DR.%26aulast%3DOfek%26aufirst%3DP.%26aulast%3DMany%26aufirst%3DA.%26aulast%3DShabat%26aufirst%3DD.%26aulast%3DSatchi-Fainaro%26aufirst%3DR.%26atitle%3DA%2520novel%2520antitumor%2520prodrug%2520platform%2520designed%2520to%2520be%2520cleaved%2520by%2520the%2520endoprotease%2520legumain%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26spage%3D500%26epage%3D510%26doi%3D10.1021%2Fbc800448u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjuri, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S. C.</span><span> </span><span class="NLM_article-title">Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1021/mp200434n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200434n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=168-175&author=Y.+Liuauthor=K.+M.+Bajjuriauthor=C.+Liuauthor=S.+C.+Sinha&title=Targeting+cell+surface+alpha%28v%29beta%283%29+integrin+increases+therapeutic+efficacies+of+a+legumain+protease-activated+auristatin+prodrug&doi=10.1021%2Fmp200434n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Cell Surface Alpha(v)beta(3) Integrin Increases Therapeutic Efficacies of a Legumain Protease-Activated Auristatin Prodrug</span></div><div class="casAuthors">Liu, Yuan; Bajjuri, Krishna Mohan; Liu, Cheng; Sinha, Subhash C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-175</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel monomethylauristatin E (MMAE) prodrug 8 was designed and prepd. that bound cell surface glycoprotein integrin αvβ3, and was activated using legumain protease as a catalyst.  Upon activation, prodrug 8 strongly induced the death of MDA-MB-435 cells that express integrin αvβ3 on cell surface.  Efficacies of prodrug 8 were also detd. in vivo using animal models of 4T1 murine breast cancer, D121 Lewis lung carcinoma, and MDA-MB-435 human breast cancer.  The results demonstrated that prodrug 8 decreased tumor growth and metastasis effectively.  In comparison to the parent cytotoxin, MMAE, and prodrug 3, prodrug 8 was less toxic to mouse white blood cells.  The latter caused no loss in wt. gain of mice at a dose 3 mg/kg, which is over 30 times in excess to MMAE (0.1 mg/kg).  We hypothesize that overexpression and colocalization of integrin αvβ3 and legumain protease on tumor cells, tumor vasculature, and/or tumor microenvironments can be exploited to enhance the efficacy and selectivity of potent cytotoxins, such as MMAE, which is otherwise too toxic to use for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0IT9GlanxCrVg90H21EOLACvtfcHk0lhaD8SPo8lIpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsbvO&md5=de275e0b82c4f4d6ad1f1f5e96c1975d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fmp200434n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200434n%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DBajjuri%26aufirst%3DK.%2BM.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSinha%26aufirst%3DS.%2BC.%26atitle%3DTargeting%2520cell%2520surface%2520alpha%2528v%2529beta%25283%2529%2520integrin%2520increases%2520therapeutic%2520efficacies%2520of%2520a%2520legumain%2520protease-activated%2520auristatin%2520prodrug%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D168%26epage%3D175%26doi%3D10.1021%2Fmp200434n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrasidlo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisfeld, R. A.</span><span> </span><span class="NLM_article-title">Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity</span> <span class="citation_source-journal">Nanomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1016/j.nano.2011.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.nano.2011.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=21419870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=665-673&author=D.+Liaoauthor=Z.+Liuauthor=W.+Wrasidloauthor=T.+Chenauthor=Y.+Luoauthor=R.+Xiangauthor=R.+A.+Reisfeld&title=Synthetic+enzyme+inhibitor%3A+a+novel+targeting+ligand+for+nanotherapeutic+drug+delivery+inhibiting+tumor+growth+without+systemic+toxicity&doi=10.1016%2Fj.nano.2011.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity</span></div><div class="casAuthors">Liao, Debbie; Liu, Ze; Wrasidlo, Wolfgang; Chen, Tingmei; Luo, Yunping; Xiang, Rong; Reisfeld, Ralph A.</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">665-673</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Unresolved problems assocd. with ligand-targeting of liposomal nanoparticles (NPs) to solid tumors include variable target receptor expression due to genetic heterogeneity and insufficient target specificity, leading to systemic toxicities.  This study addresses these issues by developing a novel ligand-targeting strategy for liposomal NPs using RR-11a, a synthetic enzyme inhibitor of Legumain, an asparaginyl endopeptidase.  Cell-surface expression of Legumain is driven by hypoxic stress, a hallmark of solid tumors.  Legumain-targeted RR-11a-coupled NPs revealed high ligand-receptor affinity, enhanced solid-tumor penetration and uptake by tumor cells.  Treatment of tumor-bearing mice with RR-11a-coupled NPs encapsulating doxorubicin resulted in improved tumor selectivity and drug sensitivity, leading to complete inhibition of tumor growth.  These antitumor effects were achieved while eliminating systemic drug toxicity.  Therefore, synthetic enzyme inhibitors, such as RR-11a, represent a new class of compds. that can be used for highly specific ligand-targeting of NPs to solid tumors.  From the Clin. Editor: This study addresses the problems assocd. with ligand-targeting of liposomal nanoparticles to solid tumors with variable target receptor expression.  A novel and efficacious targeting strategy has been developed towards a synthetic enzyme inhibitor of Legumain.  The authors demonstrate successful tumor growth inhibiting effect while eliminating systemic drug toxicity in an animal model using this strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpirlxsbelAJ7Vg90H21EOLACvtfcHk0lgNLB5gJ8yB3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmtb4%253D&md5=038a043486a10d61e52d4caa88f21729</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2011.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2011.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWrasidlo%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DR.%26aulast%3DReisfeld%26aufirst%3DR.%2BA.%26atitle%3DSynthetic%2520enzyme%2520inhibitor%253A%2520a%2520novel%2520targeting%2520ligand%2520for%2520nanotherapeutic%2520drug%2520delivery%2520inhibiting%2520tumor%2520growth%2520without%2520systemic%2520toxicity%26jtitle%3DNanomedicine%26date%3D2011%26volume%3D7%26spage%3D665%26epage%3D673%26doi%3D10.1016%2Fj.nano.2011.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obianyo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandstetter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span> </span><span class="NLM_article-title">Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">14740</span><span class="refDoi"> DOI: 10.1038/ncomms14740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2Fncomms14740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=28345579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt12gu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14740&author=Z.+Zhangauthor=O.+Obianyoauthor=E.+Dallauthor=Y.+Duauthor=H.+Fuauthor=X.+Liuauthor=S.+S.+Kangauthor=M.+Songauthor=S.+P.+Yuauthor=C.+Cabreleauthor=M.+Schubertauthor=X.+Liauthor=J.+Z.+Wangauthor=H.+Brandstetterauthor=K.+Ye&title=Inhibition+of+delta-secretase+improves+cognitive+functions+in+mouse+models+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fncomms14740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease</span></div><div class="casAuthors">Zhang, Zhentao; Obianyo, Obiamaka; Dall, Elfriede; Du, Yuhong; Fu, Haian; Liu, Xia; Kang, Seong Su; Song, Mingke; Yu, Shan-Ping; Cabrele, Chiara; Schubert, Mario; Li, Xiaoguang; Wang, Jian-Zhi; Brandstetter, Hans; Ye, Keqiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14740</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">δ-Secretase, also known as asparagine endopeptidase (AEP) or legumain, is a lysosomal cysteine protease that cleaves both amyloid precursor protein (APP) and tau, mediating the amyloid-β and tau pathol. in Alzheimer's disease (AD).  Here we report the therapeutic effect of an orally bioactive and brain permeable δ-secretase inhibitor in mouse models of AD.  We performed a high-throughput screen and identified a non-toxic and selective δ-secretase inhibitor, termed compd. 11, that specifically blocks δ-secretase but not other related cysteine proteases.  Co-crystal structure anal. revealed a dual active site-directed and allosteric inhibition mode of this compd. class.  Chronic treatment of tau P301S and 5XFAD transgenic mice with this inhibitor reduces tau and APP cleavage, ameliorates synapse loss and augments long-term potentiation, resulting in protection of memory.  Therefore, these findings demonstrate that this δ-secretase inhibitor may be an effective clin. therapeutic agent towards AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ87LrkE00NbVg90H21EOLACvtfcHk0lgNLB5gJ8yB3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt12gu7Y%253D&md5=8b7aea560cc7c4c4a05c825b3ab1d95b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fncomms14740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14740%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DObianyo%26aufirst%3DO.%26aulast%3DDall%26aufirst%3DE.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DS.%2BS.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DS.%2BP.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DSchubert%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DBrandstetter%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520delta-secretase%2520improves%2520cognitive%2520functions%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14740%26doi%3D10.1038%2Fncomms14740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Thomas, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocharski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surendran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoner, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span> </span><span class="NLM_article-title">The road map to oral bioavailability: an industrial perspective</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span><span class="refDoi"> DOI: 10.1517/17425255.2.4.591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1517%2F17425255.2.4.591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=16859407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1ahsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=591-608&author=V.+H.+Thomasauthor=S.+Bhattacharauthor=L.+Hitchinghamauthor=P.+Zocharskiauthor=M.+Naathauthor=N.+Surendranauthor=C.+L.+Stonerauthor=A.+El-Kattan&title=The+road+map+to+oral+bioavailability%3A+an+industrial+perspective&doi=10.1517%2F17425255.2.4.591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The road map to oral bioavailability: an industrial perspective</span></div><div class="casAuthors">Thomas, V. Hayden; Bhattachar, Shobha; Hitchingham, Linda; Zocharski, Philip; Naath, Maryanne; Surendran, Narayanan; Stoner, Chad L.; El-Kattan, Ayman</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">591-608</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Optimization of oral bioavailability is a continuing challenge for the pharmaceutical and biotechnol. industries.  The no. of potential drug candidates requiring in vivo evaluation has significantly increased with the advent of combinatorial chem.  In addn., drug discovery programs are increasingly forced into more lipophilic and lower soly. chem. space.  To aid in the use of in vitro and in silico tools as well as reduce the no. of in vivo studies required, a team-based discussion tool is proposed that provides a road map' to guide the selection of profiling assays that should be considered when optimizing oral bioavailability.  This road map divides the factors that contribute to poor oral bioavailability into two interrelated categories: absorption and metab.  This road map provides an interface for cross discipline discussions and a systematic approach to the experimentation that drives the drug discovery process towards a common goal - acceptable oral bioavailability using minimal resources in an acceptable time frame.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh7_zZKacXE7Vg90H21EOLACvtfcHk0lhjVuKByN1cyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1ahsLs%253D&md5=79cf4cea1b89914bd3a8826b5d7360f9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F17425255.2.4.591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2.4.591%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DV.%2BH.%26aulast%3DBhattachar%26aufirst%3DS.%26aulast%3DHitchingham%26aufirst%3DL.%26aulast%3DZocharski%26aufirst%3DP.%26aulast%3DNaath%26aufirst%3DM.%26aulast%3DSurendran%26aufirst%3DN.%26aulast%3DStoner%26aufirst%3DC.%2BL.%26aulast%3DEl-Kattan%26aufirst%3DA.%26atitle%3DThe%2520road%2520map%2520to%2520oral%2520bioavailability%253A%2520an%2520industrial%2520perspective%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2006%26volume%3D2%26spage%3D591%26epage%3D608%26doi%3D10.1517%2F17425255.2.4.591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barawkar, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramdas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panmand, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naykodi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goswami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paliwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karande, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouduri, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palle, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookhtiar, K. A.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.ejmech.2017.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=28415011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFWntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=218-229&author=S.+Basuauthor=D.+A.+Barawkarauthor=V.+Ramdasauthor=M.+Patelauthor=Y.+Wamanauthor=A.+Panmandauthor=S.+Kumarauthor=S.+Thoratauthor=M.+Naykodiauthor=A.+Goswamiauthor=B.+S.+Reddyauthor=V.+Prasadauthor=S.+Chaturvediauthor=A.+Quraishiauthor=S.+Menonauthor=S.+Paliwalauthor=A.+Kulkarniauthor=V.+Karandeauthor=I.+Ghoshauthor=S.+Mustafaauthor=S.+Deauthor=V.+Jainauthor=E.+R.+Banerjeeauthor=S.+R.+Rouduriauthor=V.+P.+Palleauthor=A.+Chughauthor=K.+A.+Mookhtiar&title=Design+and+synthesis+of+novel+xanthine+derivatives+as+potent+and+selective+A2B+adenosine+receptor+antagonists+for+the+treatment+of+chronic+inflammatory+airway+diseases&doi=10.1016%2Fj.ejmech.2017.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases</span></div><div class="casAuthors">Basu, Sujay; Barawkar, Dinesh A.; Ramdas, Vidya; Patel, Meena; Waman, Yogesh; Panmand, Anil; Kumar, Santosh; Thorat, Sachin; Naykodi, Minakshi; Goswami, Arnab; Reddy, B. Srinivasa; Prasad, Vandna; Chaturvedi, Sandhya; Quraishi, Azfar; Menon, Suraj; Paliwal, Shalini; Kulkarni, Abhay; Karande, Vikas; Ghosh, Indraneel; Mustafa, Syed; De, Siddhartha; Jain, Vaibhav; Banerjee, Ena Ray; Rouduri, Sreekanth R.; Palle, Venkata P.; Chugh, Anita; Mookhtiar, Kasim A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">218-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The identification of novel, potent and selective A2B adenosine receptor (A2BAdoR) antagonists has been shown to be potentially beneficial for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).  Towards this effort, the authors explored several prop-2-ynylated C8-aryl or heteroaryl substitutions on xanthine chemotype and found that 1-prop-2-ynyl-1H-pyrazol-4-yl moiety was better tolerated at the C8 position.  Compd. I (R1 = H, R2 = n-Pr), exhibited binding affinity (Ki) of 62 nM but was non-selective for A2BAdoR over other AdoRs.  Incorporation of substituted Ph on the terminal acetylene increased the binding affinity (Ki) significantly to <10 nM.  Various substitutions on terminal Ph group and different alkyl substitutions on N-1 and N-3 were explored to improve the potency, selectivity for A2BAdoR and the soly.  In general, compds. with meta-substituted Ph provided better selectivity for A2BAdoR compared to that of para-substituted analogs.  Substitutions such as basic amines like pyrrolidine, piperidine, piperazine or cycloalkyls with polar group were tried on terminal acetylene, keeping in mind the poor soly. of xanthine analogs in general.  However, these substitutions led to a decrease in affinity compared to compd. I (R1 = H, R2 = n-Pr).  Subsequent SAR optimization resulted in identification of compd. I [R1 = 3-(CF3O)C6H4, R2 = Et(II)] with high human A2BAdoR affinity (Ki = 13 nM), selectivity against other AdoR subtypes and with good pharmacokinetic properties.  It was found to be a potent functional A2BAdoR antagonist with a Ki of 8 nM in cAMP assay in hA2B-HEK293 cells and an IC50 of 107 nM in IL6 assay in NIH-3T3 cells.  Docking study was performed to rationalize the obsd. affinity data.  Structure-activity relationship (SAR) studies also led to identification of compd. I (R1 = 3-HO2CC6H4, R2 = n-Pr) as a potent A2BAdoR antagonist with Ki of 1.8 nM in cAMP assay and good aq. soly. of 529 μM at neutral pH.  Compd. II was further tested for in vivo efficacy and found to be efficacious in ovalbumin-induced allergic asthma model in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8O-mETdHU7LVg90H21EOLACvtfcHk0lhjVuKByN1cyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFWntrc%253D&md5=208780bfe877de2b9d9457b8e9d74376</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBarawkar%26aufirst%3DD.%2BA.%26aulast%3DRamdas%26aufirst%3DV.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DWaman%26aufirst%3DY.%26aulast%3DPanmand%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DThorat%26aufirst%3DS.%26aulast%3DNaykodi%26aufirst%3DM.%26aulast%3DGoswami%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DPrasad%26aufirst%3DV.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DQuraishi%26aufirst%3DA.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DKarande%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DI.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DBanerjee%26aufirst%3DE.%2BR.%26aulast%3DRouduri%26aufirst%3DS.%2BR.%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DChugh%26aufirst%3DA.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520xanthine%2520derivatives%2520as%2520potent%2520and%2520selective%2520A2B%2520adenosine%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520chronic%2520inflammatory%2520airway%2520diseases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D218%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2017.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of process-related impurities of antidiabetic drug linagliptin</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="refDoi"> DOI: 10.3390/molecules21081041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.3390%2Fmolecules21081041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1041&author=Y.+Huangauthor=X.+Heauthor=T.+Wuauthor=F.+Zhang&title=Synthesis+and+characterization+of+process-related+impurities+of+antidiabetic+drug+linagliptin&doi=10.3390%2Fmolecules21081041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21081041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21081041%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520process-related%2520impurities%2520of%2520antidiabetic%2520drug%2520linagliptin%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D1041%26doi%3D10.3390%2Fmolecules21081041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lhK-oktC-ccpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span> </span><span class="NLM_article-title">Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer</span> <span class="citation_source-journal">OncoTargets Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.2147/OTT.S44564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.2147%2FOTT.S44564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23874108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFymtL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=861-867&author=Y.+Huangauthor=Y.+Heauthor=S.+Yeauthor=X.+Liauthor=Q.+Zhongauthor=Z.+Chenauthor=X.+Jin&title=Combined+use+of+cyclophosphamide+and+Chalone+19-peptide+in+experimental+breast+cancer&doi=10.2147%2FOTT.S44564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer</span></div><div class="casAuthors">Huang, Yuanxi; He, Yan; Ye, Shengqian; Li, Xiaomei; Zhong, Qingqi; Chen, Zhuo; Jin, Xiaoming</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">861-867</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Cyclophosphamide is a potent anticancer drug, but its clin. utility is limited because of its severe side effects, in particular liver damage.  Chalone 19-peptide induces apoptosis of tumor cells and inhibits tumor growth.  The present study investigated the antitumor effects of a combination of cyclophosphamide and Chalone 19-peptide in exptl. breast cancer.  Methods: An animal model of breast cancer was developed, consisting of an MDA-MB-231 cell line implanted in the nude mouse.  Eight doses of a combination of cyclophosphamide 50 mg/kg or 100 mg/kg and Chalone 19-peptide 6.6 mg/kg were administered, and the mice were euthanized 28 days after the final drug injection.  Histopathol. anal. of tumor size, metastasis, and apoptosis of cancer cells was performed.  Control mice were injected i.p. with either cyclophosphamide alone or the same vol. of solvent.  Results: Tumor sizes in the treatment groups were smaller than in the controls.  No metastasis was found in the groups treated with cyclophosphamide and Chalone 19-peptide, but lung metastasis was found in controls.  Liver damage in the groups treated with cyclophosphamide was more serious than in the other groups.  Conclusion: Addn. of Chalone 19-peptide can improve the ability of cyclophosphamide to inhibit tumor growth and also reduces side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoedhkaCKDXH7Vg90H21EOLACvtfcHk0lhK-oktC-ccpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFymtL%252FN&md5=9fa706152b1652f76fe329c28c0be3dc</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2147%2FOTT.S44564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S44564%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DX.%26atitle%3DCombined%2520use%2520of%2520cyclophosphamide%2520and%2520Chalone%252019-peptide%2520in%2520experimental%2520breast%2520cancer%26jtitle%3DOncoTargets%2520Ther.%26date%3D2013%26volume%3D6%26spage%3D861%26epage%3D867%26doi%3D10.2147%2FOTT.S44564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span> </span><span class="NLM_article-title">Inhibition of breast cancer metastases by a novel inhibitor of TGFbeta receptor 1</span> <span class="citation_source-journal">J. Natl. Cancer. Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1093/jnci/djs485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1093%2Fjnci%2Fdjs485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23178439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns12luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2013&pages=47-58&author=Y.+Fangauthor=Y.+Chenauthor=L.+Yuauthor=C.+Zhengauthor=Y.+Qiauthor=Z.+Liauthor=Z.+Yangauthor=Y.+Zhangauthor=T.+Shiauthor=J.+Luoauthor=M.+Liu&title=Inhibition+of+breast+cancer+metastases+by+a+novel+inhibitor+of+TGFbeta+receptor+1&doi=10.1093%2Fjnci%2Fdjs485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Breast Cancer Metastases by a Novel Inhibitor of TGFβ Receptor 1</span></div><div class="casAuthors">Fang, Yuanzhang; Chen, Yihua; Yu, Linxi; Zheng, Cong; Qi, Ya; Li, Zhenxi; Yang, Zhengfeng; Zhang, Yong; Shi, Tieliu; Luo, Jian; Liu, Mingyao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-58</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Transforming growth factor beta (TGFβ), which is implicated in metastasis to various organs in breast cancer, is a potential target for new antitumor metastasis drugs.  Methods To identify specific inhibitors of TGFβ receptor 1 (TGFβR1) in breast cancer metastasis, a virtual library of more than 400000 different compds. was screened by mol. docking modeling and confirmed with Smad-binding element luciferase and TGFβR1 kinase assays.  Affymetrix GeneChip expression anal. of mRNA levels and real-time polymerase chain reaction were performed to det. expression changes of TGFβ-mediated, metastasis-assocd. genes in breast cancer cells after treatment with the small-mol. inhibitor YR-290.  YR-290 was also examd. for its effects on breast cancer migration, invasion, and metastasis using transwell and epithelial-to-mesenchymal transition (EMT) assays in vitro and three different mouse (BALB/c and NU/NU nude) models (n = 10 per group).  Kaplan-Meier analyses were used to assess survival.  All statistical tests were two-sided.  Results YR-290 interacted with the kinase domain of TGFβR1, abrogated kinase activity (half maximal inhibitory concn. = 137nM, 95% confidence interval = 126.4 to 147.6nM) and inhibited the TGFβ-mediated downstream signaling pathway and metastasis-assocd. genes in breast cancer cells.  YR-290 inhibited TGFβ-modulated breast cancer cell migration and invasion.  In tumor metastasis mouse models, YR-290 almost completely blocked cancer metastasis.  Nos. of lung tumor nodules of mice treated with 1mg/kg and 5mg/kg YR-290 were reduced by 74.93% (95% confidence interval = 61.45% to 88.41%) and 94.93% (95% confidence interval = 82.13% to 100%), resp., compared with control mice.  Treatment with YR-290 also statistically significantly prolonged the survival of tumor-bearing mice.  Conclusions YR-290 is a novel inhibitor of tumor metastasis that works by blocking TGFβ signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH3nni105UT7Vg90H21EOLACvtfcHk0lhK-oktC-ccpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns12luw%253D%253D&md5=54b2149c87d7fe897b21a5c4b267d734</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjs485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjs485%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520breast%2520cancer%2520metastases%2520by%2520a%2520novel%2520inhibitor%2520of%2520TGFbeta%2520receptor%25201%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D2013%26volume%3D105%26spage%3D47%26epage%3D58%26doi%3D10.1093%2Fjnci%2Fdjs485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chan, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henter, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeths, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordenskjold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara-Nishimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span> </span><span class="NLM_article-title">Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1073/pnas.0809824105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1073%2Fpnas.0809824105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=468-473&author=C.+B.+Chanauthor=M.+Abeauthor=N.+Hashimotoauthor=C.+Haoauthor=I.+R.+Williamsauthor=X.+Liuauthor=S.+Nakaoauthor=A.+Yamamotoauthor=C.+Zhengauthor=J.+I.+Henterauthor=M.+Meethsauthor=M.+Nordenskjoldauthor=S.+Y.+Liauthor=I.+Hara-Nishimuraauthor=M.+Asanoauthor=K.+Ye&title=Mice+lacking+asparaginyl+endopeptidase+develop+disorders+resembling+hemophagocytic+syndrome&doi=10.1073%2Fpnas.0809824105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0809824105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0809824105%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%2BB.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DI.%2BR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNakao%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DHenter%26aufirst%3DJ.%2BI.%26aulast%3DMeeths%26aufirst%3DM.%26aulast%3DNordenskjold%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DS.%2BY.%26aulast%3DHara-Nishimura%26aufirst%3DI.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DK.%26atitle%3DMice%2520lacking%2520asparaginyl%2520endopeptidase%2520develop%2520disorders%2520resembling%2520hemophagocytic%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D468%26epage%3D473%26doi%3D10.1073%2Fpnas.0809824105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span> </span><span class="NLM_article-title">Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span><span class="refDoi"> DOI: 10.1111/cas.12202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1111%2Fcas.12202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23691974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2013&pages=1217-1225&author=Y.+Linauthor=C.+Weiauthor=Y.+Liuauthor=Y.+Qiuauthor=C.+Liuauthor=F.+Guo&title=Selective+ablation+of+tumor-associated+macrophages+suppresses+metastasis+and+angiogenesis&doi=10.1111%2Fcas.12202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis</span></div><div class="casAuthors">Lin, Yingying; Wei, Chongyang; Liu, Yuan; Qiu, Yongming; Liu, Cheng; Guo, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1217-1225</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tumor-assocd. macrophages (TAM) play a crit. role in promoting tumor development and metastasis.  In the present study, we found that legumain, an asparaginyl endopeptidase, was highly expressed on the surface of TAM.  A doxorubicin-based prodrug specifically activated by legumain selectively ablated TAM and resulted in a significant redn. of angiogenic factors and related tumor vessel growth.  Treatment with the prodrug also suppressed circulating tumor cells and myeloid immune suppressor Gr-1+/CD11b+ cells in tumor-bearing animals.  After selective ablation of TAM using the prodrug, tumor growth and metastases were greatly inhibited in murine tumor models.  These results indicate that legumain-activated prodrugs targeting TAM in tumors might represent a novel anticancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5sVq-e_eymLVg90H21EOLACvtfcHk0lhtmairGwv4UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrtr7I&md5=683c2be4ef76cd6e4d1d5a74c7d0f20a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fcas.12202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12202%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DF.%26atitle%3DSelective%2520ablation%2520of%2520tumor-associated%2520macrophages%2520suppresses%2520metastasis%2520and%2520angiogenesis%26jtitle%3DCancer%2520Sci.%26date%3D2013%26volume%3D104%26spage%3D1217%26epage%3D1225%26doi%3D10.1111%2Fcas.12202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Reisfeld, R. A.</span><span> </span><span class="NLM_article-title">The tumor microenvironment: a target for combination therapy of breast cancer</span> <span class="citation_source-journal">Crit. Rev. Oncog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1615/CritRevOncog.v18.i1-2.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1615%2FCritRevOncog.v18.i1-2.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23237555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A280%3ADC%252BC3s3hslCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=115-133&author=R.+A.+Reisfeld&title=The+tumor+microenvironment%3A+a+target+for+combination+therapy+of+breast+cancer&doi=10.1615%2FCritRevOncog.v18.i1-2.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The tumor microenvironment: a target for combination therapy of breast cancer</span></div><div class="casAuthors">Reisfeld Ralph A</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncogenesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">115-33</span>
        ISSN:<span class="NLM_cas:issn">0893-9675</span>.
    </div><div class="casAbstract">Cancer immunotherapy is in the midst of a major paradigm shift from an approach primarily focused on attacking tumor cells to a strategy also targeting the tumor microenvironment (TME).  This strategy is designed for the use of combination therapies, several of which are reviewed here.  Particular emphasis is placed on targeting such components of the TME as tumor-associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs) overexpressing specific therapy targets such as Legumain, an asparaginyl endopeptidase, proto-oncogene  Fra-1, transcription factor Stat3 and fibroblast activation protein (FAP) as well as HER-2, respectively.  The use of DNA vaccines directed against some of these targets overexpressed on both breast tumor cells as well as TAMs and CAFs in the TME results in the elimination of tumor growth, progression, metastasis and recurrence in mouse tumor models.  This type of cancer therapy is significantly improved in efficacy by a strategy specifically designed to combine immunotherapies, including DNA vaccines, with a novel chemotherapy featuring highly effective nanoparticle-mediated drug delivery, specifically targeted to tumor cells as well as key components of the TME, leading to its modulation and subsequent elimination of tumor growth, metastasis, and, most importantly, suppression of tumor recurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqeuE8ZX7crbZpSb_XWfMrfW6udTcc2ebusTH99yT9Wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3hslCjsA%253D%253D&md5=ef484eda32092e3d2cc1622b572009db</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1615%2FCritRevOncog.v18.i1-2.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevOncog.v18.i1-2.70%26sid%3Dliteratum%253Aachs%26aulast%3DReisfeld%26aufirst%3DR.%2BA.%26atitle%3DThe%2520tumor%2520microenvironment%253A%2520a%2520target%2520for%2520combination%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DCrit.%2520Rev.%2520Oncog.%26date%3D2013%26volume%3D18%26spage%3D115%26epage%3D133%26doi%3D10.1615%2FCritRevOncog.v18.i1-2.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupack, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, R.</span><span> </span><span class="NLM_article-title">Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2679</span><span class="NLM_x">–</span> <span class="NLM_lpage">2686</span><span class="refDoi"> DOI: 10.1002/jcb.24143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1002%2Fjcb.24143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2012&pages=2679-2686&author=L.+Wangauthor=S.+Chenauthor=M.+Zhangauthor=N.+Liauthor=Y.+Chenauthor=W.+Suauthor=Y.+Liuauthor=D.+Luauthor=S.+Liauthor=Y.+Yangauthor=Z.+Liauthor=D.+Stupackauthor=P.+Quauthor=H.+Huauthor=R.+Xiang&title=Legumain%3A+a+biomarker+for+diagnosis+and+prognosis+of+human+ovarian+cancer&doi=10.1002%2Fjcb.24143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjcb.24143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.24143%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DStupack%26aufirst%3DD.%26aulast%3DQu%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DR.%26atitle%3DLegumain%253A%2520a%2520biomarker%2520for%2520diagnosis%2520and%2520prognosis%2520of%2520human%2520ovarian%2520cancer%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2012%26volume%3D113%26spage%3D2679%26epage%3D2686%26doi%3D10.1002%2Fjcb.24143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Edgington, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdoes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withana, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachmann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span> </span><span class="NLM_article-title">Functional imaging of legumain in cancer using a new quenched activity-based probe</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span><span class="refDoi"> DOI: 10.1021/ja307083b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja307083b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSqsbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=174-182&author=L.+E.+Edgingtonauthor=M.+Verdoesauthor=A.+Ortegaauthor=N.+P.+Withanaauthor=J.+Leeauthor=S.+Syedauthor=M.+H.+Bachmannauthor=G.+Blumauthor=M.+Bogyo&title=Functional+imaging+of+legumain+in+cancer+using+a+new+quenched+activity-based+probe&doi=10.1021%2Fja307083b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Imaging of Legumain in Cancer Using a New Quenched Activity-Based Probe</span></div><div class="casAuthors">Edgington, Laura E.; Verdoes, Martijn; Ortega, Alberto; Withana, Nimali P.; Lee, Jiyoun; Syed, Salahuddin; Bachmann, Michael H.; Blum, Galia; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-182</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Legumain is a lysosomal cysteine protease whose biol. function remains poorly defined.  Legumain activity is up-regulated in most human cancers and inflammatory diseases most likely as the result of high expression in populations of activated macrophages.  Within the tumor microenvironment, legumain activity is thought to promote tumorigenesis.  To obtain a greater understanding of the role of legumain activity during cancer progression and inflammation, we developed an activity-based probe that becomes fluorescent only upon binding active legumain.  This probe is highly selective for legumain, even in the context of whole cells and tissues, and is also a more effective label of legumain than previously reported probes.  Here we present the synthesis and application of our probe to the anal. of legumain activity in primary macrophages and in two mouse models of cancer.  We find that legumain activity is highly correlated with macrophage activation and furthermore that it is an ideal marker for primary tumor inflammation and early stage metastatic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmBlI6e_DeMbVg90H21EOLACvtfcHk0lh59jyFcnK7wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSqsbvP&md5=51830cee1df9b60aef194be32d4ae310</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja307083b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja307083b%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSyed%26aufirst%3DS.%26aulast%3DBachmann%26aufirst%3DM.%2BH.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DFunctional%2520imaging%2520of%2520legumain%2520in%2520cancer%2520using%2520a%2520new%2520quenched%2520activity-based%2520probe%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D174%26epage%3D182%26doi%3D10.1021%2Fja307083b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Murthy, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roodman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X. F.</span><span> </span><span class="NLM_article-title">Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2293</span><span class="NLM_x">–</span> <span class="NLM_lpage">2299</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-1642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1158%2F1078-0432.CCR-04-1642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=15788679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFaju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2293-2299&author=R.+V.+Murthyauthor=G.+Arbmanauthor=J.+Gaoauthor=G.+D.+Roodmanauthor=X.+F.+Sun&title=Legumain+expression+in+relation+to+clinicopathologic+and+biological+variables+in+colorectal+cancer&doi=10.1158%2F1078-0432.CCR-04-1642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer</span></div><div class="casAuthors">Murthy, Raghavendra Vasudeva; Arbman, Gunnar; Gao, Jingfang; Roodman, G. David; Sun, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2293-2299</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Legumain, a novel asparaginyl endopeptidase, has been obsd. to be highly expressed in several types of tumors including colorectal cancer.  However, there is no study examg. the relationship of legumain expression to clinocopathol. and biol. variables in colorectal cancers.  We investigated legumain expression in 164 primary colorectal cancers, 34 corresponding distant normal mucosa samples, 89 adjacent normal mucosa samples, and 33 lymph node metastases using immunohistochem.  We also did Western blotting anal. on three addnl. colorectal cancers and three colonic cell lines.  Legumain expression was increased in primary tumors compared with distant or adjacent normal mucosa (P < 0.05), but there was no significant change between primary tumors and metastases (P > 0.05).  Legumain expression was pos. related to poorer differentiation/mucinous carcinoma (P = 0.04), higher degree of necrosis (P = 0.03) and apoptosis (P < 0.0001), pos. proliferating cell nuclear antigen (P < 0.0001) and p53 expression (P = 0.049), and had a pos. tendency towards stromelysin 3 (P = 0.058) and PINCH positivity (P = 0.05).  The patients with tumors that showed both weak and lower percentage of the legumain expression, either in tumor (P = 0.01) or in stroma (P = 0.04), had a better prognosis.  The legumain expression may be involved in colorectal cancer development and have a prognostic value in the patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo799TIWPiXeLVg90H21EOLACvtfcHk0liHOWMtXC_Axg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFaju7g%253D&md5=e33df863890fd6521b44ba2462dbf188</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1642%26sid%3Dliteratum%253Aachs%26aulast%3DMurthy%26aufirst%3DR.%2BV.%26aulast%3DArbman%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26aulast%3DSun%26aufirst%3DX.%2BF.%26atitle%3DLegumain%2520expression%2520in%2520relation%2520to%2520clinicopathologic%2520and%2520biological%2520variables%2520in%2520colorectal%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2293%26epage%3D2299%26doi%3D10.1158%2F1078-0432.CCR-04-1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janda, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgington, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span> </span><span class="NLM_article-title">Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">980</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1158%2F0008-5472.CAN-05-2591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=16424032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=970-980&author=W.+Wuauthor=Y.+Luoauthor=C.+Sunauthor=Y.+Liuauthor=P.+Kuoauthor=J.+Vargaauthor=R.+Xiangauthor=R.+Reisfeldauthor=K.+D.+Jandaauthor=T.+S.+Edgingtonauthor=C.+Liu&title=Targeting+cell-impermeable+prodrug+activation+to+tumor+microenvironment+eradicates+multiple+drug-resistant+neoplasms&doi=10.1158%2F0008-5472.CAN-05-2591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Cell-Impermeable Prodrug Activation to Tumor Microenvironment Eradicates Multiple Drug-Resistant Neoplasms</span></div><div class="casAuthors">Wu, Wenyuan; Luo, Yunping; Sun, Chengzao; Liu, Yuan; Kuo, Paul; Varga, Janos; Xiang, Rong; Reisfeld, Ralph; Janda, Kim D.; Edgington, Thomas S.; Liu, Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">970-980</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The tumor microenvironment is notably enriched with a broad spectrum of proteases.  The proteolytic specificities of peptide substrates provide modular chem. tools for the rational design of cell-impermeable prodrugs that are specifically activated by proteases extracellularly in the tumor microenvironment.  Targeting cell-impermeable prodrug activation to tumor microenvironment will significantly reduce drug toxicity to normal tissues.  The activated prodrug attacks both tumor and stroma cells through a "bystander effect" without selectively deleting target-producing cells, therefore further minimizing resistance and toxicity.  Here, we showed that legumain, the only asparaginyl endopeptidase of the mammalian genome, is highly expressed by neoplastic, stromal, and endothelial cells in solid tumors.  Legumain is present extracellularly in the tumor microenvironment, assocd. with matrix as well as cell surfaces and functional locally in the reduced pH of the tumor microenvironment.  A novel legumain-activated, cell-impermeable doxorubicin prodrug LEG-3 was designed to be activated exclusively in the tumor microenvironment.  Upon administration, there is a profound increase of the end-product doxorubicin in nuclei of cells in tumors but little in other tissues.  This tumor microenvironment-activated prodrug completely arrested growth of a variety of neoplasms, including multidrug-resistant tumor in vivo and significantly extended survival without evidence of myelosuppression or cardiac toxicity.  The tumor microenvironment-activated prodrug design can be extended to other proteases and chemotherapeutic compds. and provides new potentials for the rational development of more effective functionally targeted cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolEhvAaZUXc7Vg90H21EOLACvtfcHk0liHOWMtXC_Axg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFyjsA%253D%253D&md5=bc75cb0d30aca3de6ab5c73005bdeee1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2591%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DP.%26aulast%3DVarga%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DR.%26aulast%3DReisfeld%26aufirst%3DR.%26aulast%3DJanda%26aufirst%3DK.%2BD.%26aulast%3DEdgington%26aufirst%3DT.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DTargeting%2520cell-impermeable%2520prodrug%2520activation%2520to%2520tumor%2520microenvironment%2520eradicates%2520multiple%2520drug-resistant%2520neoplasms%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D970%26epage%3D980%26doi%3D10.1158%2F0008-5472.CAN-05-2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisfeld, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, R.</span><span> </span><span class="NLM_article-title">Targeting tumor-associated macrophages as a novel strategy against breast cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">2132</span><span class="NLM_x">–</span> <span class="NLM_lpage">2141</span><span class="refDoi"> DOI: 10.1172/JCI27648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1172%2FJCI27648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=2132-2141&author=Y.+Luoauthor=H.+Zhouauthor=J.+Kruegerauthor=C.+Kaplanauthor=S.+H.+Leeauthor=C.+Dolmanauthor=D.+Markowitzauthor=W.+Wuauthor=C.+Liuauthor=R.+A.+Reisfeldauthor=R.+Xiang&title=Targeting+tumor-associated+macrophages+as+a+novel+strategy+against+breast+cancer&doi=10.1172%2FJCI27648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1172%2FJCI27648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI27648%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKrueger%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DDolman%26aufirst%3DC.%26aulast%3DMarkowitz%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DReisfeld%26aufirst%3DR.%2BA.%26aulast%3DXiang%26aufirst%3DR.%26atitle%3DTargeting%2520tumor-associated%2520macrophages%2520as%2520a%2520novel%2520strategy%2520against%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D2132%26epage%3D2141%26doi%3D10.1172%2FJCI27648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ovat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muindi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sojka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopacek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. C.</span><span> </span><span class="NLM_article-title">Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7192</span><span class="NLM_x">–</span> <span class="NLM_lpage">7210</span><span class="refDoi"> DOI: 10.1021/jm900849h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900849h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7192-7210&author=A.+Ovatauthor=F.+Muindiauthor=C.+Faganauthor=M.+Brounerauthor=E.+Hansellauthor=J.+Dvorakauthor=D.+Sojkaauthor=P.+Kopacekauthor=J.+H.+McKerrowauthor=C.+R.+Caffreyauthor=J.+C.+Powers&title=Aza-peptidyl+Michael+acceptor+and+epoxide+inhibitors%2D%2Dpotent+and+selective+inhibitors+of+Schistosoma+mansoni+and+Ixodes+ricinus+legumains+%28asparaginyl+endopeptidases%29&doi=10.1021%2Fjm900849h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm900849h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900849h%26sid%3Dliteratum%253Aachs%26aulast%3DOvat%26aufirst%3DA.%26aulast%3DMuindi%26aufirst%3DF.%26aulast%3DFagan%26aufirst%3DC.%26aulast%3DBrouner%26aufirst%3DM.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DDvorak%26aufirst%3DJ.%26aulast%3DSojka%26aufirst%3DD.%26aulast%3DKopacek%26aufirst%3DP.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DAza-peptidyl%2520Michael%2520acceptor%2520and%2520epoxide%2520inhibitors--potent%2520and%2520selective%2520inhibitors%2520of%2520Schistosoma%2520mansoni%2520and%2520Ixodes%2520ricinus%2520legumains%2520%2528asparaginyl%2520endopeptidases%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7192%26epage%3D7210%26doi%3D10.1021%2Fjm900849h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Loak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoury, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, C.</span><span> </span><span class="NLM_article-title">Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">1239</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span><span class="refDoi"> DOI: 10.1515/BC.2003.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1515%2FBC.2003.136" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=1239-1246&author=K.+Loakauthor=D.+N.+Liauthor=B.+Manouryauthor=J.+Billsonauthor=F.+Mortonauthor=E.+Hewittauthor=C.+Watts&title=Novel+cell-permeable+acyloxymethylketone+inhibitors+of+asparaginyl+endopeptidase&doi=10.1515%2FBC.2003.136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.136%26sid%3Dliteratum%253Aachs%26aulast%3DLoak%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DD.%2BN.%26aulast%3DManoury%26aufirst%3DB.%26aulast%3DBillson%26aufirst%3DJ.%26aulast%3DMorton%26aufirst%3DF.%26aulast%3DHewitt%26aufirst%3DE.%26aulast%3DWatts%26aufirst%3DC.%26atitle%3DNovel%2520cell-permeable%2520acyloxymethylketone%2520inhibitors%2520of%2520asparaginyl%2520endopeptidase%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D1239%26epage%3D1246%26doi%3D10.1515%2FBC.2003.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Guan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSilvio, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arpornwirat, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorvidhaya, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newstat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, H.</span><span> </span><span class="NLM_article-title">Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1947</span><span class="NLM_x">–</span> <span class="NLM_lpage">1953</span><span class="refDoi"> DOI: 10.1200/JCO.2011.40.5241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1200%2FJCO.2011.40.5241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=23509322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=1947-1953&author=Z.+Guanauthor=B.+Xuauthor=M.+L.+DeSilvioauthor=Z.+Shenauthor=W.+Arpornwiratauthor=Z.+Tongauthor=V.+Lorvidhayaauthor=Z.+Jiangauthor=J.+Yangauthor=A.+Makhsonauthor=W.+L.+Leungauthor=M.+W.+Russoauthor=B.+Newstatauthor=L.+Wangauthor=G.+Chenauthor=C.+Olivaauthor=H.+Gomez&title=Randomized+trial+of+lapatinib+versus+placebo+added+to+paclitaxel+in+the+treatment+of+human+epidermal+growth+factor+receptor+2-overexpressing+metastatic+breast+cancer&doi=10.1200%2FJCO.2011.40.5241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer</span></div><div class="casAuthors">Guan, Zhongzhen; Xu, Binghe; DeSilvio, Michelle L.; Shen, Zhenzhou; Arpornwirat, Wichit; Tong, Zhongsheng; Lorvidhaya, Vicharn; Jiang, Zefei; Yang, Junlan; Makhson, Anatoly; Leung, Wai Lim; Russo, Mark W.; Newstat, Beth; Wang, Li; Chen, George; Oliva, Cristina; Gomez, Henry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1947-1953</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Lapatinib is an oral small-mol. tyrosine kinase inhibitor of both epidermal growth factor receptor and human epidermal growth factor receptor 2 (HER2).  This study is designed to test whether the addn. of lapatinib to paclitaxel improves overall survival (OS) compared with placebo plus paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).  Patients and Methods This phase III, randomized, double-blind study assessed the efficacy and safety of lapatinib plus paclitaxel compared with placebo plus paclitaxel in patients with newly diagnosed HER2-pos. MBC.  The primary end point was OS.  Secondary end points included progression-free survival (PFS), overall response rate (ORR), clin. benefit rate, and safety.  Results The addn. of lapatinib to paclitaxel significantly improved OS vs. paclitaxel (treatment hazard ratio [HR], 0.74; 95% CI, 0.58 to 0.94; P = .0124); median OS was 27.8 vs. 20.5 mo, resp.  Median PFS was prolonged by 3.2 mo, from 6.5 mo with placebo plus paclitaxel to 9.7 mo with lapatinib plus paclitaxel (HR, 0.52; 95% CI, 0.42 to 0.64; stratified log-rank P < .001).  ORR was significantly higher with lapatinib plus paclitaxel compared with placebo plus paclitaxel (69% v 50%, resp.; P < .001).  The incidence of grades 3 and 4 diarrhea and neutropenia was higher in the lapatinib plus paclitaxel arm.  Only 4% of patients in this group reported febrile neutropenia.  Cardiac events were low grade, asymptomatic, and mostly reversible.  The incidence of hepatic events was similar in both arms.  There were no fatal adverse events in the lapatinib plus paclitaxel arm.  Conclusion This trial demonstrated that lapatinib combined with paclitaxel offers a significant and clin. meaningful survival advantage over paclitaxel alone in patients with HER2-pos. MBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEaOVfMRSDwbVg90H21EOLACvtfcHk0ljEk8dMYrLECA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbvE&md5=3940987cd66b39ae75bf0f071c8473b6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.40.5241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.40.5241%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DDeSilvio%26aufirst%3DM.%2BL.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DArpornwirat%26aufirst%3DW.%26aulast%3DTong%26aufirst%3DZ.%26aulast%3DLorvidhaya%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMakhson%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DW.%2BL.%26aulast%3DRusso%26aufirst%3DM.%2BW.%26aulast%3DNewstat%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DOliva%26aufirst%3DC.%26aulast%3DGomez%26aufirst%3DH.%26atitle%3DRandomized%2520trial%2520of%2520lapatinib%2520versus%2520placebo%2520added%2520to%2520paclitaxel%2520in%2520the%2520treatment%2520of%2520human%2520epidermal%2520growth%2520factor%2520receptor%25202-overexpressing%2520metastatic%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D1947%26epage%3D1953%26doi%3D10.1200%2FJCO.2011.40.5241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Proteases associated with invadopodia, and their role in degradation of extracellular matrix</span> <span class="citation_source-journal">Enzyme Protein</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1159%2F000468616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=8796997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaK28XjvVGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=59-71&author=W.+T.+Chen&title=Proteases+associated+with+invadopodia%2C+and+their+role+in+degradation+of+extracellular+matrix"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases associated with invadopodia, and their role in degradation of extracellular matrix</span></div><div class="casAuthors">Chen, Wen-Tien</div><div class="citationInfo"><span class="NLM_cas:title">Enzyme & Protein</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">59-71</span>CODEN:
                <span class="NLM_cas:coden">EPROEA</span>;
        ISSN:<span class="NLM_cas:issn">1019-6773</span>.
    
            (<span class="NLM_cas:orgname">Karger</span>)
        </div><div class="casAbstract">A review with 83 refs.  Metastasizing cancer cells invade the extracellular matrix using plasma membrane protrusions (invadopodia) that contact and dissolve the matrix.  Evidence suggests that membrane-assocd. proteases, 170 kDa gelatinase (seprase) and Gelatinase A, exert their mechanisms of action on invadopodia.  Potential roles that other metallo- and serine-types of membrane proteases, including membrane-type matrix metalloprotease, meprin, dipeptidyl peptidase IV, fibroblast activation protein α and guanidinobenzoatase, play in the cell surface proteolysis are also discussed.  It is proposed that formation of a structurally and functionally linked protease complex on invadopodia allows the invasion of cancer cells into the extracellular matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor4TlhjNwOL7Vg90H21EOLACvtfcHk0ljEk8dMYrLECA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVGjtbw%253D&md5=b01332439c1460660374409cbf646ab9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1159%2F000468616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000468616%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DProteases%2520associated%2520with%2520invadopodia%252C%2520and%2520their%2520role%2520in%2520degradation%2520of%2520extracellular%2520matrix%26jtitle%3DEnzyme%2520Protein%26date%3D1996%26volume%3D49%26spage%3D59%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Corcoran, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiner, D. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetler-Stevenson, W. G.</span><span> </span><span class="NLM_article-title">MMP-2: expression, activation and inhibition</span> <span class="citation_source-journal">Enzyme Protein</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1159%2F000468613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=8796994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADyaK28XjvVGjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=7-19&author=M.+L.+Corcoranauthor=R.+E.+Hewittauthor=D.+E.+Kleinerauthor=W.+G.+Stetler-Stevenson&title=MMP-2%3A+expression%2C+activation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-2: expression, activation and inhibition</span></div><div class="casAuthors">Corcoran, Marta L.; Hewitt, Robert E.; Kleiner, David E.; Stetler-Stevenson, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Enzyme & Protein</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">7-19</span>CODEN:
                <span class="NLM_cas:coden">EPROEA</span>;
        ISSN:<span class="NLM_cas:issn">1019-6773</span>.
    
            (<span class="NLM_cas:orgname">Karger</span>)
        </div><div class="casAbstract">A review with 79 refs.  Remodeling of the extracellular matrix (ECM), which occurs during many physiol. and pathol. processes, is one of the requisite events of cellular invasion.  The matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases that are responsible for proteolytic degrdn. of specific ECM components.  Regulating the activity of the MMPs at both mRNA and/or protein levels modulates the degrdn. of the ECM components which in turn alter cellular invasion.  Although most MMPs are regulated via similar mechanisms at the mRNA and protein levels, the modulation of gelatinase A is unique.  Understanding the mechanisms that regulate gelatinase A is important since expression and activation of this particular MMP is consistently correlated with a majority of malignant phenotypes.  In this report, the authors will contrast the mechanisms that regulate the expression, activation and inhibition of gelatinase A with the mechanisms that modulate the rest the MMP family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXXrF9bojru7Vg90H21EOLACvtfcHk0lg-ys5hQd6zYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVGjtLc%253D&md5=f12bf21fe14215bbed2979540eceedba</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1159%2F000468613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000468613%26sid%3Dliteratum%253Aachs%26aulast%3DCorcoran%26aufirst%3DM.%2BL.%26aulast%3DHewitt%26aufirst%3DR.%2BE.%26aulast%3DKleiner%26aufirst%3DD.%2BE.%26aulast%3DStetler-Stevenson%26aufirst%3DW.%2BG.%26atitle%3DMMP-2%253A%2520expression%252C%2520activation%2520and%2520inhibition%26jtitle%3DEnzyme%2520Protein%26date%3D1996%26volume%3D49%26spage%3D7%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Nishida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span> </span><span class="NLM_article-title">Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">9096</span><span class="NLM_x">–</span> <span class="NLM_lpage">9104</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-2522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1158%2F0008-5472.CAN-08-2522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=18974156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSkur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9096-9104&author=Y.+Nishidaauthor=H.+Miyamoriauthor=E.+W.+Thompsonauthor=T.+Takinoauthor=Y.+Endoauthor=H.+Sato&title=Activation+of+matrix+metalloproteinase-2+%28MMP-2%29+by+membrane+type+1+matrix+metalloproteinase+through+an+artificial+receptor+for+proMMP-2+generates+active+MMP-2&doi=10.1158%2F0008-5472.CAN-08-2522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Matrix Metalloproteinase-2 (MMP-2) by Membrane Type 1 Matrix Metalloproteinase through an Artificial Receptor for ProMMP-2 Generates Active MMP-2</span></div><div class="casAuthors">Nishida, Yuki; Miyamori, Hisashi; Thompson, Erik W.; Takino, Takahisa; Endo, Yoshio; Sato, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9096-9104</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The suggested model for pro-matrix metalloproteinase-2 (proMMP-2) activation by membrane type 1 MMP (MT1-MMP) implicates the complex between MT1-MMP and tissue inhibitor of MMP-2 (TIMP-2) as a receptor for proMMP-2.  To dissect this model and assess the pathol. significance of MMP-2 activation, an artificial receptor for proMMP-2 was created by replacing the signal sequence of TIMP-2 with cytoplasmic/transmembrane domain of type II transmembrane mosaic serine protease (MSP-T2).  Unlike TIMP-2, MSP-T2 served as a receptor for proMMP-2 without inhibiting MT1-MMP, and generated TIMP-2-free active MMP-2 even at a low level of MT1-MMP.  Thus, MSP-T2 did not affect direct cleavage of the substrate testican-1 by MT1-MMP, whereas TIMP-2 inhibited it even at the level that stimulates proMMP-2 processing.  Expression of MSP-T2 in HT1080 cells enhanced MMP-2 activation by endogenous MT1-MMP and caused intensive hydrolysis of collagen gel.  Expression of MSP-T2 in U87 glioma cells, which express a trace level of endogenous MT1-MMP, induced MMP-2 activation and enhanced cell-assocd. protease activity, activation of extracellular signal-regulated kinase, and metastatic ability into chick embryonic liver and lung.  MT1-MMP can exert both max. MMP-2 activation and direct cleavage of substrates with MSP-T2, which cannot be achieved with TIMP-2.  These results suggest that MMP-2 activation by MT1-MMP potentially amplifies protease activity, and combination with direct cleavage of substrate causes effective tissue degrdn. and enhances tumor invasion and metastasis, which highlights the complex role of TIMP-2.  MSP-T2 is a unique tool to analyze physiol. and pathol. roles of MMP-2 and MT1-MMP in comparison with TIMP-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6nTjTSAlkrLVg90H21EOLACvtfcHk0lg-ys5hQd6zYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSkur3F&md5=66043bb711e9d0e7bbed01a42689f461</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2522%26sid%3Dliteratum%253Aachs%26aulast%3DNishida%26aufirst%3DY.%26aulast%3DMiyamori%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DE.%2BW.%26aulast%3DTakino%26aufirst%3DT.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DH.%26atitle%3DActivation%2520of%2520matrix%2520metalloproteinase-2%2520%2528MMP-2%2529%2520by%2520membrane%2520type%25201%2520matrix%2520metalloproteinase%2520through%2520an%2520artificial%2520receptor%2520for%2520proMMP-2%2520generates%2520active%2520MMP-2%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D9096%26epage%3D9104%26doi%3D10.1158%2F0008-5472.CAN-08-2522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Chang, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D. N.</span><span> </span><span class="NLM_article-title">Epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and ERK1/2 pathway</span> <span class="citation_source-journal">Biomed. Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">141582</span><span class="refDoi"> DOI: 10.1155/2014/141582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1155%2F2014%2F141582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=25184134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FnvVCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=141582&author=C.+W.+Changauthor=Y.+H.+Hsiehauthor=W.+E.+Yangauthor=S.+F.+Yangauthor=Y.+Chenauthor=D.+N.+Hu&title=Epigallocatechingallate+inhibits+migration+of+human+uveal+melanoma+cells+via+downregulation+of+matrix+metalloproteinase-2+activity+and+ERK1%2F2+pathway&doi=10.1155%2F2014%2F141582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and ERK1/2 pathway</span></div><div class="casAuthors">Chang Chi-Wu; Hsieh Yi-Hsien; Yang Wei-En; Yang Shun-Fa; Chen Yueqin; Hu Dan-Ning</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141582</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The effects of epigallocatechingallate (EGCG) on the migration and expression of MMP-2 of uveal melanoma cells have not been reported.  We studied this effect and relevant signaling pathways in a human uveal melanoma cell line (M17).  MTT study found that EGCG did not affect the cell viability of M17 cells up to 100 μM.  Wound-healing assay showed that EGCG significantly reduced the migration of melanoma cells in a dose-dependent manner from 20 to 100 μM.  Gelatin zymography showed that secreted MMP-2 activity was dose-dependently inhibited by EGCG, whereas the MMP-2 expression at protein and mRNA levels was not affected as determined by western blot and RT-PCR analysis.  EGCG significantly increased the expressions of MMP-2 endogenous inhibitors (TIMP-2 and RECK) in M17 cells.  Western blot analysis of MAPK signal pathways showed that EGCG significantly decreased phosphorylated ERK1/2 levels, but not p38 and JNK levels, in melanoma cells.  ERK1/2 inhibitors also reduced the migration and activity of MMP-2 in M17 cells.  The present study suggested EGCG at nontoxic levels could inhibit migration of melanoma cells via downregulation of activities of secreted MMP-2 through the inhibition of the ERK1/2 phosphorylation.  Therefore, EGCG may be a promising agent to be explored for the prevention of metastasis of uveal melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPQjDyJ_luQrjnyZkbE8yXfW6udTcc2eYHBq7vWBzaNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FnvVCitg%253D%253D&md5=daadb8d33b4477800578094263592ce3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1155%2F2014%2F141582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F141582%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BW.%26aulast%3DHsieh%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DW.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DD.%2BN.%26atitle%3DEpigallocatechingallate%2520inhibits%2520migration%2520of%2520human%2520uveal%2520melanoma%2520cells%2520via%2520downregulation%2520of%2520matrix%2520metalloproteinase-2%2520activity%2520and%2520ERK1%252F2%2520pathway%26jtitle%3DBiomed.%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D141582%26doi%3D10.1155%2F2014%2F141582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kubben, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sier, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duijn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffioen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanemaaijer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Velde, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Krieken, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verspaget, H. W.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6603041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1038%2Fsj.bjc.6603041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=16538217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=1035-1040&author=F.+J.+Kubbenauthor=C.+F.+Sierauthor=W.+van+Duijnauthor=G.+Griffioenauthor=R.+Hanemaaijerauthor=C.+J.+van+de+Veldeauthor=J.+H.+van+Kriekenauthor=C.+B.+Lamersauthor=H.+W.+Verspaget&title=Matrix+metalloproteinase-2+is+a+consistent+prognostic+factor+in+gastric+cancer&doi=10.1038%2Fsj.bjc.6603041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer</span></div><div class="casAuthors">Kubben, F. J. G. M.; Sier, C. F. M.; van Duijn, W.; Griffioen, G.; Hanemaaijer, R.; van de Velde, C. J. H.; van Krieken, J. H. J. M.; Lamers, C. B. H. W.; Verspaget, H. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1035-1040</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In a pioneer study, we showed 10 years ago that enhanced tissue levels of the matrix metalloproteinases (MMPs) MMP-2 and MMP-9 in gastric cancers, as detd. by zymog., were related with worse overall survival of the patients.  To corroborate these observations, we now assessed MMP-2 and MMP-9 with new techniques in an expanded group of gastric cancer patients (n=81) and included for comparison MMP-7, MMP-8 and the tissue inhibitors of MMPs, TIMP-1 and -2.  All MMPs and TIMP-1 were significantly increased in tumor tissue compared to normal gastric mucosa.  Matrix metalloproteinase-7, -8 and -9, and the TIMPs showed some correlations with the clinicopathol. parameters TNM, WHO and Lauren classification, but their levels were not related with survival.  Regardless of the detn. method used, i.e., ELISA or bioactivity assay, an enhanced tumor MMP-2 level did not show a significant correlation with any of the clinicopathol. parameters, but was confirmed to be an independent prognostic factor in gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSS3LO-2iEirVg90H21EOLACvtfcHk0ljZt_-d4kkzfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7o%253D&md5=2031b65f44b50d3d00af0c259f67f301</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603041%26sid%3Dliteratum%253Aachs%26aulast%3DKubben%26aufirst%3DF.%2BJ.%26aulast%3DSier%26aufirst%3DC.%2BF.%26aulast%3Dvan%2BDuijn%26aufirst%3DW.%26aulast%3DGriffioen%26aufirst%3DG.%26aulast%3DHanemaaijer%26aufirst%3DR.%26aulast%3Dvan%2Bde%2BVelde%26aufirst%3DC.%2BJ.%26aulast%3Dvan%2BKrieken%26aufirst%3DJ.%2BH.%26aulast%3DLamers%26aufirst%3DC.%2BB.%26aulast%3DVerspaget%26aufirst%3DH.%2BW.%26atitle%3DMatrix%2520metalloproteinase-2%2520is%2520a%2520consistent%2520prognostic%2520factor%2520in%2520gastric%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D1035%26epage%3D1040%26doi%3D10.1038%2Fsj.bjc.6603041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Morita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahama-Noda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara-Nishimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, I.</span><span> </span><span class="NLM_article-title">Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1424</span><span class="refDoi"> DOI: 10.1016/j.febslet.2007.02.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=10.1016%2Fj.febslet.2007.02.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=17350006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVWnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=1417-1424&author=Y.+Moritaauthor=H.+Arakiauthor=T.+Sugimotoauthor=K.+Takeuchiauthor=T.+Yamaneauthor=T.+Maedaauthor=Y.+Yamamotoauthor=K.+Nishiauthor=M.+Asanoauthor=K.+Shirahama-Nodaauthor=M.+Nishimuraauthor=T.+Uzuauthor=I.+Hara-Nishimuraauthor=D.+Koyaauthor=A.+Kashiwagiauthor=I.+Ohkubo&title=Legumain%2Fasparaginyl+endopeptidase+controls+extracellular+matrix+remodeling+through+the+degradation+of+fibronectin+in+mouse+renal+proximal+tubular+cells&doi=10.1016%2Fj.febslet.2007.02.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells</span></div><div class="casAuthors">Morita, Yoshikata; Araki, Hisazumi; Sugimoto, Toshiro; Takeuchi, Keisuke; Yamane, Takuya; Maeda, Toshinaga; Yamamoto, Yoshio; Nishi, Katsuji; Asano, Masahide; Shirahama-Noda, Kanae; Nishimura, Mikio; Uzu, Takashi; Hara-Nishimura, Ikuko; Koya, Daisuke; Kashiwagi, Atsunori; Ohkubo, Iwao</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1417-1424</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Legumain/asparaginyl endopeptidase (EC 3.4.22.34) is a novel cysteine protease that is abundantly expressed in the late endosomes and lysosomes of renal proximal tubular cells.  Recently, emerging evidence has indicated that legumain might play an important role in control of extracellular matrix turnover in various pathol. conditions such as tumor growth/metastasis and progression of atherosclerosis.  We initially found that purified legumain can directly degrade fibronectin, one of the main components of the extracellular matrix, in vitro.  Therefore, we examd. the effect of legumain on fibronectin degrdn. in cultured mouse renal proximal tubular cells.  Fibronectin processing can be inhibited by chloroquine, an inhibitor of lysosomal degrdn., and can be enhanced by the overexpression of legumain, indicating that fibronectin degrdn. occurs in the presence of legumain in lysosomes from renal proximal tubular cells.  Furthermore, in legumain-deficient mice, unilateral ureteral obstruction (UUO)-induced renal interstitial protein accumulation of fibronectin and renal interstitial fibrosis were markedly enhanced.  These findings indicate that legumain might have an important role in extracellular matrix remodeling via the degrdn. of fibronectin in renal proximal tubular cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3Nj7LQTaaLVg90H21EOLACvtfcHk0ljZt_-d4kkzfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVWnsLs%253D&md5=d6fda469791a3ab8971c20e1046f2201</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2007.02.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2007.02.064%26sid%3Dliteratum%253Aachs%26aulast%3DMorita%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DH.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DYamane%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DNishi%26aufirst%3DK.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DShirahama-Noda%26aufirst%3DK.%26aulast%3DNishimura%26aufirst%3DM.%26aulast%3DUzu%26aufirst%3DT.%26aulast%3DHara-Nishimura%26aufirst%3DI.%26aulast%3DKoya%26aufirst%3DD.%26aulast%3DKashiwagi%26aufirst%3DA.%26aulast%3DOhkubo%26aufirst%3DI.%26atitle%3DLegumain%252Fasparaginyl%2520endopeptidase%2520controls%2520extracellular%2520matrix%2520remodeling%2520through%2520the%2520degradation%2520of%2520fibronectin%2520in%2520mouse%2520renal%2520proximal%2520tubular%2520cells%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D1417%26epage%3D1424%26doi%3D10.1016%2Fj.febslet.2007.02.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00228">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57225"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00228">10.1021/acs.jmedchem.7b00228</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Complete blood count (CBC) of vehicle and compound <b>38u</b> treated nude mice; substrate reversibility of compound <b>38</b> toward AEP; DTT and <span class="smallcaps smallerCapital">l</span>-cysteine reversiblitiy of compound <b>38</b> toward AEP (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00228/suppl_file/jm7b00228_si_001.pdf">PDF</a>)</p></li><li><p class="inline">(Molecular formula strings<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00228/suppl_file/jm7b00228_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00228/suppl_file/jm7b00228_si_001.pdf">jm7b00228_si_001.pdf (84.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00228/suppl_file/jm7b00228_si_002.csv">jm7b00228_si_002.csv (1.75 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00228&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00228" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00228" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999c95e9dfd1a3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
